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1General Introduction
1.  Background
Bone is a dynamic and vascularized tissue responsible for providing structural 
support to the body and protection of the internal organs. In addition, it plays a 
key role in supporting muscle contraction, blood production and the storage of 
mineral components. Clinically, the occurrence of bone defects is common and 
can be caused by a variety of reasons, including congenital deformity, trauma/
injury, infection and tumorectomy. Although bone possesses a remarkable ability 
to heal and remodel, in many clinical cases the regeneration of bone defects 
exceeds its self‐healing potential. It has been reported that bone is the second 
most transplanted tissue after blood with over 2.2 million bone grafting procedure 
being performed annually worldwide [1]. In addition, the treatment for fractures 
and other musculoskeletal injuries will continue to boost as a result of increasing 
life expectancy and dynamism in daily activities.
Current clinical treatments for bone defects involve the transplantation of autograft 
(from the patient) or allograft (from the donor), which can be harvested from the 
iliac crest, fibula, scapula or radius [2]. So far, this approach has been established 
as the “gold standard” for bone reconstructive surgery. However, the inherent 
drawbacks of this approach, such as limited source of available tissue, donor‐site 
morbidity, risk of rejection or disease transmission (when using allograft), and 
relevant surgical complications, hinder its applications in the clinical practice, 
especially for the treatment of large bone defects [3, 4].  This has strongly urged the 
clinicians and researches to explore alternative treatment options.
2. Bone tissue engineering 
Since the concept of tissue engineering has been introduced by Langer and 
Vacanti [5], it has emerged as a promising approach for regenerating bone tissue. 
The essential rationale behind this is to utilize the body’s own capacity for bone 
healing in conjunction with engineering principles. Three important elements 
are involved in bone tissue engineering, i.e. scaffolds, cells and biomolecules. A 
conventional tissue engineering strategy starts with loading progenitor cells onto 
proper designed biomaterials to induce cell differentiation in a specific pathway, 
followed by transplantation of this cell‐scaffold complex into the defect site to 
regenerate bone tissue. In this procedure, cells are the main source to form the 
new bone tissue, among which the progenitor/stem cells isolated from bone 
marrow have been recognized as the most efficient cell source [6]. 
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3. Intramembranous and endochondral approach for bone 
tissue engineering
During osteogenesis, bone is essentially formed through two different mechanisms: 
intramembranous ossification and endochondral ossification. Accordingly, this 
has inspired researchers to implement bone tissue engineering through two 
specific pathways of cell differentiation. In the first approach, bone is directly from 
osteoprogenitor cells in a manner akin to intramembranous ossification [7]. This 
method is the most commonly used strategy in bone tissue engineering for years, 
a standard procedure of which involves the differentiation of osteoprogenitor 
cells into osteoblasts. The second approach resembles endochondral ossification, 
whereby a cartilage intermediate is created and used as an osteoinductive 
template to transform into bone in vivo [8]. Such endochondral approach has been 
recently proposed and shows superiority to generate vascularized bone tissue, as 
cartilage is hypoxia tolerant and chondrocytes can secrete angiogenic factors to 
promote vascular invasion into the engineered constructs [9, 10].
4. Scaffolds for bone tissue engineering
Besides the cells, the choice of biomaterial as scaffold is also critical to the success 
of tissue engineering. It provides a three‐dimensional environment for the cells 
and plays an imperative role in regulating the cellular behaviors, i.e. proliferation 
and differentiation [11]. The shape and architecture of the scaffold define the 
ultimate structure of newly formed tissue [12].
Since the introduction of the tissue engineering concept, a variety of biomaterials 
of natural derivation or synthetic origin has been suggested as potential scaffold 
candidates. Among them, ceramic‐based materials, such as hydroxyapatite (HA) 
and calcium phosphate (CaP), and polymer‐based materials, such as collagen, 
polycaprolactone (PCL), polyurethanes (PUs), polyglycolide (PGA), polylactide 
(PLA) and their copolymers, are currently the most widely used. Along with 
research on biomaterials, techniques to manufacture scaffolds have also been 
intensively studied, such as gas foaming and electrospinning.
In general, scaffolds for application in bone tissue engineering have to meet the 
following requirements, 1) provide a biologically compatible and porous framework 
to facilitate nutrients supply and waste removal, and 2) possess sufficient 
mechanical strength to function from the time of cell seeding up to the point when 
the host tissue begins to remodel the seeded construct after implantation [11]. 
More importantly, the cellular growth and osteogenic capacity of the seeded cells 
should be supported/promoted by the scaffolds to form the ultimate bone tissue. 
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When the endochondral approach is applied, the scaffolds should also be able to 
support cells in differentiating into the chondrogenic lineage, as the creation of an 
in vitro cartilage template is necessary.
5. Objectives of this thesis
With the potential to overcome the drawbacks of the current autografts and 
allografts, bone tissue engineering undoubtedly has been suggested as a promising 
technique for reconstructing bone defects. However, until recently, the clinical 
translation of this strategy is still unsatisfactory. Lack of timely and sufficient 
vascular supply, resulting in immediate cell death after implantation, is generally 
thought to be the cause of failure of the cell‐scaffold constructs in patients [4]. To 
overcome this issue, a potential strategy is to differentiate cells in a metabolically 
less‐demanding and angiogenic pathway, i.e. along the endochondral ossification 
pathway, as this seems to hold promise for achieving better cell survival and 
vascularization of the implanted constructs in vivo. Nevertheless, compared to 
the available knowledge on bone regeneration via the intramembranous pathway, 
such an endochondral approach is still in its infancy. Therefore, the overall 
objective of thesis was to contribute to a better understanding of endochondral 
bone tissue engineering. In particular, the studies focused on 1) exploiting new 
porous scaffolds for bone regeneration applications, 2) establishing a cell‐scaffold 
model for studying endochondral bone formation, 3) testing the applicability 
of endochondral approach with different scaffold materials, 4) investigating 
the optimal in vitro priming time for the creation of cartilage templates, and 5) 
exploring the underlying mechanism of the transformation from cartilage into 
bone. 
More specifically, the following research questions were addressed:
1. What is the current state of the art of combining stem cells and biodegradable 
materials for bone regeneration via the endochondral pathway? (Chapter 2)
2. Is the porous aliphatic polyurethane/hydroxyapatite composite a suitable 
scaffold for bone tissue engineering applications? (Chapter 3)
3. Is it possible to fabricate a 3D scaffold by electrospinning technique and utilize 
it as cell carrier to enable effective in vivo endochondral bone generation? 
(Chapter 4)
4. Can in vivo endochondral bone generation be achieved in various scaffold 
materials and how is this process influenced by the scaffold properties? 
(Chapter 5 and Chapter 6)
5. What is the effect of in vitro chondrogenic priming time of MSCs on in vivo 
endochondral bone formation? (Chapter 6)
18
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6. What is the role of cartilage templates in mediating MSC behavior in the process 
of endochondral bone formation? (Chapter 7)
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1. Introduction
Musculoskeletal malconditions (e.g. arthritis, back pain, spinal disorders, 
osteoporosis, bone fractures, trauma, and congenital problems) affect hundreds of 
millions of people across the world. According to ‘The Burden of Musculoskeletal 
Diseases in the United States’ (BMUS), over 130 million patient visits to healthcare 
providers occur annually, and the economic impact of these conditions is 
staggering: in 2004, the annual costs for bone and joint health has been estimated 
to be $849 billion dollars, and the burden of musculoskeletal conditions is expected 
to escalate in the next 10‐20 years as the population ages and lifestyles become 
more active (http://www.boneandjointburden.org).
The most favorable choice for treatment of bone defects is the graft of the patient’s 
own healthy bone (so‐called autograft) harvested from a donor site, usually iliac 
crest; or, alternatively, from a cadaveric bone typically sourced from a bone bank 
(allograft). In addition to the respective benefits of these approaches, several 
drawbacks limit their clinical applications. Autografts reduce the risk of rejection 
but require an additional surgical site, thus increasing post‐operative pain and 
complications for the patient. Allograft eliminates the risk of donor site morbidity 
and is hence associated with less pain and discomfort for the recipient; however, 
rejection or disease transmission cannot be ruled out.
In view of these drawbacks associated with autografts and allografts, the 
multidisciplinary field of regenerative medicine (RM) holds the promise of creating 
appealing new possibilities regarding the quality and duration of life. Currently, 
RM‐based treatment strategies for critical‐size bone defects (i.e. defects that will 
not heal spontaneously) propose the design of biomaterials either alone or in 
combination with stem cells and signaling molecules, which resemble the three 
dimensional in vivo tissue arrangements and promote restoration of normal tissue 
functions following grafting in the body [1]. To that end, a deep knowledge of bone 
biology will lead to better understanding of the mechanisms of interaction between 
cells and scaffolds, including cell adhesion, proliferation, and differentiation, 
which are all important steps for the success of a man‐made bone graft. Up to 
now, thousands of scaffolds with variable properties and chemical composition, 
including ceramics, natural and synthetic polymers, as well as cell culture 
strategies have been proposed. Nevertheless, as for most of these approaches, 
the developmental stage is in its infancy and the challenge is to obtain proof of 
clinical efficacy in order to proceed towards routine clinical implementation.
The present chapter will firstly describe bone tissue and its developmental 
mechanisms, in order to reach fundamental understanding of the processes 
involved in RM‐based approaches for bone regeneration utilizing biomaterials 
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and cell culture strategies. Subsequently, current results in basic research on 
biomaterials for bone repair, with emphasis on the endochondral ossification 
approach, will be discussed.
2. Bone tissue
Bone is a dynamic and vascularized tissue with a remarkable ability to heal and 
remodel, and it is responsible for providing structural support to the body and 
protection of the internal organs. In addition, bone plays a key role in supporting 
muscle contraction, blood production and the storage of mineral components [2].
Bone is not a uniformly solid structure, but is rather composed of two distinct 
parts, namely compact and trabecular bone. Compact bone (also called cortical 
bone) forms the hard outer component of the bones, whereas trabecular bone 
(also called cancellous bone) fills the inner side. Compact bone contributes 
approximately 80% of the weight of a human skeleton with a very dense and stiff 
structure and is usually located in the shaft of the long bones and in the peripheral 
layer of flat bones. In contrast, trabecular bone has a lower density, larger surface 
area, and is composed of a highly porous network that creates space for bone 
marrow and blood vessels.
From a material perspective, bone is composed of an inorganic and organic 
component. The inorganic matrix represents ~70% of bone mass and is mainly 
composed of hydroxyapatite, which provides stiffness and strength. The organic 
matrix, which represents ~30% of bone mass, provides flexibility and tensile 
strength, and is composed of proteins and cells. Collagen type I is the main 
component of the organic matrix; whereas other proteins, such as osteocalcin, 
bone sialoprotein and osteonectin, play important signaling functions and are 
involved in mineralization process.
The three types of cells that populate bone tissue are osteoblasts, osteocytes and 
osteoclasts. Osteoblasts are bone‐forming cells that originate from osteoprogenitor 
cells located in the deeper layer of periosteum and bone marrow, which produce 
an osteoid matrix that successively mineralizes into bone. Although the term 
osteoblast implies an immature cell type, osteoblasts are the mature cells of bone 
that generate bone tissue. At a later stage, osteoblasts can either become bone 
lining cells or differentiate into osteocytes. Bone lining cells are inactive osteoblasts 
that reside along the quiescent bone surface forming a protective layer. Although 
their function is not well understood, they may play a role in the activation of bone 
remodeling [3]. Osteocytes are embedded within bone matrix in so‐called bone 
lacunae. These mature bone cells are involved in different functions, including 
matrix maintenance, calcium homeostasis and regulation of bone response to 
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mechanical stimuli. Osteoclasts are responsible for bone resorption by (locally) 
decreasing the pH and activating lytic enzymes, which in turn break down the 
mineralized matrix.
2.1 Osteogenesis
During osteogenesis, two different processes can result in the formation of 
normal, healthy bone tissue, i.e. intramembranous ossification and endochondral 
ossification (Figure 1).
Intramembranous ossification
Intramembranous ossification occurs in a vascularized environment and involves 
the direct differentiation of mesenchymal stem cells (MSCs) into osteoblasts. 
Initially, MSCs are widely dispersed within an extracellular matrix that is devoid 
of collagen. Groups of adjacent MSCs proliferate and form a dense nodule of cell 
aggregation, which undergoes morphological changes toward the osteoblastic 
phenotype. Subsequently, cells start to produce new organic matrix (i.e. osteoid), 
mainly consisting of type I collagen fibrils, and eventually develop into mature 
osteoblasts. Some osteoblasts align along the periphery of the nodule and keep 
forming osteoid, whereas others are incorporated into the nodule and become 
osteocytes. At this point, the osteoid becomes mineralized and forms the 
rudimentary bone tissue.
Endochondral ossification
Endochondral ossification is the type of osteogenesis that accounts for the 
development of most bones of the vertebrate skeleton (e.g. long bones) and is 
the most commonly occurring process in fracture healing. As such, endochondral 
ossification takes place in a poorly or non‐vascularized environment, in which 
loosely connected MSCs condense at the sites pre‐determined for bone 
formation. The increased cell‐cell contacts and low oxygen condition (i.e. hypoxia) 
trigger the differentiation of MSCs into the chondrogenic lineage. The cartilage 
template takes shape through the deposition of abundant cartilaginous matrix, 
and the chondrocytes gradually differentiate until reaching a hypertrophic stage, 
during which the chondrocytes mineralize and eventually become apoptotic. 
Simultaneously, these chondrogenic cells release vascular endothelial growth 
factor (VEGF), which induces blood vessel formation [4]. At this point, osteoclasts 
and osteoblasts, which receive nutrition and oxygen supply from the blood vessels, 
reach the mineralized matrix and promote the transformation of the cartilage into 
bone.
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3. Basic tools for RM purposes - stem cells and biomaterial 
scaffolds
3.1 Stem cells
Stem cells are undifferentiated cells with a high proliferation capability, which 
have the capacity of self‐renewal or differentiate into specialized cell types of our 
body [5]. The central focus of RM are human stem cells, for which two main types 
of stem cells exist based on their origin: embryonic stem cells (ESCs) and adult 
stem cells. ESCs are derived from the inner cell mass of the blastocyst (i.e. an 
early‐stage embryo) and are able to differentiate into all cell types of the adult 
organism. The multi‐differentiation potential of ESCs has been reported by several 
researchers [6, 7], and has attracted wide interest for many medical applications, 
including regeneration of bone tissue. Indeed, ESCs have demonstrated the 
capacity to differentiate into osteoblasts when cultured in the presence of 
osteogenic differentiation‐inducing factors, such as dexamethasone [8]. However, 
many issues regarding the clinical use of ESCs need to be addressed, including 
the risk of tumorogenesis, the labor‐intensive procedures, and important ethical 
Figure 1. Schematic representation of the two types of osteogenesis. 1) 
Intramenbranous ossification involves bone formation through the direct osteoblastic 
differentiation; 2) endochondral ossification generates bone via transition from an 
avascular hypertrophic cartilage to a vascularized and mineralized matrix.
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considerations [9]. Adult stem cells, also called somatic stem cells, are present in 
the body at many sites and are responsible for growth and maintenance of normal 
tissues, as well as restoration of injured tissues. Initially, adult stem cells were 
discovered in the bone marrow and, successively, in many other different tissues, 
including heart, liver, pancreas, brain, epidermis, dental pulp and spinal cord. In 
the last 30 years, substantial efforts have been devoted to studies of adult stem 
cells for a broad range of applications for tissue regeneration. Among the different 
sources for adult stem cells, mesenchymal stem cells (MSCs) are of great interests 
in RM applications. MSCs have been initially identified in bone marrow as non‐
hematopoietic stem cells that can differentiate into tissues of mesodermal origin, 
such as adipocytes, osteoblasts, chondrocytes, tenocytes, skeletal myocytes and 
visceral stromal cells [10]. Friedenstein and co‐workers were the first to reveal the 
bone‐forming capacity of MSCs [11].
3.2 Biomaterial scaffolds
As anticipated earlier in the introduction, a promising strategy to optimize 
and simplify the treatment of muscoloskeletal disorders is represented by 
bone grafts from man‐made source. Several decades of progress in techniques 
and understanding of the mechanisms involved in the interaction between 
synthetic materials and living surrounding tissues resulted in the establishment 
of ‘biomaterials’ as a scientific discipline, and a rapid progression in the design 
of increasingly sophisticated materials that provide a template for tissue 
regeneration. As a result of this evolution, the definition of “biomaterial” has 
constantly changed over the years. Currently, the most appropriate and used 
definition depicts biomaterial as “a substance that has been engineered to take a 
form which, alone or as part of a complex system, is used to direct, by control of 
interactions with components of living systems, the course of any therapeutic or 
diagnostic procedure, in human or veterinary medicine” [12].
The history of biomaterials for bone repair is marked by three generations, namely, 
from tolerant and bioinert (the first generation), to bioactive and osteoconductive 
(the second generation), and to osteoinductive biomaterials (the third generation) 
that induce neighboring tissue to become bone [13]. Primordial biomaterials were 
meant to be tolerated by the body and to passively replace missing or damaged 
tissue. The difficult adaptation of the human body to these foreign materials 
raised the need to create improved artificial substitutes. These scaffolds reproduce 
the complex three dimensional environment to which cells are exposed to and 
actively participate in the dialog with the natural environment (i.e. bioactive). To 
this end, bone healing requires scaffolds that provide a porous and biologically 
compatible framework onto which (precursors of) bone‐forming cells migrate 
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(i.e. osteoconduction) and form new bone tissue, or even direct differentiation of 
stem cells into mature osteogenic cells (i.e. osteoinduction) [14]. Last, but not least, 
biomaterials should degrade over time in concert with the growth of new bone, 
and the degradation products should be non‐toxic and completely eliminated from 
the body. Table 1 lists the most important properties and respective definitions for 
appropriate bone graft materials.
Table 1. Properties and definitions for a bone graft material
Properties Definitions
Biocompatibility
Behavior of a biomaterial and its byproducts to elicit little or no immune 
response into the body
Bioactivity
Ability of a biomaterial to interact with the natural environment of the 
body and determine a biological effect
Osteointegration
The full process of obtaining firm anchoring and incorporation of a 
biomaterial into living bone without fibrous tissue formation at the 
interface
Osteoconductivity
The ability of a biomaterial to stimulate the migration of adjacent bone‐
forming cells in order to induce the growth of  bone tissue
Osteoinductivity
The ability of a biomaterial to stimulate the migration of undifferentiated 
cells and induce their differentiation into active osteoblasts, in order to 
promote de novo bone formation
Biodegradability
The ability of a biomaterial to degrade in concert with the natural bone 
remodeling process
3.2.1 Ceramic-based materials
In the past three decades, ceramics, such as hydroxyapatite (HA), tricalcium 
phosphate (TCP) and bioglass, were the main scaffolds studied for bone 
regeneration, being similar in their chemical composition and crystallographic 
structure to the mineral component of bone tissue. These characteristics govern 
the bioactive and osteoconductive behavior, which in turn favor the formation of 
new bone; although the brittleness and weak mechanical properties represent the 
major drawbacks that still require optimization [15].
3.2.2 Polymer-based materials
An alternative approach in RM is to engineer new bone tissues by using selective 
cell transplantation on polymer scaffolds [16]. Some of the most commonly explored 
polymers as scaffold materials include poly(lactic acid) (PLA), poly(lactic‐co‐glycolic 
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acid) (PLGA), poly(2‐hydroxyethyl methacrylate) (pHEMA), poly(ε‐caprolactone) 
(PCL), poly(ethylene glycol) (PEG), polyglycolic acid (PGA), polyurethanes and 
composites [17]. Polymers exhibit biocompatibility, degradability and have good 
processability. These properties confer to polymers a great potential to serve 
as artificial ECM, thus mimicking and recreating in some extent the structural 
organization of bone. 
4. Cell culture strategies for bone tissue regeneration
Initial in vitro culture set‐up, including selection of cell types (mono‐ or co‐
culture), growth factors, medium composition and timing are pivotal to determine 
the possible benefits of well‐timed implantation [4]. Figure 2 depicts all the steps 
required for the synthesis of a cell‐scaffold construct for bone tissue regeneration, 
which include (1) cell isolation and expansion in complete medium, (2) cell seeding 
and cell maturation (via intramembranous or endochondral ossification), either 
prior to or after loading into 3D scaffolds, and (3) in vivo grafting.
4.1 Isolation and expansion
As described above, natural bone regeneration is a complex process, during which 
multiple cell types, dispersed in a three dimensional environment, are spatially 
and temporally regulated by several environmental stimuli. In order to re‐create 
the natural situation, millions of cells are necessary for incorporation into an 
artificial matrix. From a clinical point of view, it is possible to isolate osteoblasts 
from biopsies taken from the patients, however, this procedure is time consuming 
and allows to obtain only a limited number of cells. Therefore, stem cells represent 
a favorable alternative. Stem cells, derived from bone marrow or other tissues, are 
usually expanded with complete medium in culture plates or flasks, where they 
adhere, start proliferating and form colony‐forming cell clusters. Before these cells 
become completely confluent, they are passaged and expanded in multiple flasks, 
thus becoming a more and more homogenous adherent cell population that may 
proliferate without differentiating up to several generations [18].
4.2 Seeding and differentiation
Intramembranous ossification pathway 
Except for a few reports, regenerative medicine efforts in the field of bone tissue 
repair have focused on generating bone directly from osteoprogenitor cells in a 
manner akin to intramembranous ossification in vivo. The standard procedure of 
this strategy involves stem cell differentiation into osteoblasts. To that end, MSCs 
are exposed to specific culture supplements, such as dexamethasone, ascorbic 
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acid, and beta glycerolphosphate [19]. Cells can either be differentiated in flasks 
(2D‐environment) and loaded into scaffolds just prior to grafting in vivo, or be 
loaded into scaffolds when they are still uncommitted and undergo maturation 
in a 3D‐environment. Although the second approach is more appealing, as it 
resembles the in vivo situation, its success has not been satisfactory to date. A 
major issue with this approach is the limited long‐term cell survival and necrosis, 
arising from lack of nutrient delivery to and waste removal from the center of 
tissue‐engineered constructs, and lack of blood supply [20]. First, blood vessels 
formation is not an instantaneous process and usually occurs too slowly for cells 
to survive without nutrients. Second, culturing a cell‐laden scaffold in vitro for 
several weeks can lead to the formation of an extensive extracellular matrix, which 
can prevent or seriously hamper blood vessel infiltration in vivo by sealing the 
pores of a scaffold [21].
Endochondral ossification pathway
Because chondrocytes can survive in a hypoxic environment and they produce 
anabolic and catabolic factors important for the conversion of avascular tissue 
into vascularized tissue, it seems straightforward to exploit the chondrocyte‐
mediated route (i.e. endochondral) for ossification in RM‐based approaches, 
rather than intramembranous ossification [4]. Either human ESCs and MSCs are 
able to form bone via the endochondral pathway, i.e. differentiate to chondrocytes 
in vitro and turn into bone when implanted in vivo [20, 22]. Chondrogenic priming 
of mesenchymal stem cells can be obtained by culturing cells in differentiation 
medium containing a mixture of specific supplements, such as dexamethasone, 
ascorbic acid, insulin, transferrin, selenious acid, sodium pyruvate, transforming 
growth factor‐beta (TGF‐β), and a phosphate donor [23]. Three‐dimensional 
conformation of the cells in aggregates with high cell density and cell‐cell 
interaction play an important role in the mechanism of cartilage formation. The 
main idea would be to induce the secretion of the angiogenic factors from the 
hypertrophic chondrocytes or in vitro pre‐vascularization of the templates in order 
to facilitate blood vessel formation when implanted in vivo. However, no in vitro 
system is known to support vascularization necessary for the formation of bone 
following the endochondral ossification pathway. Different culture systems can 
offer a solution for the development of in vitro tissue engineering approaches 
for the creation of vascularized bone in vivo. Among these strategies, the use of 
bioreactors [24] and an environment with low oxygen tension have demonstrated to 
support growth and differentiation of cartilage that forms bone [25]. 
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Figure 2. Illustration of all the fundamental steps required for the synthesis and 
application of a cell-material system for bone tissue regeneration. (1) cell isolation 
and expansion, (2) cell seeding and differentiation, and (3) in vivo grafting.
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4.3 In vivo grafting
Osteo‐ or chondroprogenitor cells, previously differentiated from stem cells under 
prolonged conventional culture conditions, are implanted in vivo in conjunction 
with natural or synthetic scaffolds. Osteoprogenitor cells differentiate directly into 
osteoblasts that will deposit new bone matrix, while chondrogenic‐committed 
cells fulfill hypertrophy and further deposit cartilaginous extracellular matrix that 
becomes calcified, and eventually undergo apoptosis. Meanwhile, blood vessels 
and osteoblasts differentiated from the surrounding stem/progenitor cells, invade 
the hypertrophic cartilage and give rise to bone [26].
5. Preliminary investigations on cell-biomaterial constructs for 
endochondral bone formation
Regarding endochondral ossification, it is a very unique transition process, 
which includes two distinguished stages: chondrogenesis and osteogenesis. 
Cartilage matrix consists of highly hydrated proteoglycan embedded into a type 
II collagen network. On the other hand, bone tissue is more rigid than cartilage 
and impregnated mainly with hydroxyapatite (HA) and type I collagen. Regarding 
the endochondral bone tissue engineering, the scaffolds should be able to 
support cells to form transient cartilage‐like tissue in vitro and also promote the 
calcification of such cartilage template into bone after in vivo implantation. The 
following sections describe the cell‐scaffold systems that have been explored so 
far for the generation of bone tissue via endochondral ossification approach.
5.1 Calcium phosphate (CaP) ceramics
Before being used as scaffold materials, CaP ceramics have been widely applied as 
bone substitutes and implant coatings because of their resemblance to the mineral 
composition of the natural bone. Commercially available CaP‐based biomaterials 
include HA, β‐tricalcium phosphate (β‐TCP), and biphasic CaP (BCP, containing 
HA and β‐TCP). The CaP ceramics are generally considered to be bioactive and 
osteoconductive, which posses the ability to guide formation of the new bone tissue 
tightly along their surfaces. This has made them the superior scaffold candidates 
for bone tissue engineering. However, the development of three‐dimensional in 
vitro models of bone using bioceramics remains an important challenge that is 
still to be overcome. CaP ceramics are reactive and their reactivity depends on 
their characteristics (such as composition, dissolution, sintering temperature, 
microstructure). When ceramics are cultured in vitro, calcium and phosphates are 
released in the medium and, as a result, can hamper cellular function [27]. Since 
testing the in vitro cellular activity is a pertinent step, and scaffolds and cells are in 
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contact for a certain period in vitro before being implanted, a number of studies 
have been focusing on solving the difficulties of removal of excessive ions, as well 
as oxygen and nutrients supply to cells within ceramic scaffolds [28]. One solution 
is using bioreactors to convey the medium directly throughout the interconnected 
pores to continuously introduce nutrients and remove wastes, so that the cell 
viability and activities can be favored in long‐term culture within 3D ceramic 
scaffolds  [29]. 
Teixeira et al. reported that a BCP scaffold, consisting of 60% HA and 40% β‐TCP, 
had the potential to support the chondrocytes isolated from chick embryonic 
tibia to form bone via the endochondral route [15]. Tortelli et al. compared the 
biological responses between murine MSCs and mature osteoblasts, when seeded 
in HA scaffolds and subsequently implanted in immunocompromised mice. The 
results showed that new vascularized bone was formed through the activation of 
an endochondral ossification process in the MSCs‐scaffolds complex. Conversely, 
osteoblasts directly formed bone via an intramembranous ossification, without 
however any signs of vascularization [30]. In another study, mouse embryonic stem 
cells (ESCs) seeded onto ceramic scaffolds and cultured in osteogenic medium, 
failed to form bone tissue upon implantation in subcutaneous pockets of nude 
mice. Differently, when ESCs‐ceramic constructs were cultured in chondrogenic 
differentiation medium, they showed cartilage maturation toward the hypertrophic 
stage, calcification and ultimately bone formation in vivo [22]. All together, these 
studies indicated that the origin of bone cells and the ossification type are closely 
related to the nature and commitment of the seeded cells.
5.2 Hydrogels
Hydrogels are networks of hydrophilic, crosslinked polymer chains with a distinctive 
quality to absorb water in aqueous fluids, and hence to exhibit mechanical and 
visco‐elastic properties that closely resemble the structural three dimensional 
environment of natural extracellular matrix (ECM). These attributes make 
hydrogels appealing substrates for cells to adhere, proliferate, secrete new ECM 
and eventually restore the damage tissue [31]. Most importantly, from a clinical 
perspective, hydrogels are available ready‐to‐use grafts, can be injected into the 
wound site using minimally invasive techniques and allow complete filling of 
irregularly shaped defects, thus avoiding an open surgery procedure. In combination 
with stem cells, these scaffolds have been evaluated for their suitability as potential 
replacements for bone and cartilage. Hydrogels can be broadly classified into 
natural and synthetic, based on their origin [32]. Natural hydrogels (e.g. agarose, 
alginate, chitosan, collagen/gelatin, fibrin, hyaluronan, and silk), exhibit excellent 
bioactivity, as they mimic the native extracellular environment structurally, have 
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unique mechanical properties and are biodegradable by enzymatic or hydrolytic 
mechanisms. Synthetic hydrogels can be formed by crosslinking of polymer chains 
through physical (temperature, UV light or pH) or chemical reactions under 
controlled conditions. Representative synthetically derived polymers explored in 
combination with stem cells for bone regeneration purposes include poly(ethylene 
glycol) (PEG), poly(vinyl alcohol) (PVA), oligo(poly(ethylene glycol) fumarate) (OPF) 
hydrogels, and poly(ethylene glycol)‐diacrylate (PEG‐DA) hydrogels [33‐35].
In regenerative medicine and tissue engineering of bone, the vast majority of 
studies have been focused on the formation of new bone directly from stem cells 
or mature osteogenic cells encapsulated within hydrogel matrices. However, more 
recently, stimulation of cells toward the endochondral ossification using cell‐laden 
hydrogel systems has shown to be not only appealing for the understanding of 
the regulatory mechanisms of cartilage and bone formation, but also a potential 
approach for bone repair.
5.2.1 Alginate
Alginate is a linear heteropolysaccharides composed of D‐mannuronic acid and 
L‐guluronic acid, and are derived primarily from brown algae. Due to the presence 
of the carboxyl groups along the polymer chain, alginates can form gels in the 
presence of divalent ions such as calcium ions [36]. Due to easy preparation under 
gentle conditions, low toxicity and readily availability, alginate hydrogels have 
been extensively investigated as matrices for encapsulating cells and delivering 
drugs. Alginate hydrogels have been shown to be suitable matrices for generation 
of bone tissue via endochondral ossification when associated with committed 
stem cells and appropriate combinations of regulatory signals (e.g. BMP‐2, VEGF, 
TGF‐β3) [37]. Chang et al. followed the progression of osteogenically induced MSCs 
along the endochondral pathway [38]. At 2 weeks after subcutaneous implantation, 
cell‐alginate constructs presented islands of cartilage formation and cells had 
the typical round morphology of the chondrocyte phenotype. By 6 weeks, 
endochondral ossification with trabecular bone deposition started to appear, 
whereas osteoblasts and osteocytes were seen in the new bone at week 8 and at 
week 12, respectively. Simultaneously, increasing calcification was detected over 
time. Similarly, in another study, hMSC were suspended in alginate beads with a 
chondrogenesis‐induction medium containing transforming growth factor TGF‐β3. 
During the first stage of culture, specific chondrogenic markers, such as collagen 
type II, type X and proteoglycan, were detectable, and their expression decreased 
over time in concert with the increase of osteogenic markers, such as osteocalcin 
[39].
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5.2.2 Chitosan
Chitosan is a linear polymer of (1‐4) β‐linked d‐glucosamine residues with N‐acetyl 
glucosamine groups derived from chitin, a naturally occurring polysaccharide which 
forms the outer shell of crustaceans, insect exoskeletons, and fungal cell walls. 
Chitosan is completely soluble in aqueous solutions with pH lower than 5.0 and it 
undergoes biodegradation in vivo enzymatically by lysozyme to nontoxic products 
[40]. Biocompatibility, biodegradability and structural similarity to natural GAGs 
make crosslinked chitosans hydrogels attractive materials for tissue engineering 
applications. Moreover, the feasibility of forming porous scaffolds showed to 
promote osteoblastic differentiation in vitro and might support angiogenesis and 
osteogenesis in vivo [41]. Oliveira et al. fabricated the chitosan sponges via freeze‐
drying chitosan acidic solutions and further demonstrated that these chitosan 
sponges with adequate pore structure and mechanical properties could serve as 
a support for hypertrophic chondrocytes to induce endochondral ossification [42]. 
5.2.3 Collagen
Collagen represents the most abundant protein in the human body, being the 
major component of bone, skin, ligament, cartilage, and tendon. It also forms 
the structural framework for other tissues such as blood vessels. There are 
at least 19 different types of collagen, but the basic unit of all is a polypeptide 
consisting of a three‐amino‐acid sequence (glycine, proline, and hydroxyproline) 
forming polypeptide chains, which wrap around one another to form the left‐
handed triple helix structure [43]. Due to its excellent biocompatibility, enzymatic 
degradability and resemblance to the organic composition of natural bone, 
collagen‐based matrices find wide application in tissue engineering and have 
been extensively investigated in combination with cells and growth factors [44]. 
Abrahamsson et al. seeded human MSCs suspended collagen gel on a non‐woven 
PCL scaffold. Cultured in chondrogenic condition, cartilaginous tissue was formed 
by day 21, and hypertrophic mineralization was observed in the newly formed 
ECM at the interface with underlying scaffold by day 45 [37]. Collagen hydrogels 
could also be fabricated into porous sponges before cell seeding. MSCs‐collagen/
glycosaminoglycan constructs pre‐cultured in chondrogenic culture medium and 
subsequently implanted subcutaneously in the dorsum of nude mice showed 
good cell survival and progression along the endochondral ossification route, 
and more interesting, blood vessels formation. Conversely, the osteogenically 
primed scaffolds showed a mineralized matrix of poor quality, no vascularization, 
likely due to too much matrix deposition or a lack of release of inductive factors, 
and few surviving cells, as a result of absence of oxygen and nutrients [4, 20]. In 
another study, chondrocytes isolated from chick embryo were cultured in 
collagen sponges treated with retinoic acid to induce chondrocyte maturation 
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and extracellular matrix deposition. Biological properties and stiffness of collagen 
matrices supported chondrocytes attachment, proliferation and endochondral 
bone maturation after implantation [45].
6. Conclusion and future perspective
Regenerative medicine is a multidisciplinary field aiming at restoration of normal 
function to injured tissues, by the development of increasingly sophisticated 
biomaterials, either alone or in combination with cells and/or stimulating factors. 
The enormous progress achieved so far at the laboratory stage and the continuous 
worldwide effort towards new insights and technologies, direct researchers to face 
new challenges. In order to translate basic scientific advantages into approved 
medical products, all the materials requirements (e.g. safety and efficacy) must 
comply the guidelines established by regulatory agencies, including the Food and 
Drug Administration Agency (FDA) and the European Medicinal Agency (EMEA), 
and clinical trials must be carried out within acceptable clinical practice and due 
ethical considerations. 
In conclusion, although great challenges still remain, research on combining 
stem cells with biomaterial for the creation of bone grafts is at the precipice of 
major breakthroughs that likely will change and simplify the treatment of bone 
disorders, thus to bring major benefits to patients, including reduced need and 
cost of medical attention, and short‐term recovery.
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Summary of this chapter
Biomaterial scaffolds meant to function as supporting structures to osteogenic cells 
play a pivotal role in bone tissue engineering. Recently, we synthesized an aliphatic 
polyurethane (PU) scaffold via a foaming method using non‐toxic components. 
Through this procedure a uniform interconnected porous structure was created. 
Furthermore, hydroxyapatite (HA) particles were introduced into this process to 
increase the bioactivity of the PU matrix. To evaluate the biological performances 
of these PU based scaffolds, their influence on in vitro cellular behavior and in vivo 
bone forming capacity of the engineered cell‐scaffold constructs was investigated in 
this chapter. A simulated body fluid (SBF) test demonstrated that the incorporation 
of 40wt% HA particles significantly promoted the biomineralization ability of the 
PU scaffolds. Enhanced in vitro proliferation and osteogenic differentiation of 
the seeded mesenchymal stem cells (MSCs) were also observed on the PU/HA 
composite. Next, the cell‐scaffold constructs were implanted subcutaneously in 
a nude mice model. After 8 weeks, a considerable amount of vascularized bone 
tissue with initial marrow stroma development was generated in both PU and PU/
HA40 scaffold. In conclusion, the PU/HA composite is a potential scaffold for bone 
regeneration applications. 
1. Introduction 
Since the concept of tissue engineering was introduced, researchers have been 
seeking a solution for bone repair and regeneration by combining the three 
key factors, i.e. a porous scaffold, exogenous stem cells and biological cues.[1] 
Essentially, the choice of a biomaterial as scaffold is critical to the success of bone 
tissue engineering.[2] It is well accepted that an optimal scaffold should possess a 
porous and biologically compatible framework onto which the bone‐forming cells 
can attach, function, and eventually form new bone tissue.[3] 
Recently, polyurethanes (PUs) gained popularity and have been investigated as 
scaffold material. A typical PU is a block copolymer consisting of a hard segment 
contributed by isocyanates and a soft segment formed by polyether or polyester 
polyols. For that reason, the material properties of PU, such as mechanical strength, 
biodegradability and cytocompatibility, can be easily modified by adjusting the 
components of the hard and soft segments during PU synthesis.[4, 5] For instance, 
a PU synthesized from aliphatic diisocyanate, e.g. isophorone diisocyanate (IPDI), 
non‐toxic castor oil and 1,4‐butanediol (BDO) gives rise to non‐toxic degradation 
products, which is more desirable to be used as a scaffold material than the 
conventional PUs made from aromatic diisocyanates.[6, 7] However, like most 
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synthetic polymers, PUs lack bioactive groups to facilitate biomineralization. 
The most common strategy to counteract the poor bioactivity is by introducing 
bioactive ceramics, e.g. hydroxyapatite (HA) particles, into the PU matrix during 
the polymerization process.[8, 9] Due to the presence of the polar groups in the 
molecular chain, PUs have relatively high affinity to HA.[10] 
Another attractive feature of PUs is that they have a preference to spontaneously 
foam during the copolymerization process, which facilitates a one‐step process of 
making porous scaffolds. For instance, water, which is either unavoidably present 
in the reaction mixture or added intentionally during the copolymerization 
process, reacts with the isocyanate causing the release of CO2 gas. The released 
CO2 gas creates bubbles and eventually leads to foaming. Our previous study 
has demonstrated that a mild foaming process could be achieved to allow the 
formation of a uniform porous PU structure by carefully choosing a low reaction 
rate isocyanate.[11] We also demonstrated that nanosized HA particles could be 
added into this process, resulting the formation of a porous PU/HA composite 
scaffold with good dispersion and high occupancy of HA particles.[11, 12] 
In this study, we aimed to further test the biological performance of such PU/
HA scaffolds in comparison to HA free PU scaffolds, including the scaffold effect 
on cellular behavior and in vivo bone forming capacity of the engineered cell‐
scaffold constructs. Firstly, the scaffolds were immersed in simulated body fluid 
(SBF) to test biomineralization ability. Furthermore, rat bone marrow derived 
mesenchymal stem cells (MSCs) were seeded onto the scaffolds, and the cell 
viability and osteogenic capacity were tested in vitro. Finally, the efficacy of bone 
formation on the cell‐scaffold constructs was evaluated in vivo after subcutaneous 
implantation in nude mice. 
2. Materials and methods
2.1 Scaffold fabrication and morphology characterization 
All the reagents were of analytic grade and purchased from Kelong Co. Ltd. 
(Chengdu, China), except that castor oil and isophorone diisocyanate (IPDI) 
were obtained from Aladdin Co. Ltd. (Shanghai, China). Both castor oil and 
1,4‐butanediol (BDO) were dehydrated under decompression with a vacuum of 
1330 Pa at 120°C. IPDI was preserved in a refrigerator before use. Nano‐sized HA 
slurry was prepared by wet synthesis as previously described,[13] then spray‐dried 
to particles of approximately 5‐15 μm in diameter for further experiments. 
The PU and PU/HA scaffolds were prepared by copolymerization and simultaneous 
foaming following our previously reported method [11]. The reaction was performed 
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in a 250 ml three‐necked round‐bottom flask under a dry nitrogen atmosphere. 
Firstly, 38 g castor oil, and a certain amount of HA powders, were put into the 
flask and stirred uniformly. Subsequently, 11.2 g IPDI was added drop‐wise into the 
HA/castor oil mixture and the reaction was kept for 4 h to form the prepolymer. 
Then 4.5 g BDO was used as a chain extender to cross‐link the prepolymer and 
0.9 g deionized water was added in the cross‐linked prepolymer by stirring for 
5 min. The mixture was placed in an oven at 120°C for 4 h accompanied with 
simultaneous foaming, after which the three‐dimensional porous bulk scaffold 
was obtained. Three types of scaffolds were prepared based on the amount of HA. 
They were named as PU, PU/HA20 and PU/HA40 with the PU:HA weight ratios of 
100:0, 80:20 and 60:40, respectively. For all three types of scaffolds, the overall 
porosity was 78‐81%.[11] 
Disk‐shaped samples with a diameter of 6 mm and a thickness of 2.5 mm were 
punched out of the bulk scaffolds. In order to achieve further exposure of the 
HA particles on the surfaces, all types of scaffolds were immersed in 20M NaOH 
solution for 5 days under gentle agitation, as NaOH has the erosive effect on PU.[14] 
After that all scaffolds were cleaned thoroughly in deionized water and freeze‐
dried before being used in the further experiments. The scaffold morphology was 
examined by scanning electron microscopy (SEM; JEOL6340F, Tokyo, Japan) after 
being sputter‐coated with gold. 
2.2 Simulated body fluid (SBF) immersion test
SBF immersion test was used to evaluate the biomineralization behavior of the 
scaffolds. The recipe of SBF was adopted from Kokubo [15] and the pH value of 
the solution was adjusted to 7.4 after complete preparation. Immersion studies 
were performed by incubating each sample in 10 ml SBF solution in a 15 ml tube 
(n=3). All tubes were placed in a water bath at 37 °C under continuous shaking. 
After immersion periods of 1 and 4 weeks, the scaffolds were gently washed with 
deionized water and freeze‐dried. SEM and elemental analysis of the deposits 
was carried out using a Philips XL30 scanning electron microscope (Eindhoven, 
the Netherlands) equipped with an energy dispersive spectrometer (EDS, AMETEK 
Materials Analysis Division, Mahwah, NJ, USA) after the samples were sputter‐
coated with gold (Cressington 108A, Watford, UK). The accelerating voltage was 
10 KeV and the working distance was 10 mm. EDS analysis provided information 
on the distribution of elements of interest (Ca and P) in the analyzed area. 
2.3 Cell isolation and seeding 
Rat MSCs were isolated from 6‐week‐old male Wistar rats after the approval from 
Radboud University Nijmegen Animal Ethics Committee. Briefly, two femora of 
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each rat were extracted and the epiphyses were cut off. MSCs were flushed out 
of the remaining diaphyses using the primary cell culture medium, consisting of 
alpha Minimal Essential Medium (aMEM; Gibco, Grand Island, USA) supplemented 
with 10% fetal bovine serum (FBS; Sigma, St. Louis, USA), 100 U/ml penicillin and 
100 μg/ml streptomycin (Gibco). The flush‐out was cultured for two days in a 
humidified incubator (37 °C, 5% CO2), after which the medium was refreshed to 
remove non‐adherent cells. Prior to detaching the cells, they were cultured for an 
additional three days. Then, the cells were detached using trypsin/EDTA (0.25% 
w/v trypsin, 0.02% w/v EDTA; Sigma) and counted. 
The PU scaffolds for cell culture experiments were sterilized by autoclave and pre‐
wetted in primary cell culture medium overnight. For cell seeding, 5× 104 cells 
were suspended in 50 µl medium and statically seeded onto each scaffold. All 
scaffolds were placed in 24‐well non‐adherent culture plates (1 scaffold per well) 
and incubated for 3 h in a humidified incubator (37 °C, 5% CO2) allowing the initial 
cell attachment to the scaffolds. Subsequently, osteogenic medium was added, 
which contained 50 μg/ml ascorbic acid (Sigma), 10nM dexamethasone (Sigma) 
and 10 mM sodium β‐glycerophosphate (Sigma) on the basis of the primary 
culture medium. Scaffolds were maintained in culture for 24 days, with the cell 
culture medium being refreshed twice per week. Cell viability, DNA amount, 
alkaline phosphatase (ALP) activity and osteogenic gene expression were tested.
2.4 Cell viability 
LIVE/DEAD® Assay (Invitrogen) was used to assess cell viability after 24 h of cell 
seeding. The cell‐scaffold constructs were washed in PBS and exposed to calcein 
AM / ethidium homodimer‐1 / PBS working solution for 30 min at 37 °C according to 
the manufacturer’s instructions. Dye uptake was detected by using an automated 
fluorescent microscope (Axio Imager Microscope Z1; Carl Zeiss Micro Imaging 
GmbH) with a wave length of 488 nm for visualizing the live cells (green) and 568 
nm for the dead cells (red). 
2.5 DNA content and ALP activity 
DNA content (n=3) was quantified by PicoGreen assay (Quant‐iT PicoGreen dsDNA, 
Invitrogen) after 4, 8, 16 and 24 days of osteogenic culture condition. After the 
culture medium was removed, scaffolds were washed twice with PBS. Cells were 
harvested by placing the cell‐scaffold constructs in a 1.5‐ml tube. One ml of 
deionized water was added to each sample, after which 2 freeze‐thaw cycles and 
ultrasonication were performed. One‐hundred μl cell lysate or DNA standard from 
the PicoGreen assay kit was added to 100 μl freshly made working solution in 
the wells. The results were read using a fluorescence microplate reader (Bio‐Tek 
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Instruments, Abcoude, The Netherlands) with an excitation wavelength at 485nm 
and an emission wavelength at 530nm.
The ALP activity (n=3) was measured as a marker for early osteogenic differentiation 
using the same samples as for the DNA assay. Eighty μl of cell lysate or standard 
(serial dilutions of 4‐nitrophenol at the concentrations of 0‐25 nM) and 20μl of 
buffer solution (5 mM MgCl2, 0.5 M 2‐amino‐2‐methyl‐1‐propanol) were added into 
a 96‐well plate. Then 100μl of substrate solution (5 mM paranitrophenylphosphate) 
was added into all wells. Subsequently, the plate was incubated for 1 h at 37 °C 
before the reaction was stopped by adding 100 μl of 0.3M NaOH. The plate was 
read in an ELISA reader (Bio‐Tek Instruments) at 405 nm. ALP activity results were 
normalized by the amount of DNA. 
2.6 RNA extraction and real-time PCR analysis
To analyze the expression of osteogenic‐related genes of the cells seeded on each 
scaffold, a real‐time PCR was performed. Total RNA was extracted using Trizol® 
method (Invitrogen) after 4 and 8 days of culturing. Briefly, scaffolds with cells were 
washed with PBS before 1 ml of Trizol® solution was added. The cell extract was 
then collected, mixed with chloroform and centrifuged. Only the upper aqueous 
phase was collected and mixed with equal amount of isopropanol. After 10min of 
incubation at room temperature, the extract was centrifuged and washed twice 
with 75% alcohol. The RNA pellet was dissolved in RNA free water and the total 
RNA concentration was measured with spectrophotometer (NanoDrop 2000, 
Thermal scientific, Wilmington, USA). 
Table 1. Overview of the primer sequences
Forward (5’ → 3’) Reverse (5’ → 3’)
Oc CGGCCCTGAGTCTGACAAA GCCGGAGTCTGTTCACTACCTT
Bsp TCCTCCTCTGAAACGGTTTCC GGAACTATCGCCGTCTCCATT
Runx-2 GAGCACAAACATGGCTGAGA TGGAGATGTTGCTCTGTTCG
Gapdh CTTCACCACCATGGAGAAGGC GGCATGGACTGTGGTCATGAG
First strand cDNA was reverse transcribed from RNA using the SuperScript First‐
Strand Synthesis System kit (Invitrogen). Afterwards cDNA was further amplified 
and the expression of specific genes was quantified using IQ SYBR Green Supermix 
PCR kit (BioRad, Hemel Hempstead, United Kingdom) in a real‐time PCR (BioRaD, 
CFX96™ real‐time system). Osteogenic markers expressed on RNA level were 
evaluated, including osteocalcin (Oc), bone sialoprotein (Bsp) and runt‐related 
transcription factor 2 (Runx2) (Table 1). The expression levels were analyzed and 
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compared to the housekeeping gene glyceraldehyde‐3‐phosphate dehydrogenase 
(Gapdh). The specificity of the primers was tested separately before the real‐time 
PCR reaction. The expression of the tested genes was calculated via the 2‐∆∆Ct 
method [15] and the PU scaffolds were used as the reference group.
2.7 In vivo implantation
Based on the in vitro results, two types of scaffolds, PU and PU/HA40 with 
distinct biological properties were sterilized by autoclave and selected for the in 
vivo study. The protocol was approved by the Animal Ethical Committee of the 
Radboud University Nijmegen Medical Centre (Approval no: RU‐DEC 2010‐254) 
and the national guidelines for the care and use of laboratory animals were 
applied. Before in vivo implantation, 250,000 cells were seeded on each scaffold 
and cultured for 5 days in vitro. Afterwards, the cell‐scaffold constructs were 
implanted subcutaneously in three male nude mice (HsdCpb:NMRI‐nu, Harlan). 
Surgery was performed under general inhalation anesthesia with a combination 
of isoflurane, nitrous oxide, and oxygen. All mice received analgesic before and 
after the surgery. The back of the mice was shaved and disinfected with povidone‐
iodine. Subsequently, four small longitudinal incisions were made. Lateral to 
each incision, a subcutaneous pocket was created. A cell‐scaffold construct and 
a cell‐free scaffold from both PU and PU/HA40 groups were implanted in each 
mouse. Afterwards the skin was closed using staples. After 8 weeks, the mice were 
euthanized by CO2‐suffocation for sample collection.
2.8 Histological analysis
All the in vivo samples were fixed in 10% phosphate buffered formalin for 30 h 
and dehydrated through graded ethanol before embedding in methylmetacrylate 
(MMA, L.T.I., Bilthoven, the Netherlands). Embedded samples were sectioned using 
a microtome equipped with diamond blade (Leica SP1600, Leica microsystem, 
Wetzlar, Germany) and stained with methylene blue and basic fuchsin (both 
reagents from Merck). The staining was imaged using a light microscope (Zeiss 
Imager Z1, Carl Zeiss AG Microscopy, Germany) equipped with AxioCam MRc5 
camera.
2.9 Statistic analysis 
Statistical significance in this study was evaluated using ANOVA analysis followed 
by Tukey’s Multiple Comparison Test (GraphPad Software Inc., San Diego, USA). 
Results are reported as mean values and standard deviation. Differences were 
considered statistically significant at p < 0.05.
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Figure 1. SEM micrographs of the PU(a and d), PU/HA20 (b and e) and PU/HA40 (c 
and f) scaffolds. The PU and PU/HA scaffolds displayed a porous structure, containing 
both macropores and micropores. Compared to PU scaffolds, PU/HA20 and PU/HA40 
scaffolds exhibited a less regular shape of the macropores and also a less number of 
the micropores (a-c). In the magnified figures (d-f), an increased unevenness on pore 
surfaces of PU/HA20 and PU/HA40 was observed due to the presence of HA particles. 
(White arrows indicate the micropores.) 
3. Results
3.1 Scaffold morphology
As shown in the SEM micrographs (Figure 1), the PU and PU/HA scaffolds displayed 
a porous structure, containing both macropores ranging from 300 to 1000 μm 
and micropores from 50 to 300 μm which were mainly located on the surface 
of macropores (Figure 1a‐c). Compared to PU scaffolds, PU/HA20 and PU/HA40 
scaffolds exhibited a less regular shape of the macropores and also a less number 
of the micropores. In addition, due to the presence of the HA particles, the two 
PU/HA composites showed an unevenness of the pore wall topography compared 
to the PU scaffolds (Figure 1d‐f).
3.2 Biomineralization test  
After 1‐week immersion in SBF solution, no obvious calcium phosphate (CaP) 
precipitation was observed on either PU or PU/HA20 scaffolds by SEM, whereas 
EDS detected marginal quantities of calcium and phosphorus (Figure 2a‐d). In 
comparison, a significant extent of coverage by flake‐like crystal structure was 
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observed on the surfaces of the PU/HA40 scaffold (Figure 2e). The EDS detected 
considerable amount of calcium and phosphorus from these deposits, which 
confirmed the formation of CaP (Figure 2f). These flake‐like CaP depositions 
formed a dense multi‐layer crystal structure when the immersion period reached 
4 weeks (Figure 3f). EDS also confirmed a more pronounced signal of calcium and 
phosphorus on the PU/HA40 scaffolds (Figure 3e). By contrast, only limited CaP 
crystal deposition was observed to scatter on the surface of PU and PU/HA20 
scaffolds after 4 weeks (Figure 3a‐d). 
Figure 2. Biomineralization of the scaffolds after 1-week immersion in SBF. EDS 
detected marginal quantities of calcium and phosphorus on PU (a) and PU/HA20 (c) 
scaffolds, while no obvious CaP precipitation was observed on these scaffolds by SEM 
(b and d). In comparison, significant coverage by flake-like crystal structure was 
observed on the PU/HA40 scaffold (e), from which a considerable amount of calcium 
and phosphorus were detected by EDS (f).
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Figure 3. Biomineralization of the scaffolds after 4-week immersion in SBF. A limited 
CaP crystal deposit was shown on the surfaces of PU (a and b) and PU/HA20 (c and d) 
scaffolds, while a dense multi-layer crystal structure with pronounced calcium and 
phosphorus composition was detected on the PU/HA40 scaffolds (e and f).
3.3 Cell viability and proliferation
As assessed by the Live/Dead assay, more than 95% of the cells were viable on 
all experimental scaffolds after 24 h of cell seeding (Figure 4). Furthermore, the 
DNA contents (Figure 5a), associated with the cell numbers, increased gradually 
until day 8 for all groups. On day 16, a decreased DNA content was detected on all 
groups compared to that on day 8, while the amount maintained stable thereafter. 
At all time points, the PU/HA20 and PU/HA40 groups displayed a significantly 
enhanced DNA content compared to the PU group. From day 16 onwards, a higher 
DNA content was also found on group PU/HA40 compared to PU/HA20. 
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Figure 5. DNA contents (a) and ALP activity (b) on PU, PU/HA20 and PU/HA40 
scaffolds. *: p<0.05, **: p<0.01; error bars represent standard deviation (n=3).
Figure 4. Cell viability on PU(a), PU/HA20 (b) and PU/HA40 (c) scaffolds. More than 
95% of the cells were viable on all experimental scaffolds after 24 h of cell seeding. 
(Live cells are stained green and dead cells are stained red.)
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3.4 Osteogenic differentiation
The expression of ALP activity was measured as a marker of osteogenic 
differentiation of the cells (Figure 5b). Higher ALP activity was found on the PU 
scaffolds compared to PU/HA composite in the early stage of cell culture until 
day 8. However, the PU/HA40 scaffolds exhibited considerably higher ALP activity 
compared to that on PU scaffolds at day 16 and day 24. On RNA level, the PCR 
results also revealed that the PU/HA composites, compared to the PU scaffold, 
promoted the expression of Bsp and Runx2 at day 4 (Figure 6a), and the expression 
of Oc at day 8 (Figure 6b).
3.5 In vivo evaluation
All animals remained in good health and no signs of wound complications were 
observed postoperatively. After 8 weeks, all implanted scaffolds were retrieved. 
Neither macroscopic signs of inflammation nor adverse tissue responses were 
discerned. Histological observation showed that all scaffolds (with or without cell 
seeded) were encapsulated by a thin fibrous layer (3‐6 layers of fibroblasts) without 
significant inflammatory cells infiltration (Figure 7). Inside of the fibrous capsule, 
new bone formation (stained red) was observed in all cell‐scaffold constructs for 
both PU and PU/HA40 groups, which was present not only at the periphery of the 
scaffolds (Figure 7a and b), but also penetrated in the core areas (Figure 8). By 
contrast, the implanted cell‐free PU/HA scaffolds only exhibited fibrous capsulation 
without any bone formation (Figure 7c). Due to the deformation of the scaffolds 
during histological processing and the transparency of the PU scaffolds after being 
Figure 6. Expression of osteogenic related genes. Compared to PU, the PU/HA 
scaffolds promoted the expression of Bsp and Runx2 at day 4 (a), and Oc at day 8 (b). 
*: p<0.05, **: p<0.01; error bars represent standard deviation (n=4). 
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embedded in MMA, quantification of the bone volume on the scaffolds could not 
be performed to determine which group had higher amount of bone formation. 
Nevertheless, similar bone quality was observed on the PU and PU/HA40 scaffolds 
from the histological evaluation. As shown in Figure 8a and b, lamellar like bone 
tissue was observed inside of the pores and mainly aligned along the pore surface. 
The central area displayed a bone marrow structure, which was filled with a great 
number of hematopoietic cells (stained dark blue) and adipocytes (with bubble‐
like morphology) (Figure 8c‐d). Meanwhile, an immature woven bone like structure 
was also found in some pores, which showed the onset of bony matrix deposition 
with randomly arranged osteocytes. Osteoblasts were observed to align on the 
periphery of the newly formed bone matrix (Figure 8d). 
4. Discussion
In the current study, aliphatic PU scaffolds incorporated with different amounts of 
HA particles were synthesized by in situ polymerization and simultaneous foaming 
method, subsequently their biological performance for bone tissue engineering 
applications was evaluated.
Biomineralization of the PU and PU/HA scaffolds, which is related to bone‐bonding 
capacity, was evaluated by examining the apatite formation ability on the scaffold 
surfaces by incubating the scaffolds in SBF with ion concentrations equal to human 
blood plasma [15]. Our results indicated that, the incorporation of 40% HA particles 
significantly enhanced the biomineralization ability of the PU scaffolds. This might 
be attributed to the partial dissolution of HA and the subsequent release of calcium 
ions from PU/HA40 scaffold, which was more sufficient to favor CaP deposition 
compared to that from the PU or PU/HA20 scaffolds. Additionally, the exposure 
Figure 7. Capsulation and bone formation on the periphery of the scaffolds after in 
vivo implantation. All implanted scaffolds (with or without cell seeded) were 
encapsulated by a thin fibrous layer without significant inflammatory infiltration. 
Inside of the fibrous capsule, new bone formation (stained red) was observed in cell-
scaffold constructs for both PU/HA40 (a) and PU (b) groups, but not in the cell-free 
PU/HA scaffolds (c). (S: scaffolds; black arrow: fibrous capsule)
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of HA particles on the surface of PU/HA40 provided more nucleation sites for CaP 
formation and growth.[16] 
Biocompatibility is a primary feature of scaffold materials for tissue engineering 
applications. Recently, Williams has re‐evaluated the definition of biocompatibility 
and pointed out that, biocompatibility of a scaffold should not be solely dependent 
on not eliciting any undesirable effects on the cells or the host as an insertable 
material [17]. More importantly, the scaffolds should also support the appropriate 
cellular activity to optimize tissue regeneration.[17] Our results showed that both 
PU and PU/HA scaffolds maintained the viability and supported progressive 
growth of the seeded cells in vitro. Notably, loading HA particles into the PU 
matrix improved the proliferation of the cells. The enhanced cell growth on the 
PU/HA composite might be closely related to the HA particles which increased 
the initial anchoring and spreading of serum proteins on the polymer surfaces.[18] 
Figure 8. Bone in-growth to the scaffolds after in vivo implantation. On both PU/
HA40 (a and c) and PU (b and d) constructs with cell seeded, lamellar like bone tissue 
(stained red) was observed in the core area of the scaffolds, mainly aligning along the 
pore surface. Surrounded by the bone matrix, a large number of hematopoietic cells 
(stained dark blue) and adipocytes (with bubble-like morphology) were observed, 
which displayed a bone marrow structure. (B: bone; BM: bone marrow; S: scaffold)
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Moreover, the addition of HA could increase surface oxygen,[19] which has been 
shown to improve the attachment and the proliferation of osteoblast‐like cells on 
biomaterials.[20] 
An enhanced osteogenic differentiation of the seeded cells has also been 
demonstrated with the PU/HA scaffolds by the increase of ALP activity and the up‐
regulation of the osteogenic related genes. The up‐regulated genes were Bsp and 
Runx2, which are important for orienting osteoprogenitors toward osteo‐lineage 
and regulating the initial stages of crystal growth,[21] and Oc, which is closely 
related to the late mineralization process. Addition of HA promoting osteogenic 
differentiation of the cells is probably attributed to two reasons: 1) the increased 
roughness of the PU/HA scaffolds, and 2) the release of calcium and phosphate 
from the PU/HA scaffolds into the cell culture medium or the microenvironment 
of the seeded cells. Previous studies have shown that an increase roughness in 
three‐dimensional scaffolds resulted in an enhanced osteogenic differentiation.
[22] However, such topography is expected to have a limited impact when a highly 
porous and interconnected scaffold is applied, as it will be only effective for the 
cells directly attached on the rough surface but not those present in the pores.[23] 
Thus we speculate that the calcium and phosphate release from HA represents a 
more effective differentiation signal. Our data is also consistent with other studies, 
which showed that HA provides a favorable environment for osteoblast‐like cell 
differentiation.[24, 25]
The engineered cell‐scaffold constructs were further implanted subcutaneously 
to gain insight in their role to support osteogenic differentiation of the cells after 
transplantation. The reason to choose an ectopic model instead of an orthotopic 
model for this study was to eliminate or reduce the number of variables involved 
in bone formation present in a bony environment, for instance bone stimulating 
cytokines, endogenous progenitor/stem cells and potentially bone‐stimulating 
mechanotransduction.[26] Our result indicated that the PU and PU/HA40 scaffolds 
supported the cellular growth in vivo. Furthermore, the cell‐scaffold constructs 
worked as an osteoinductive complex and were capable of generating new bone 
tissue. After 8 weeks of implantation, the bone was still in an active forming and 
remodeling phase.
On the other hand, no obvious degradation of these two scaffolds was observed 
after 8 weeks of in vivo implantation. In theory, the PU matrix can undergo 
degradation through the hydrolysis of ester linkages which were introduced 
by castor oil.[4] The breakdown of these ester bonds yields hydroxyl and 
carboxylic groups.[7] The acidic carboxyl group accelerates further hydrolysis 
and the degradation becomes autocatalytic.[6] Previous results demonstrated an 
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approximate 10% weight loss of aliphatic PU/HA40 scaffolds after being soaked in 
PBS for 8 weeks in vitro.[12] In our study, however, no significant degradation was 
observed after 8 weeks of implantation. The possible reason is, due to the in vivo 
fluid exchange and transportation, carboxyl products were easily removed from 
the local environment of the scaffolds, thereby impeding the autocatalyzation 
process and slowing down the progression of degradation. Considering the bone 
was still in an active forming and remodeling stage, such degradation rate ensured 
the PU/HA scaffolds providing sufficient mechanical support for the neotissue 
before it can fulfill the structural role.[27] Still, further investigations are necessary 
to evaluate the degradation of the PU/HA scaffolds in a longer term and monitor 
their replacement by the tissue in‐growth.
Although the PU/HA40 scaffolds showed higher biomineralization ability and 
significant enhancement of osteoblastic differentiation of the seeded cells in vitro 
compared to the PU scaffolds, similar quality of the ectopic bone formation was 
revealed on these two scaffolds after 8 weeks in vivo. Previous studies have also 
shown that there was a lack of correlation and predictability of in vitro osteogenic 
marker expression on subsequent in vivo ectopic bone formation.[23, 28] One possible 
reason might be that, the release of calcium and phosphate from PU/HA40 was 
not sufficient to influence the cellular behaviors and local ionic concentration to 
trigger more bone formation or faster bone maturation once implanted. On the 
other hand, it should be noted that, the ectopic bone formation occurred in an 
intradermal environment, which lacks of naturally bone‐forming stem cells and 
stimulators [26]. Such an environment also differs from the condition used for in vitro 
cell culture where the osteogenic growth factors and supplements are sufficiently 
supplied. Therefore, it is expected that the PU/HA40 scaffolds will probably 
show superior behavior in promoting the osteoblastic differentiation of the 
osteoprogenitors and/or stem cells when applied in the orthotopic locations. Our 
study warrants further investigation towards a clinical implementation of the PU/
HA scaffolds, including 1) scaling up of the implanted constructs and 2) orthotopic 
implantation in an immunocompetent animal model in which endogenous stem 
cells, mechanical load and biochemical/inflammatory factors are closely involved 
in the bone forming process.
5. Conclusions
Porous aliphatic PU and PU/HA composite scaffolds were synthesized by a 
foaming method and their biological performances were evaluated in this study. 
The incorporation of 40wt% HA nanoparticles into PU significantly promoted the 
biomineralization ability of the scaffolds and enhanced the in vitro proliferation 
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and osteogenic differentiation of the seeded MSCs. In vivo implantation 
revealed that a considerable amount of vascularized bone tissue with marrow 
stroma development was generated on both PU and PU/HA40 scaffold after 8 
weeks. Overall, with improved mechanical strength and efficacy of supporting 
osteogenesis, the PU/HA composite is a potential scaffold for bone regeneration 
applications. 
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Summary of this chapter
A new concept of generating bone tissue via the endochondral route might 
have superiority over the standard intramembranous ossification approach. 
To implement the endochondral approach, suitable scaffolds are required to 
provide a three‐dimensional (3D) substrate for cell population, differentiation 
and eventually for the generation of osteochondral tissue. Therefore, a novel 
wet‐electrospinning system, using ethanol as collecting medium, was exploited in 
this chapter to fabricate a cotton‐like poly(lactic‐co‐glycolic acid) (PLGA)/poly(ε‐
caprolactone) (PCL) scaffold that consisted of an accumulation of fibers in a very 
loose and uncompressed manner. On these scaffolds rat bone marrow cells were 
seeded and chondrogenically differentiated in vitro for 4 weeks followed by 
subcutaneous implantation in vivo for 8 weeks. Cell pellets were used as a control. 
The glycosaminoglycan (GAG) assay and Safranin O staining showed that the cells 
infiltrated throughout the scaffolds and deposited an abundant cartilage matrix 
after in vitro chondrogenic priming. Histological analysis of the in vivo samples 
revealed extensive new bone formation through the remodeling of the cartilage 
template. In conclusion, using the wet‐electrospinning method, we are able to 
create a 3D scaffold in which bone tissue can be formed via the endochondral 
pathway. This system can be easily processed for various assays and histological 
analysis. Consequently, it is more efficient than the traditional cell pellets as a tool 
to study endochondral bone formation for tissue engineering purposes. 
1. Introduction
Bone lesions and defects present a significant problem in clinics due to the limited 
self‐healing capacity of the bone tissue. Therefore, the use of a biodegradable 
scaffold provided with multipotent cells and biological cues offers a promising 
approach for bone repair and regeneration [1]. Since the introduction of this concept, 
experiments to engineer bone tissue have been primarily focused on a process 
resembling intramembranous ossification, i.e. direct osteoblastic differentiation 
[2]. However, the success of this approach is hindered by poor vascularization 
inside the entire cell‐based construct [3]. In line with skeleton development and 
bone fracture healing, a new tactic has been reported recently, which is based 
on mimicking endochondral bone formation. Thereby, the bone is generated 
after a cartilage intermediate stage instead of direct osteoblastic differentiation 
[4‐7]. The rationale behind this approach is that chondrocytes are able to survive 
with limited nutrition and oxygen. Secondly, they can secrete vascular endothelial 
growth factor (VEGF) in the hypertrophic stage, which is beneficial for blood vessel 
in‐growth [8]. As a consequence, this route has the potential to circumvent the 
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issue faced by the conventional bone tissue engineering, that is upon implantation 
the constructs will be cut off from the supply of nutrition and oxygen.
To study this endochondral pathway, the cell pellet culture system is so far the 
most frequently used technique [9]. The cell pellet system provides a three‐
dimensional (3D) environment and allows cell‐cell interactions, which are similar 
to pre‐cartilage condensation during embryonic development. However, this 
model is not suitable for the regeneration of bone tissue because of limitations 
in the size, quantity, and lack of mechanical stability [10]. As a consequence, for 
final clinical application of this endochondral pathway a scaffold material has to be 
used, which can serve as a carrier for the cells to provide a 3D environment as well 
as mechanical support. In this way, a robust cell proliferation and differentiation 
can be achieved, which leads to the formation of proper extracellular matrix (ECM) 
and eventually functional tissue. 
Tremendous efforts have been made in the development of bone supporting 
scaffolds with different compositions and 3D configurations using a wide variety 
of techniques, among which electrospinning has recently gained popularity. 
Electrospinning, also named electric spinning, is known as a simple and versatile 
method to produce fibrous polymeric meshes [11]. With the range of tens of 
nanometers to a few microns in diameter and the form of non‐woven structure, 
electrospun fibers are morphologically similar to natural ECM, which makes them 
attractive for cells to populate on and to function effectively [12, 13]. However, a 
scaffold made by the conventional electrospinning process is mostly composed 
of a compact fiber network; thus it is very difficult for the cells to penetrate into 
the internal part of the scaffold [14, 15]. Such a scaffold cannot be considered a 3D 
structure as the cells only populate on the superficial surface. 
To address the aforementioned issues, the aim of this study was to fabricate a 3D 
scaffold using a modified electrospinning technique, and to further test its efficacy 
in endochondral bone formation. To this end, the newly developed scaffolds were 
seeded with rat bone marrow cells (RBMCs), followed by in vitro chondrogenic 
differentiation and in vivo subcutaneous implantation. It was hypothesized that 
the RBMCs can generate bone in vivo on the 3D electrospun scaffolds via the 
endochondral pathway.
2. Materials and methods
2.1. Fabrication of electrospun scaffolds
Poly(lactic‐co‐glycolic acid) (PLGA, Purasorb® PDLG 8531) and poly(ε‐caprolactone) 
(PCL, LACTEL® Absorbable Polymers, inherent viscosity range: 1.0 – 1.3 dl/g) were 
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purchased from Purac Biomaterials BV (Gorinchem, The Netherlands) and DURECT 
Corporation (Pelham, USA), respectively, and used in the electrospinning process. 
Organic solvent 2,2,2‐trifluoroethanol (TFE) (purity≥99.8%) was obtained from 
Acros (Geel, Belgium). The electrospinning solution was prepared by dissolving 
PLGA/PCL (weight ratio 3:1) in TFE at a concentration of 0.12 g/ml.
The 3D scaffolds were fabricated using a so‐called wet‐electrospinning technique 
as depicted in Fig. 1 in a commercial available electrospinning set‐up (Esprayer 
ES‐2000S, Fuence Co., Ltd, Tokyo, Japan). The optimal processing parameters for 
stable formation of electrospun fibers were selected based on an earlier pilot 
study. Briefly, the prepared polymer solution was fed into a syringe and delivered 
to an 18G nozzle at a feeding rate of 50 μl/min. A high voltage of 20 kV was applied 
at the nozzle to generate a stable polymer jet by overcoming the surface tension 
of the polymer solution [16]. Different from the conventional electrospinning setup, 
Figure 1. Illustration of 3D scaffold generation by the wet-electrospinning method. A 
polymer solution was fed into a syringe and a high voltage was applied at the nozzle 
to generate the polymer jet. A grounded bath filled with 100% ethanol was used as 
collector. As ethanol is a wetting agent for both PLGA and PCL, the resulting fibers 
formed a loose cotton-like mesh in the bath.
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a grounded bath filled with 100% ethanol was used to collect the fibers, located 
15 cm under the nozzle. To control the size of resulting fiber meshes, the process 
was stopped every 10 minutes for fiber mesh collection. Subsequently, the wet‐
electrospun scaffolds were washed thoroughly in MilliQ water and freeze‐dried for 
3 days. For comparison, electrospun fibers were also collected by the conventional 
electrospinning method on top of flat aluminum foil, using the same processing 
parameters and collecting time. 
2.2. Characterization of the scaffolds
The morphology of the wet‐ and conventional electrospun scaffolds was observed 
by scanning electron microscopy (SEM; JEOL6340F, Tokyo, Japan) after being 
sputter‐coated with gold‐platinum. The fiber diameters were measured from the 
SEM micrographs as obtained at random locations (n=30) using Image J software 
(National Institutes of Health, Bethesda, USA).
The porosity of scaffolds was evaluated by a gravimetric measurement [17]. In brief, 
the electrospun scaffolds (n = 4) were punched into disc shape forms (a diameter 
of 6 mm for wet‐electrospun scaffolds and a diameter of 15 mm for conventional 
scaffolds) and their dimensions were measured to calculate the volume of the 
scaffolds. The weight of the scaffolds was also measured to determine the 
apparent density of the scaffolds (ρap). The porosity was then calculated according 
to the following equation: 
Porosity = (1 ‐ ρap/ ρm) × 100%
where ρm is the density of the blend PLGA/PCL and was calculated as 1.215 g/cm
3 
based on the weight ratio and respective densities of PLGA (ρ = 1.24 g/cm3, Purac 
MSDS database) and PCL (ρ = 1.145 g/cm3, Sigma‐Aldrich MSDS database).
2.3. Cell isolation, seeding and culture
RBMCs were isolated from 7‐week‐old male Fischer rats after the approval from 
Radboud University Nijmegen Animal Ethics Committee (Approval no: RU‐DEC 
2011‐142). Briefly, two femora of each rat were removed and the epiphyses 
were cut off. RBMCs were flushed out of the remaining diaphyses using the 
proliferation medium through an 18G needle (BD Microlance, Drogheda, Ireland). 
The proliferation medium consisted of alpha Minimal Essential Medium (aMEM; 
Gibco, Grand Island, USA) supplemented with 10% fetal bovine serum (FBS; 
Sigma, St. Louis, USA), 100 U/ml penicillin, 100μg/ml streptomycin (Gibco), 50 
μg/ml l‐ascorbic acid (Sigma) and 10nM dexamethasone (Sigma). The flush‐out 
was cultured for 2 days in a humidified incubator (37 °C, 5% CO2), after which the 
medium was refreshed to remove non‐adherent cells. Prior to detaching the cells, 
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they were cultured for an additional 3 days then the cells were detached using 
trypsin/EDTA (0.25% w/v trypsin, 0.02% w/v EDTA; Sigma) and counted. 
Disk‐shaped scaffolds with a diameter of 6 mm and a thickness of about 2.5 
mm were punched out (biopsy punch; Kai medical, Gifu, Japan) from each wet‐
electrospun mesh that was collected for 10 minutes. Afterwards they were 
sterilized in 70% ethanol for 2 hours and soaked in the proliferation medium 
overnight after washed with PBS. During cell loading, the scaffolds were incubated 
in the cell suspension with a concentration of 1 × 106 cells/ml (4 scaffolds per 1 ml 
of cell suspension) and gently rotated for 3 hours. Successively, the scaffolds were 
placed in non‐adherent tissue culture plates and the unattached cells from the 
suspension were collected, centrifuged and reseeded onto the scaffolds to ensure 
a high cell loading efficiency. The cell‐scaffold constructs were then cultured 
for 1 week in proliferation medium. Thereafter, the medium was changed to 
chondrogenic medium, consisting of high‐glucose DMEM (Gibco), 1% FBS, 100 U/
ml penicillin, 100 μg/ml streptomycin, 50 μg/ml l‐ascorbic acid, 100 mM of sodium 
pyruvate (Gibco), 1:100 insulin‐transferrin‐selenium (ITS; BD Biosciences, Bedford, 
USA), 100nM dexamethasone, 10 ng/ml of transforming growth factor beta‐2 
(TGF‐β2; R&D systems, Minneapolis, USA) and 100 ng/ml bone morphogenetic 
protein 2 (BMP‐2; BD biosciences). The constructs were cultured for 4 weeks 
and the medium was refreshed twice a week. As a control, also a pellet culture 
was made to induce chondrogenic differentiation. To ensure a similar amount 
of cell doublings compared to the constructs, the cells were re‐seeded after the 
first passage in tissue culture flasks and kept in proliferation medium for 1 week. 
Subsequently, cell pellets (250,000 cells/pellet) were made by centrifugation for 8 
minutes at 200g and cultured in the chondrogenic medium for 4 weeks. Both the 
cell‐scaffold constructs and the pellets were then used for in vitro and in vivo tests.
2.4. In vitro studies
After 4 weeks of chondrogenic differentiation, both the cell‐scaffold constructs and 
the cell pellets were tested for their glycosaminoglycan (GAG) and DNA content. A 
Safranin O staining was performed to analyze the in vitro formed cartilage.
The amount of GAG in each sample was detected by a sulfated glycosaminoglycan 
(sGAG) assay (n=3). After being washed twice in PBS, all samples were digested 
in proteinase K solution (1 mg/ml proteinase K in 50 mM Tris with 1 mM EDTA, 1 
mM iodoacetamide, and 10 μg/ml pepstatin A) (all reagents from Sigma) for 16 
hours at 56°C. The GAG content was determined by using dimethylmethylene blue 
(Polysciences Inc., Warrington, USA), with chondroitin sulfate (Sigma) as standard 
control. All results were measured with an ELISA reader (Bio‐Tek Instruments Inc., 
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Winooski, USA) at 530 nm and 590 nm. For each sample, the GAG content was 
normalized by the amount of DNA as described below.
DNA content (n=3) was quantified by PicoGreen assay (Quant‐iT PicoGreen dsDNA, 
Invitrogen, Oregon, USA) using the same cell extract solution as used for the GAG 
assay. A DNA standard curve was made and the results were obtained using a 
fluorescence microplate reader (Bio‐Tek Instruments Inc.) with an excitation 
wavelength at 485nm and an emission wavelength at 530nm.
For the Safranin O staining, the in vitro scaffolds (n=4) were fixed in 10% phosphate 
buffered formalin for 1 hour and embedded in paraffin. The microtome sections 
with 6 μm of thickness were stained with Safranin O (Merck, Darmstadt, Germany) 
after deparaffinization in xylene and rehydration through graded ethanol.
2.5. In vivo implantation
After 4 weeks of in vitro culture, the cell‐scaffold constructs and the cell pellets 
were implanted subcutaneously in ten 8‐week‐old male nude rats (Crl:NIH‐Foxn1mu, 
Charles River). The protocol was approved by the Animal Ethical Committee of the 
Radboud University Nijmegen Medical Centre (Approval no: RU‐DEC 2011‐142) and 
the national guidelines for the care and use of laboratory animals were applied. 
Surgery was performed under general inhalation anesthesia with a combination 
of isoflurane, nitrous oxide, and oxygen. The back of the rats was shaved and 
disinfected with povidone‐iodine. Subsequently, two small longitudinal incisions 
were made. Lateral to each incision, a subcutaneous pocket was created. After 
placing the samples, the skin was closed using staples. One cell‐scaffold construct 
or three cell pellets were inserted in each pocket. After 8 weeks, the rats were 
euthanized by CO2‐suffocation for sample collection.
2.6. Histological staining
All in vivo samples were fixed in 10% phosphate buffered formalin for 36 hours and 
dehydrated through graded ethanol before embedding in either methylmetacrylate 
(MMA, L.T.I., Bilthoven, the Netherlands) or paraffin. 
MMA embedded samples (n = 5) were sectioned using a sawing microtome 
technique (Leica SP1600, Leica microsystem, Wetzlar, Germany) and stained with 
methylene blue and basic fuchsin (both reagents from Merck). 
Prior to paraffin embedding, the fixed samples (n = 5) were decalcified by 10% 
EDTA and the decalcification process was monitored via X‐ray. Six μm‐thick sections 
were made from each sample and used for hematoxylin/eosin (HE), elastic Van 
Gieson (EVG) and Safranin O staining.
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2.7. Back-scattering scanning electron microscopy (BS-SEM)
Thick MMA sections (n=3) were polished by silicon carbide sandpapers up to grit 
4000 and then sputter‐coated with gold–platinum. The micrographs were acquired 
by high resolution SEM in the backscattering mode at 25kV (JEOL6340F, Tokyo, 
Japan). 
2.8. Statistic analysis 
All data in this study was reported as means ± SD. Statistical significance was 
evaluated using an unpaired t‐test (Instat 3.05, GraphPad Software Inc., San Diego, 
USA). Differences were considered statistically significant at p < 0.05. 
3. Results
3.1. Scaffold characterization
The wet‐electrospinning technique developed in this study displayed obvious 
differences in the collected fiber structures compared with conventional 
electrospinning. After 10 minutes of collection, the wet‐electrospun PLGA/PCL 
mesh showed a loose and fluffy structure with a diameter of 3‐4 cm and a thickness 
of 2‐3 mm (Fig. 2a, I). In contrast, the fibers collected via the conventional way 
formed a thin and compressed membrane with a diameter of around 12 cm and 
a thickness of 40 μm (Fig. 2a, II). The SEM micrographs show that the fibers were 
oriented in a random and dispersive manner, forming a porous structure for both 
types of scaffolds (Fig. 2b and 2c). The average fiber diameters measured from the 
SEM micrographs are 1.98 ± 0.51 µm for the wet‐electrospun scaffolds and 2.01 ± 
0.56 µm for the conventional electrospun scaffolds, with no statistical significant 
difference. However, there exists a significant difference between the measured 
porosities, showing 99.0 ± 0.2% for the wet‐electrospun scaffolds and 79.4 ± 2.8% 
for the conventional scaffolds, respectively. 
3.2. DNA and GAG content
RBMCs were seeded onto the scaffolds to test their chondrogenic potential 
compared to the cell pellet system. Prior to in vivo implantation the amount of 
DNA and deposited GAG in the pellets and scaffolds were measured. As shown 
in Fig. 3a, a significantly higher amount of DNA could be found in the PLGA/PCL 
scaffolds compared to the cell pellets after 4 weeks of chondrogenic differentiation 
in vitro. Moreover, the amount of GAG formed on the PLGA/PCL scaffolds, after 
normalization by the DNA amount, was five times higher compared to that of the 
cell pellets (Fig. 3b).
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3.3. Histological analysis of in vitro cartilage formation
To visualize the cartilage matrix deposition in the cell pellets and the scaffolds, 
sections were made and stained with Safranin O after 4 weeks of chondrogenic 
culture. As shown in Fig. 3e, the cell‐scaffold constructs displayed an abundant 
GAG content stained strongly in orange‐red color, representing the cartilage 
matrix. The PLGA/PCL fibers were embedded within the cartilage matrix and a 
homogeneous distribution of cells could be observed inside of the fibrous structure. 
The cell morphology differed due to the different stages of cell differentiation. A 
proportion of cells displayed fibroblast‐like morphology, while a great number of 
cells had a typical chondrocyte morphology embedded in large lacunae and formed 
isogenous groups (Fig. 3f). In contrast, the cell pellets only displayed chondrogenic 
differentiation in the outer layer. There was no cartilage matrix found in the central 
region and a number of cells displayed a necrotic phenotype, leaving empty spaces 
inside of the pellets (Fig. 3c and d).
Figure 2. Comparison of different PLGA/PCL scaffolds. The cotton-like scaffold made 
via the wet-electrospinning method (a, I) showed an uncompressed structure and 
increased thickness compared to the membrane made via the conventional method 
(a, II). Dispersive and randomly oriented fiber arrangement was observed by SEM for 
both wet-electrospun scaffolds (b) and conventional electrospun scaffolds (c), 
showing a porous structure. 
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3.4. Histological analysis of in vivo bone formation
After 8 weeks of implantation, an increased hardness of the scaffolds could be 
sensed during sample retrieval. Unfortunately, the implanted cell pellets could not 
be traced. To evaluate the bone forming quality and quantity, different histological 
staining methods were used for either MMA or paraffin embedded samples. 
Figure 3. DNA content and chondrogenic differentiation. After 28 days of chondrogenic 
differentiation in vitro, a significantly higher amount of DNA (a) and GAG (b, 
normalized for DNA), was found in the PLGA/PCL scaffolds compared to the cell 
pellets.  In the cell pellets, only a limited region in outer layer underwent chondrogenic 
differentiation (c and d). In PLGA/PCL scaffolds, abundant GAG (orange-red color) 
was secreted, which was visualized by a Safranin O staining (e). Cells with different 
morphologies could be observed; chondrocyte-like cells were embedded in lacunae 
and formed isogenous groups (f, black arrows), while a proportion of cells kept their 
original fibroblast-like morphology (f, white arrows). ** p<0.01; error bars represent 
standard error of the mean (n=3).
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Four out of five MMA embedded scaffolds showed bone formation. The bone 
forming quality and quantity were similar in the four samples. As shown in Fig. 4a, 
extensive bone formation can be observed inside the scaffolds. Islets of bone tissue 
are scattered amongst the remnants of scaffold material, indicating the onset of 
the newly formed bone (Fig. 4b). Concentrically organized bone structures which 
indicate mature bone could hardly be seen in the bone forming area. 
To better discriminate tissue structures within the scaffolds, HE staining was applied 
to the paraffin embedded samples. All five scaffolds demonstrated bone formation 
with similar quality and quantity. As shown in Fig. 5a, woven bone like structure 
can be observed throughout the scaffold. A large amount of immature osteocytes 
with round shapes were embedded and arranged randomly, while chondrocytes 
were hardly seen at this time point. The newly formed bone resembled a mixture 
of cartilage and calcified cartilage tissues (bone). The vascular invasion could be 
observed among the material remnants and the fibrous tissue (Fig. 5d).  
To further investigate the state of bone maturation, an EVG staining was performed. 
Thereby the bone area and the surrounding fibrous tissue, as well as the different 
maturities of the new bone, were distinguished by the clear contrast between 
the red, pink and light brown colors, representing bone, uncalcified cartilage and 
fibrous tissue, respectively (Fig. 5c). 
Figure 4. In vivo bone formation in PLGA/PCL electrospun scaffolds. Sections of 
samples after 8 weeks in vivo were stained with methylene blue and basic fuchsin. 
Bone formation (red) occurred inside of the scaffold (a). The osteocytes embedded in 
the bone matrix showed a random arrangement (b, white arrows). The onset of the 
newly formed bone tissue (b, black arrows) was scattered amongst the remnants of 
scaffold material. 
73
4
In Vivo Endochondral Bone Generation on Wet-electrospun Fibers
Furthermore, a Safranin O staining (Fig. 5b and e) confirmed the existence of the 
remaining GAG (red color) among calcified cartilage (green color). Compared 
to the cell‐scaffold constructs before implantation (Fig. 3e), the in vivo samples 
consisted extracellular matrix with considerably reduced GAG levels. Although a 
few sporadic cells with strong red color remained, most regions of the cartilage 
matrix were remodeled and calcified into bone tissue.
3.5. BS-SEM analysis
The grey levels in the BS‐SEM images showed that there is a clear difference 
between the electrospun fibers and newly formed bone (Fig. 6a). Bone tissue, with 
the highest density, displayed by a grey opaque in the black background of the 
MMA block. A great number of electrospun fibers were distributed dispersively 
inside the bone area, visualized by black round dots or needle‐like shapes, 
depending on the sectioning angles (Fig. 6b). Moreover, the differences in bone 
density could also be addressed according to the grey scales. Immature bone was 
found in most of the bone forming areas displayed by a relatively darker color.
Figure 5. Histological stainings of PLGA/PCL electrospun scaffolds after in vivo 
implantation. After 8 weeks of implantation, HE staining (a and d) showed an 
extensive distribution of woven bone like structure and blood vessel infiltration (d, 
black arrows).  Safranin O staining (b and e) confirmed the existence of remaining 
GAG (red color) (e, black arrow) among calcified cartilage (green color) (e, asterisk). 
Bone (f, asterisk), uncalcified cartilage (f, black arrow) and the surrounding fibrous 
tissue were distinguished by the contrast between red, pink and light brown color in 
EVG staining (c and f).
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4. Discussion
In this study, we successfully developed a simple wet‐electrospinning system by 
using ethanol as the collecting media to fabricate a highly porous 3D electrospun 
scaffold for bone tissue engineering applications. Successively, the capacity of 
RBMCs to generate de novo bone tissue in vivo through the endochondral pathway 
was investigated using this 3D scaffold. After 4 weeks of in vitro chondrogenic 
priming, a cell infiltration throughout the scaffolds and abundant cartilage matrix 
formation were observed. Upon subcutaneous implantation, the bone tissue was 
generated ectopically by extensive calcification of the cartilage templates with 
significant blood vessel infiltration. 
Essentially, the lack of a real 3D structure in conventional electrospun scaffolds 
hampers their use in tissue regeneration. To overcome this drawback, various 
methods have been recently explored. A salt leaching/gas forming technique was 
used to introduce micro‐voids into the scaffold after electrospinning [18]. However, 
the fiber morphology of the scaffolds could not be well preserved after the post‐
spinning processes. Ultrasonication of the electrospun membrane in an aqueous 
solution was also applied to make the densely packed fibers become loose, while 
the increase in pore size and the thickness of the membrane was limited [19]. 
Pham et al. designed bilayered constructs consisting of microfibers with varying 
thicknesses of nanofibers on top to improve the cell infiltration [17]. However, 
Figure 6. Back scattering SEM images of PLGA/PCL electrospun scaffolds after in vivo 
implantation. In the black background of the MMA (M), bone forming area (B) 
demonstrated grey opaque with a great number of electrospun fibers (black color) 
penetrating. In the magnified image of the red squared box (b), bone tissue with 
different densities showed in different grey scales; brighter colors indicated the 
regions of more mature bone.
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this method implied an increased complexity of the technique. To modify the 
collecting apparatus, Blakeney et al. embedded a metal array in a semi‐spherical 
dish which allowed the fibers to accumulate in an open space and formed a 
focused and uncompressed 3D scaffold, resembling a cotton ball [20]. It was shown 
that such a scaffold allowed better cell penetration and proliferation compared 
to the conventional electrospun scaffolds. In this study, a similar cotton ball like 
structure was made by wet‐electrospinning technique, simply using ethanol as the 
collecting media. The general technique of electrospinning into a coagulation bath 
was first introduced by Yokoyama et al. in 2009 [21]. Using ethanol as collecting 
media was first reported by Fang et al. and used for studying the evolution of fiber 
morphology [22]. As ethanol is a wet agent for synthetic polymers, e.g. PLGA and 
PCL, it prevents the electrospun fibers from densely packing on top of each other 
in contrary to the conventional flat collector. Afterwards, ethanol was replaced by 
water and the sample was freeze‐dried. During this process, the loose structure 
could be well preserved and characterized. Moreover, the use of ethanol did 
not alter the morphology and size of the electrospun fiber. To further prove the 
efficacy of wet‐electrospinning, fabricated 3D PLGA/PCL scaffolds were combined 
with RBMCs to test their bone forming ability in vivo. 
Loosened electrospun scaffolds have been used before for bone tissue engineering 
purposes [23, 24]. However, these were implanted in rodent calvaria using different 
methods for cell differentiation. Our study is the first instance of endochondral 
bone formation subcutaneously using an electrospun scaffold as a tool to improve 
efficacy. To achieve in vivo bone generation, we chose the pathway that resembles 
endochondral ossification by first forming a cartilage template in vitro and 
subsequently allowing the cartilage to be replaced by bone in vivo. This process 
relies on the specialized functions of hypertrophic chondrocytes, from which a 
type X collagen‐rich avascular cartilaginous matrix can be produced in vitro. 
After in vivo implantation, it is expected that the hypertrophic chondrocytes at 
the periphery of the cartilage template instruct the surrounding mesenchymal 
cells to differentiate into osteoblasts. In parallel, the chondrocytes in the central 
regions lead mineralization of the hypertrophic cartilage by initiating remodeling 
via the production of specific matrix metalloproteinases (MMPs) and attract blood 
vessels by releasing VEGF [25]. Using this approach, a high number of well‐organized 
blood vessels were present within the scaffolds, which showed the feasibility and 
superiority of endochondral route for engineering a vascularized bone construct. 
As demonstrated by Chan at al [26], endochondral ossification is required for the 
haematopoietic stem cell niche formation with a subpopulation of fetal progenitor 
cells giving rise to bone with a marrow cavity. This happens only if they would 
undergo endochondral ossification as opposed to intramembranous ossification. 
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In this study, extensive and robust bone formation was demonstrated. It is known 
that osteogenesis and angiogenesis are two closely correlated processes during 
bone growth, remodeling and repair [27]. In the endochondral bone formation, the 
released VEGF regulates blood vessel invasion into the hypertrophic cartilage [28]. 
Afterwards, undifferentiated mesenchymal cells are brought to the mineralization 
front through the invading blood vessels thereby participating in the osteogenesis 
[29]. Thus the turnover from cartilage to bone is synergized when a good 
vascularization is established inside the cell‐scaffold constructs. 
In this study, cell pellets were used as control because they provide a 3D 
environment and high cell density for cell‐cell interactions which mimic the pre‐
cartilage condensation during embryonic development [30, 31]. This system has 
been applied as a study model for engineering chondrogenically differentiated 
constructs in vitro and also for the creation of vascularized bone in vivo [32]. The 
in vitro results in our study showed greater cartilage production in PLGA/PCL 
scaffolds, while the cell pellets exhibited limited chondrogenic differentiation in 
the outer layer and necrosis in the core area. This could be related to the fact 
that the scaffolds provide a solid surface for cell attachment while allowing better 
penetration of fluid flows carrying the oxygen and nutrient for the developing 
matrix in vitro. Moreover, the form of cell‐scaffold system might not only mimic 
the condensation phase directly but also provide some physical stimulus and 
biomechanical cues related to the cellular environments in vivo [33]. During the in 
vivo experiment, the implanted cell pellets could unfortunately not be retrieved. 
In a previous study the pellets were retrievable when a nude mouse model was 
used [4]. This time we used nude rats and the small pellets might have fused with 
the thick subcutaneous adipose tissue thereby hampering sample retrieval. It is 
known that the pellets occasionally get lost in an in vivo model due to their small 
size. Obviously, the scaffold system provided better handling abilities. Besides the 
aforementioned aspects, various assays and histological processing could also be 
implemented using this PLGA/PCL scaffold, which makes it a superior model for 
studying endochondral bone regeneration. 
It is known that the progression of bone formation in vivo varies when the 
cartilaginous templates are generated in different developmental stages in 
vitro before implantation [30]. However, no conclusion has been reached on the 
length of in vitro chondrogenic priming time because different cell resources or 
scaffold types were applied in previous studies [4, 34‐36]. In this study 4‐weeks of 
in vitro chondrogenic differentiation were applied. Histological staining showed 
extensively cartilage matrix deposition within the scaffolds and a number of 
chondrocytes presented hypertrophic morphology. In vivo results demonstrated 
that 8 weeks of implantation was not sufficient to ossify the complete construct, 
77
4
In Vivo Endochondral Bone Generation on Wet-electrospun Fibers
while a comprehensive remodeling of the cartilage has been revealed. The 
new bone (woven bone) mainly consisted of immature characteristic of bone 
and uncalcified cartilage. A prolonged in vivo implantation time may result in 
the complete maturation and eventually the functional bone tissue formation 
with marrow stroma. On the other hand, more research work is still needed to 
determine the optimal in vitro priming time to obtain satisfactory bone formation 
in vivo.
From material aspects, it should also be noted that PLGA and PCL, as synthetic 
polymers, are in general not osteoconductive. In most cases, polymers are combined 
or coated with osteoconductive components, for instance calcium phosphates 
and hydroxyapatite (HA), to improve their osteo‐compatibility [37]. Previous studies 
verified that a composite electrospun scaffold based on HA and PCL could stimulate 
bone formation by promoting cell proliferation and osteoblastic differentiation 
[38]. Therefore, the addition of osteoconductive components may offer some 
extra biological cues to influence the bone forming process during endochondral 
route. Additionally, the modulation of material properties of PLGA/PCL, such as 
degradation time [39], may also influence the in vivo outcome. It has been found 
that the incorporation of nano sized HA could slow down the degradation of PLGA/
PCL materials in a HA amount‐dependent manner and significantly improved the 
tissue response during 4‐week of subcutaneous implantation [39]. For that reason, 
it is necessary to address the relationship between the supporting material and 
endochondral bone formation in future research, so that this PLGA/PCL constructs 
can be eventually applied for maxillofacial or dental applications, e.g. bone 
reconstruction for dental implantation and bone defects in non‐load bearing sites. 
5. Conclusions
In this study the new concept of engineering bone tissue via the endochondral route 
was successfully combined with a 3D PLGA/PCL blend scaffold fabricated using a 
wet‐electrospinning system. After 4 weeks of in vitro chondrogenic priming, a cell 
infiltration and abundant cartilage matrix deposition by RBMCs could be observed 
throughout the scaffolds. Eight weeks of in vivo implantation revealed extensive 
new bone formation through the remodeling of cartilage template. This system 
can be easily processed for various assays and histological analysis. Therefore, it is 
more efficient than the cell pellets as a tool to study endochondral bone formation 
for tissue engineering purposes. 
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Summary of this chapter
In the context of skeletal tissue development and repair, endochondral ossification 
has inspired a new approach to regenerate bone tissue in vivo via a cartilage 
intermediate as an osteoinductive template. The aim of this chapter was to 
investigate the behavior of mesenchymal stem cells (MSCs) in regard to in vitro 
cartilage formation and in vivo bone regeneration when combined with different 
three‐dimensional (3D) scaffold materials, i.e. hydroxyapatite/tricalcium phosphate 
(HA/TCP) composite block, polyurethane (PU) foam, poly(lactic‐co‐glycolic acid)/
poly(ε‐caprolactone) electrospun fibers (PLGA/PCL) and collagen I gel. To this end, 
rat MSCs were seeded on these scaffolds and chondrogenically differentiated in 
vitro for 4 weeks followed by in vivo subcutaneous implantation for 8 weeks. After 
in vitro chondrogenic priming, comparable cell amounts and cartilage formation 
were observed in all types of scaffolds. Nonetheless, the quality and maturity of 
in vivo ectopic bone formation appeared to be scaffold/material‐dependent. Eight 
weeks of implantation was not sufficient to ossify the entire PLGA/PCL constructs, 
albeit a comprehensive remodeling of the cartilage had occurred. For HA/TCP, 
PU and collagen I scaffolds, more mature bone formation with rich vascularity 
and marrow stroma development could be observed. These data suggest that 
chondrogenic priming of MSCs in the presence of different scaffold materials allows 
the establishment of reliable templates for generating functional endochondral 
bone tissue in vivo without using osteoinductive growth factors. The morphology 
and maturity of bone formation can be dictated by the scaffold properties. 
1. Introduction
Since the introduction of tissue engineering concept, cell‐based bone regeneration 
strategies have received much attention [1, 2]. The conventional approach in this 
field is to combine mesenchymal stem cells (MSCs) with biomaterials/scaffolds 
followed by directing MSCs towards the bone lineage in vitro, which resembles 
intramembranous ossification [3]. However, the clinical translation of this approach 
so far has been unsatisfactory [2]. Lack of sufficient vascular supply, resulting in 
immediate cell death after implantation, is generally thought to be the cause of 
failure of the cell‐scaffold constructs in patients [4]. 
Recently, in the context of skeletal tissue development and repair, endochondral 
ossification has inspired a new approach to regenerate bones [5‐7]. In this approach, 
MSCs seeded on scaffolds are first primed towards the chondrogenic lineage in 
vitro before implantation. These cartilage intermediates work as osteoinductive 
templates and transform into bone tissue in vivo [4, 8, 9]. The recent findings suggest 
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that this endochondral ossification approach may be more successful compared 
to the intramembranous route. It is known that cartilage is well adapted to limited 
nutrition supply and hypoxic conditions [10]. In addition, during the hypertrophic 
stage of the endochondral process, the chondrocytes produce substantial 
amount of vascular endothelial growth factor (VEGF), which plays a critical role 
in the establishment of vessel in‐growth and extracellular matrix remodeling [11]. 
The morphogenetic signals from the chondrocytes also promote the osteogenic 
differentiation of local MSCs [12, 13]. Hence, the endochondral bone tissue 
engineering route may allow for a longer temporal window for vascularization and 
has potential for engineering larger bone constructs .
For the final clinical application of such a strategy, an appropriate scaffold is an 
indispensable element, which provides a three‐dimensional (3D) environment 
as well as the mechanical support for the cells [14]. Regarding endochondral bone 
formation, it is a unique transition process from chondrogenesis to osteogenesis 
and involves several instances of extracellular matrix (ECM) degradation and 
remodeling. Thus, the scaffolds for endochondral bone tissue engineering should 
be able to support cells in differentiating into chondrogenic lineage in vitro and 
meanwhile, also promote the calcification of a cartilage template into bone after 
in vivo implantation. Cartilage matrix consists of highly hydrated proteoglycan 
embedded into a type II collagen network. Based on the previous findings, 
hydrogels made from natural or synthetic polymers have shown to support the 
phenotype of chondrocyte [15]. On the other hand, bone tissue is more rigid than 
cartilage and impregnated mainly with hydroxyapatite (HA) and type I collagen. 
Among the candidate scaffold materials, porous bioceramics and degradable 
polymers are widely studied because of their mechanical competence and 
structural feasibility for fluid perfusion and vessel in‐growth. Apart from the 
aforementioned, nanofibrous scaffolds made by electrospinning has also gained 
research interests in both cartilage and bone tissue engineering due to their 
morphological resemblance to the natural extracellular matrix [16, 17].   
In this study, we aimed at testing the performance of different 3D scaffolds for 
endochondral bone tissue engineering. To that end, four representative scaffolds 
(ceramic‐ or polymer‐based) with distinct structural features were selected 
from the aforementioned materials, including porous hydroxyapatite/tricalcium 
phosphate (HA/TCP), porous polyurethane (PU), fibrous poly(lactic‐co‐glycolic 
acid) (PLGA) electrospun scaffolds and collagen I hydrogel. Rat primary MSCs were 
seeded on these scaffolds and chondrogenically primed for 4 weeks in vitro. The 
formation of cartilage templates was characterized by matrix quantification and 
gene analysis. After 4 weeks of in vitro culture, the chondrogenically primed cell‐
scaffold constructs were subcutaneously implanted in rats for 8 weeks and then 
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the spatial pattern of bone formation and cartilage remains were assessed in each 
construct in terms of quality and quantity via immunohistological stainings and 
polarized microscopy. 
2. Materials and Methods
2.1 Scaffold preparation 
Four different types of scaffold materials were used in this study: 
Porous sintered HA/TCP composite (CAM bioceramics B.V., Leiden, the Nethelands) 
was obtained in a cubic shape of 3×3×3 mm3 and consisted of HA and TCP with 
a 75/25 ratio. The volumetric porosity was 75% (provided by the manufacturer). 
HA/TCP (Fig. 1a) showed a macro‐porous structure with pore sizes ranging from 
300‐800 mm. 
Porous PU scaffold was fabricated by in situ polymerization and simultaneous 
foaming as previously described [18, 19]. The scaffold displayed a similar porous 
structure as HA/TCP (Fig. 1b) and the porosity is 80% [18]. 
Fibrous PLGA (Purasorb® PDLG 8531, Purac Biomaterials BV, Gorinchem, the 
Netherlands) combined with poly(ε‐caprolactone) (PCL, LACTEL® Absorbable 
Polymers, DURECT Corporation , Pelham, USA) electrospun scaffold was made 
by a wet‐electrospinning technique (Esprayer ES‐2000S, Fuence Co., Ltd, Tokyo, 
Japan) as previously described [20]. The obtained scaffold (Fig. 1c) displayed an 
uncompressed structure with an average fiber diameter of 1.98 ± 0.51mm and a 
porosity of 99% [20]. 
Figure 1. SEM micrographs of HA/TCP (a), PU (b) and PLGA/PCL (c) scaffolds. (Scale 
bar in a and b: 100µm; c: 10µm) (Micrograph of collagen I scaffold is not shown 
because the structure could not be preserved after freeze-drying.) 
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Collagen hydrogel was prepared from type I collagen (rat tail) (BD Biosciences, 
Bedford, USA) with the final concentration at 6 mg/ml according to the 
manufacturer’s instructions. 
Both PLGA/PCL and PU scaffolds were punched into a disk shape for the following 
experiments with a diameter of 6 mm and a thickness of 2 mm. Collagen I gel was 
shaped to the same size during the cell seeding procedure. The morphology of the 
scaffolds was observed by scanning electron microscopy (SEM; JEOL6340F, Tokyo, 
Japan) after being sputter‐coated with gold‐platinum.
2.2 Cell isolation, seeding and culture
MSCs were isolated from 6‐week‐old male Fischer rats (12 rats in total) (Charles 
River) after the approval from Radboud University Nijmegen Animal Ethics 
Committee (Approval no: RU‐DEC 2011‐142). Briefly, two femora of each rat 
were removed and the epiphyses were cut off. Rat MSCs were flushed out of the 
remaining diaphyses using the proliferation medium through an 18G needle (BD 
Microlance, Drogheda, Ireland). The proliferation medium consisted of alpha 
Minimal Essential Medium (αMEM; Gibco, Grand Island, USA) supplemented with 
10% fetal bovine serum (FBS; Sigma, St. Louis, USA), 100 U/ml penicillin, 100μg/ml 
streptomycin (Gibco), 50 μg/ml l‐ascorbic acid (Sigma) and 10nM dexamethasone 
(Sigma). The flush‐out was cultured for 2 days in a humidified incubator (37 °C, 5% 
CO2), after which the medium was refreshed to remove non‐adherent cells. The 
cells were cultured for an additional 3 days followed by detachment using trypsin/
EDTA (0.25% w/v trypsin, 0.02% w/v EDTA; Sigma) and counted. 
Before cell seeding, the scaffolds were sterilized either by autoclave (PU and 
HA/TCP) or incubation in 70% ethanol for 2 hours (PLGA/PCL) then washed 
with PBS. Subsequently, all scaffolds were soaked in the proliferation medium 
overnight. During cell loading, the scaffolds were incubated in the cell suspension 
with a concentration of 1 × 106 cells/ml (4 scaffolds per 1 ml of cell suspension) 
and gently rotated for 3 hours. Successively, the scaffolds were placed in non‐
adherent tissue culture plates and the unattached cells from the suspension 
were collected, centrifuged and reseeded onto the scaffolds to ensure a high cell 
loading efficiency. For collagen I scaffolds, the gel was made aseptically according 
to the manufacturer’s instructions, mixed with cells, and set in cell culture inserts 
(ThinCertTM  for 24‐well plate, Greiner Bio‐One, Germany). A concentration of 
250,000 cells per insert (with 120µl gel) was used to obtain a disc shaped cell/
collagen gel construct with a diameter of 6 mm and a thickness of 2 mm. 
All cell‐scaffold constructs were cultured for 1 week in the proliferation medium. 
Thereafter, the medium was changed to the chondrogenic medium, consisting of 
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high‐glucose DMEM (Gibco), 1% FBS, 100 U/ml penicillin, 100 μg/ml streptomycin, 
50 μg/ml l‐ascorbic acid, 100 mM of sodium pyruvate (Gibco), 40μg/ml l‐proline 
(Sigma), 1:100 insulin‐transferrin‐selenium (ITS; BD Biosciences, Bedford, USA), 
100nM dexamethasone, 10 ng/ml of transforming growth factor beta‐2 (TGF‐β2; 
R&D systems, Minneapolis, USA) and 100 ng/ml bone morphogenetic protein 
2 (BMP‐2; BD biosciences). The constructs were cultured for 4 weeks and the 
medium was refreshed twice a week. Afterwards the samples were divided into 
two groups, one for in vitro characterization and the other for in vivo implantation.
2.3 In vitro tests
2.3.1 GAG content
The amount of GAG in each sample was detected by a sulfated glycosaminoglycan 
(sGAG) assay (n=3). After being washed twice in PBS, all samples were digested 
in proteinase K solution (1 mg/ml proteinase K in 50 mM Tris with 1 mM EDTA, 1 
mM iodoacetamide, and 10 μg/ml pepstatin A) (all reagents from Sigma) for 20 
hours at 56°C. The GAG content was determined by using dimethylmethylene blue 
(Polysciences Inc., Warrington, USA), with chondroitin sulfate (Sigma) as standard 
control. Measurements of absorption were performed at 530 nm and 570 nm 
using an ELISA reader (Bio‐Tek Instruments Inc., Winooski, USA). The results were 
calculated according to the previously described method [21]. For each sample, the 
GAG content was normalized by the amount of DNA as described in 2.3.2.
2.3.2 DNA content
To evaluate the seeding efficiency on each type of scaffolds and the cell number 
before the implantation, DNA content of the seeded cells was measured after 
24 hours of seeding and 28 days of chondrogenic differentiation, respectively. 
PicoGreen assay (Quant‐iTTM PicoGreen® dsDNA kit, Invitrogen, Oregon, USA) 
was performed using the same cell extract solution as treated for the GAG assay. 
A DNA standard curve was used to quantify the amount of DNA in each sample 
and the results were measured using a fluorescence microplate reader (Bio‐
Tek Instruments Inc.) with an excitation wavelength at 485nm and an emission 
wavelength at 530nm.
2.3.3 RNA extraction and qPCR analysis
Total RNA was extracted using Trizol method after 4 weeks of chondrogenic culture 
(n=4). Briefly, scaffolds with cells were washed with PBS and cut into small pieces 
before adding 1 ml of Trizol (Invitrogen). The cell extract was collected, mixed 
with chloroform and centrifuged. Only the upper aqueous phase was collected 
and mixed with equal amount of isopropanol. After 10 min of incubation at room 
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temperature, the mixture was centrifuged and washed twice with 75% alcohol. 
Thereafter, the obtained RNA pellet was dissolved in RNase free water and the 
RNA concentration was measured with spectrophotometer (NanoDrop 2000, 
Thermal scientific, Wilmington, USA). 
Table 1. Primer sequences used for qPCR
Forward (5’ → 3’) Reverse (5’ → 3’)
Col2α1 GACGCCACGCTCAAGTCGCT CGCTGGGTTGGGGTAGACGC
Col10α1 GGGCCCTATTGGACCACCAGGTA CCGGCATGCCTGTTACCCCC
Acan CATTCGCACGGGAGCAGCCA TGGGGTCCGTGGGCTCACAA
Vegfa ACTCATCAGCCAGGGAGTCT GGGAGTGAAGGAGCAACCTC
Gapdh CGATGCTGGCGCTGAGTAC CGTTCAGCTCAGGGATGACC
First strand cDNA was reverse transcribed from RNA using the SuperScript® First‐
Strand Synthesis System kit (Invitrogen). Afterwards cDNA was further amplified 
and the expression of specific genes was quantified using IQ SYBR Green Supermix 
PCR kit (BioRad, Hemel Hempstead, United Kingdom) in a real‐time PCR (BioRaD, 
CFX96™ real‐time system) (n=4). Chondrogenic differentiation related gene 
markers were evaluated, including collagen type II (Col2α1), collagen type X 
(Col10α1), aggrecan (Acan), and VEGF (Vegfa) (Table 1). The expression levels were 
analyzed and compared to the housekeeping gene glyceraldehydes 3‐phosphate 
dehydrogenase (Gapdh). The specificity of the primers was confirmed separately 
before the real‐time PCR reaction. The expression of the tested genes was 
calculated via the 2‐∆∆Ct method [22] using HA/TCP as the reference group.
2.3.4 Histological analysis
All the samples were fixed in 10% phosphate buffered formalin for 1 hour before 
embedding. The in vitro PLGA/PCL and collagen I scaffolds were embedded in 
paraffin (n=3). The microtome sections with 6 μm of thickness were stained with 
0.4% thionin (Sigma) after deparaffinization in xylene and rehydration through 
graded ethanol. Simultaneously, HA/TCP and PU scaffolds were embedded in 
methylmetacrylate (MMA, L.T.I., Bilthoven, the Netherlands) because of their rigid 
character. The samples were sectioned to 15μm using a microtome equipped with 
diamond blade (Leica SP1600, Leica microsystem, Wetzlar, Germany) and then 
stained with 0.4% thionin solution. 
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2.4 In vivo implantation
After 4 weeks of in vitro culture, the cell‐scaffold constructs were implanted 
subcutaneously in ten 8‐week‐old male nude rats (Crl:NIH‐Foxn1mu, Charles River). 
The protocol was approved by the Animal Ethical Committee of the Radboud 
University Nijmegen Medical Centre (Approval no: RU‐DEC 2011‐142) and the 
national guidelines for the care and use of laboratory animals were applied. All 
rats received analgesic before and after the surgery. The surgical operations were 
performed under general inhalation anesthesia with a combination of isoflurane, 
nitrous oxide, and oxygen. The back of the rats was shaved and disinfected with 
povidone‐iodine. Subsequently, four small longitudinal incisions were made. 
Lateral to each incision, a subcutaneous pocket was created. Each rat received 
a cell‐scaffold construct from each of the four materials and the constructs were 
randomized. After placing the samples, the skin was closed using staples. After 8 
weeks, the rats were euthanized by CO2‐suffocation for sample collection.
2.5 Histological analysis of the in vivo samples
All in vivo samples were fixed in 10% phosphate buffered formalin for 30 hours and 
dehydrated through graded ethanol before embedding either in MMA or paraffin.
MMA embedded samples (n = 5) were sectioned to 15μm using a microtome with 
diamond blade (Leica SP1600, Leica microsystem, Wetzlar, Germany) and then 
stained with methylene blue and basic fuchsin (both reagents from Merck). 
Prior to paraffin embedding, the fixed samples (n = 5) were decalcified by 10% 
EDTA and the decalcification process was monitored via X‐ray. Five μm‐thick 
sections were made from each sample and used for hematoxylin/eosin (HE), 
collagen II and tartrate‐resistant acid phosphatase (TRAP) staining. For collagen 
II staining, sections were treated with 0.1% pronase and 1% hyaluronidase for 
antigen retrieval (both from Sigma). Afterwards the sections were incubated for 1 
h at room temperature with mouse monoclonal antibody against collagen type II 
(II‐II6B3 antibody, 1:100; Developmental Studies Hybridoma Bank, Iowa City, USA) 
linked with a biotin‐labeled secondary antibody (1:500, Jackson Immuno Research, 
Newmarket, England). Then alkaline phosphatase‐conjugated streptavidin 
(1:50, Biogenex HK‐321‐UK) was used as the third antibody and the activity was 
visualized by using a new fuchsin substrate (Sigma). An isotype immuno‐globulin 
G1 monoclonal antibody was used as negative control. Counterstaining was 
performed with Gill’s hematoxylin (Sigma). For TRAP staining, sections were first 
incubated in TRIS/MgCl2‐buffer for 1 hour. Afterwards they were stained with acid 
phosphatase substrate solution at 37 °C for 30 min, which contained Naphthol 
AS‐BI phosphate, sodium nitrite, N, N‐ dimethylformamide, potassium sodium 
tartrate and pararosaniline (all reagents from sigma). 
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2.6 Polarized light microscopy
The in vivo MMA cross‐sections were observed under polarized light using a 
light microscope (DM RBE Leica, Bensheim, Germany) in which the polarizer and 
analyzer were fixed perpendicularly to each other (cross‐polarized light).
2.7 Statistic analysis 
The data were analyzed using one‐way ANOVA followed by Tukey’s Multiple 
Comparison Test (GraphPad Prism 5, GraphPad Software Inc., San Diego, USA). 
Results are reported as mean values and standard deviation. Differences were 
considered statistically significant at p < 0.05.
3. Results
3.1 Cell seeding efficiency
After 24 hours of cell seeding, DNA content of the seeded cells on each group was 
measured to assess the seeding efficiency (Fig. 2a). Highest cell number was found 
on collagen I group, as all of the cells were encapsulated in the gel during cell 
seeding. Comparable amount of cells was detected on PU and PLGA/PCL scaffolds, 
which was around 65% of the total cell number seeded onto the scaffolds. In 
comparison, lowest cell number was shown on HA/TCP scaffolds, with the seeding 
efficiency of around 25%.
3.2 DNA and GAG content pre-implantation
After 1 week of proliferation and 4 weeks of chondrogenic differentiation in vitro, 
comparable amounts of DNA could be found in HA/TCP, PLGA/PCL and collagen 
Figure 2. DNA (a and b) and GAG (c) content on different scaffolds. DNA content after 
24 hours of seeding (a) was measured to evaluate the seeding efficiency. GAG content 
(c) was measured after 4 weeks of chondrogenic priming to assess the cartilage 
formation and normalized by the amount of DNA (b). ** indicates statistically 
significant difference at p<0.01; error bars represent standard deviation (n=3).
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I scaffolds, which was significant higher than that on the PU scaffolds as shown 
in Fig. 2b. Likewise, the normalized GAG content on the aforementioned three 
scaffolds was also comparable, but the PLGA/PCL constructs showed significant 
higher GAG/DNA ratios than the PU samples (Fig. 2c). 
3.3 Expression of chondrogenic genes pre-implantation
After 4 weeks of chondrogenic differentiation in vitro, a 2‐fold higher level of 
aggrecan expression was observed for HA/TCP group compared to collagen I 
group, while there was no difference detected among HA/TCP, PU and PLGA/PCL 
groups (Fig. 3a). Similar result was also found for VEGF expression that HA/TCP 
group showed significantly higher level of VEGF compared to collagen I group (Fig. 
3d). For collagen II gene expression, all groups showed a similar level (Fig. 3b). In 
Figure 3. Gene expression of aggrecan (a), collagen II (b), collagen X (c) and VEGF (d) 
after in vitro chondrogenic priming. The gene expression level of the cells seeded on 
HA/TCP scaffold was used for normalization. * indicates statistically significant 
difference at p<0.05; ** indicates statistically significant difference at p<0.01; error 
bars represent standard deviation (n=4). The red dash line indicates the gene 
expression level of the reference group (HA/TCP).
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contrast, a significant higher expression of collagen X was detected for PLGA/PCL 
groups (Fig. 3c).
Figure 4. In vitro chondrogenic differatiation. The cartilage matrix deposition (stain 
purple) in the scaffolds was visualized by thionin staining after 4 weeks of in vitro 
culture. On HA/TCP (a and e) and PU (b and f), the cartilage matrix was formed in the 
pores of the scaffolds. The cells exhibited typical chondrocyte like morphology and 
hypertrophy could be observed, whereby the lacunae of the cells were enlarged and 
the matrix was reduced (e and f). The shrinkage of the PLGA/PCL (c and g) and 
collagen I (d and h) scaffolds during the histological processing compromised the 
morphology of the cells. However, obvious cartilage matrix deposition was displayed 
in both scaffolds and a homogeneous distribution of cells could be observed. (S: 
scaffolds)
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3.4 Histological evaluation pre-implantation
To visualize the cartilage matrix deposition in the scaffolds, histological sections 
were made and stained with thionin after 4 weeks of chondrogenic culture. For 
both HA/TCP and PU, as shown in Fig. 4a and b, the cartilage matrix was formed 
in the pores of the scaffolds and stained purple. The cells had a rounded or 
polygonal shape and formed isogenous groups, exhibiting typical chondrocyte like 
morphology (Fig. 4e and f). Furthermore, the majority of the cells had reached 
the hypertrophic stage whereby the lacunae were enlarged and the matrix was 
reduced.
The shrinkage of the fibrous scaffold during the histological processing compromised 
the morphology of the cells on PLGA/PCL. Nevertheless, a substantial GAG content 
was displayed in the scaffolds stained strongly in purple, representing the cartilage 
matrix (Fig. 4c). The PLGA/PCL fibers were embedded within the matrix and 
a homogeneous distribution of cells could be observed throughout the fibrous 
structure (Fig. 4g). Similarly, the collagen I scaffolds also showed cartilage matrix 
deposition although here the shrinkage was less, while the total amount appeared 
to be lower than PLGA/PCL scaffolds. (Fig. 4d and h). 
3.5 Histological analysis of in vivo bone formation
All animals recovered uneventfully from the surgical procedure and remained in 
good health. No signs of wound complications were observed post‐operatively. 
After 8 weeks of implantation, all samples were retrieved and an obvious increase 
in hardness of PLGA/PCL, collagen I and PU scaffolds could be sensed by hand. 
Macroscopic signs of inflammation or adverse tissue responses were absent for all 
retrieved samples. 
To evaluate the bone forming quality and quantity, different histological staining 
methods were used for either MMA (Fig. 5) or paraffin (Fig.6) embedded samples. 
Bone formation was found in all HA/TCP, PU and collagen I constructs, and nine 
(out of ten) PLGA/PCL scaffolds. For the bone‐formed samples within each group, 
the bone forming quality was similar as observed from the histological stainings. 
Due to the deformation of PU and PLGA/PCL scaffolds during the tissue processing 
procedures, the original material area could not be defined to quantify the ratio of 
bone formation within the scaffolds.
3.5.1 HA/TCP scaffolds
As shown in Fig. 5a, substantial bone formation was present at both the periphery 
and inside of the scaffolds. Within the macro‐pores, the structure of a marrow 
cavity filled with hematopoietic cells and adipocytes could be observed, surrounded 
by concentric deposition of bone matrix. Moreover, plenty of blood vessels 
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penetrated randomly in these bone forming areas (Fig. 6a and b). Osteocytes 
were embedded in the bone matrix, showing relatively round shapes. Collagen II 
staining confirmed that only a small amount of cartilage (stained pink) remained, 
which was occasionally found in the small pores of a few samples where cells kept 
the chondrocyte like shape without breaking down the surrounding matrix (Fig. 
6c).
3.5.2 PU scaffolds
PU scaffold underwent deformation during the histological processing. Bone 
formation was observed in the scaffolds, especially in the pores located in the 
peripheral area (Fig. 5b). Surrounded by the bone tissue, a marrow‐like structure 
or a loosely organized fibrous tissue‐like structure was detected in these pores 
together with blood vessel in‐growth (Fig. 6d and e). The amount of bone formation 
in the central pores was relatively low compared to HA/TCP scaffolds. Chondrocytes 
or cartilage like structure could not be seen at this time point. Collagen II staining 
revealed a slight amount of tissue stained light pink, indicating the replacement of 
in vitro cartilage with bone tissue was nearly completed (Fig. 6f).
Figure 5. Overview of in vivo bone formation. MMA sections of HA/TCP (a), PU (b), 
PLGA/PCL (c) and Collagen I (d) samples after 8 weeks of implantation were stained 
with methylene blue and basic fuchsin. Bone formation (stained red) displays in 
different spatial arrangements on each type of scaffold.  
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3.5.3 PLGA/PCL scaffolds
Extensive cartilage remodeling could be observed inside of PLGA/PCL scaffolds. 
Islets of bone tissue were scattered amongst the remnants of scaffold material, 
Figure 6. Histological analysis of in vivo bone formation on scaffolds. After 8 weeks of 
implantation, HE (left and middle column) staining showed that the bone formation 
on HA/TCP (a), PU (d) and Collagen I (j) scaffolds was associated with bone marrow 
development while on PLGA/PCL scaffold (g) the bone tissue displayed a woven bone 
like structure without concentrically organized structure and marrow formation. In 
the magnified images of the black squared box (middle column), osteocytes were 
embedded in the bone matrix and blood vessels penetrated in the bone forming areas 
on all scaffolds. Collagen II staining (right column) confirmed significant remaining of 
cartilage matrix (red color) on PLGA/PCL (i) while the remodeling of in vitro cartilage 
into bone tissue was nearly completed on HA/TCP (c), PU (f) and Collagen I (l) 
scaffolds. The black arrow indicates a blood vessel and the arrow head in the white 
magnified box indicates embedded electrospun fibers. (B: bone; BM: bone marrow; S: 
scaffold; C: cartilage)
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indicating the onset of the newly formed bone. Concentrically organized bone 
tissue with marrow cavity structures could not be observed (Fig. 5c). HE staining 
Figure 7. Histological analysis of in vivo osteoclast activity. After 8 weeks of in vivo 
implantation, the activity of osteoclasts (stain red) was visualized by TRAP staining. 
For HA/TCP, PU and collagen I scaffolds, osteoclast activity was positive (Fig. 7a, b 
and d) which scattered along the edge of bone matrix (Fig. 7e, f and h). In comparison, 
an extensive level of osteoclast activity was observed throughout the PLGA/PCL 
scaffolds (Fig. 7c), which was not only located along the edge of new bone formation, 
but also present in the middle area of the bone/cartilage mixed matrix (Fig. 7g). 
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revealed that the bone tissue displayed a woven bone like structure with vascular 
invasion. A large number of immature osteocytes were embedded in the matrix 
and randomly arranged (Fig. 6g and h). Interestingly, the remained PLGA/PCL 
fibers of the scaffolds were also embedded in the matrix as indicated in Fig. 6h. 
Furthermore, the collagen II staining (Fig. 6i) confirmed the existence of the 
remaining cartilage matrix (red color). Compared to the PLGA/PCL constructs 
before implantation (Fig. 3c), the in vivo samples contained considerably reduced 
amount of cartilage matrix. However, the newly formed bone still resembled a 
mixture of cartilage and calcified cartilage tissue or bone. 
3.5.4 Collagen scaffolds 
Bone formation with marrow development was observed in collagen I gel. An 
intact bone layer was displayed along the fibrous capsule. Trabecular bone‐like 
structure, together with a great number of adipocytes and hematopoietic cells, 
was distributed in the middle part (Fig. 5d). Blood vessels penetrated in the stroma 
and were also present inside the bone tissue (Fig. 6j and k). There was no remaining 
cartilage matrix visualized by a collagen II staining which indicated the complete 
replacement of in vitro cartilage by new bone tissue (Fig. 6l).
3.6 Histological analysis of osteoclast activity
The activity of osteoclasts was visualized by TRAP staining. After 8 weeks of in 
vivo implantation, osteoclast activity was positive on HA/TCP, PU and collagen I 
scaffolds (Fig. 7), which scattered along the edges of bone matrix. In comparison, 
an extensive level of osteoclast activity was observed throughout the PLGA/PCL 
scaffolds, which was not only located along the edges of new bone formation, but 
also present in the middle area of the bone/cartilage mixed matrix.  
3.7 Polarized light observation
The collagen bundle arrangement of the newly formed bone tissue on each scaffold 
was examined under the polarized light on the basis of its birefringent character. 
As shown in Fig. 8, the collagen bundles within the bone forming areas which were 
oriented transversely to the direction of the light propagation were visualized in 
bright pink under the polarized light. In HA/TCP (Fig. 8a and e), PU (Fig. 8b and 
f) and collagen I scaffolds (Fig. 8d and h), a parallel pattern of the collagen fibril 
arrangement could be observed partially in the bone forming regions, indicating 
the initial organization of the lamellar bone. However, in the PLGA/PCL scaffolds 
(Fig. 8c and g), the bone matrix displayed a random spatial organization, as shown 
by an isotropic and un‐polarized structure.
98
Chapter 5
Figure 8. Observation of in vivo bone formation under polarized light. Newly formed 
bone tissue in each scaffold (embedded in MMA) was stained with methylene blue / 
basic fuchsin (a-d) and examined under the polarized light (e-h). The bone tissue was 
stained red (a-d) and the collagen bundles which were oriented transversely to the 
direction of the light propagation were distinguished in bright pink under the 
polarized light (e-h). In HA/TCP (a and e), PU (b and f) and collagen I (d and h) 
scaffolds, a concentric and parallel pattern of the collagen fibril arrangement could 
be observed partially in the bone forming regions. For PLGA/PCL scaffolds (c and g), 
the bone matrix displayed an isotropic organization. (Scale bar: 50µm)
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4. Discussion
An appropriate scaffold material is an essential component in bone tissue 
engineering as it regulates the cellular behaviors, such as cell proliferation and 
differentiation, on both chondrogenic and osteogenic pathways [23, 24]. In this 
study, we aimed to evaluate and compare the efficacy of four scaffolds for bone 
tissue regeneration via the endochondral ossification, which were porous HA/TCP 
composites, porous PU foam, PLGA/PCL electrospun fibers and collagen I gel. 
Our results showed different cell seeding efficiencies on the tested scaffolds due to 
their varied structural features, among which the HA/TCP scaffolds had the lowest 
initial cell number. Nevertheless, 1‐week culture in proliferation medium ensured 
a comparable amount of cells present on these scaffolds prior to the implantation, 
as the low‐serum chondrogenic culture condition would principally not stimulate 
the cell proliferation. The results also indicated that, all of the selected scaffolds 
supported cell growth and proliferation. Similarly, comparable cartilage formation 
in the scaffolds was also shown before the in vivo implantation. However, cells 
cultured on the PLGA/PCL scaffolds expressed a significantly higher level of collagen 
X compared to those on the other types of scaffolds. In vivo results revealed that, 
8 weeks of implantation was sufficient to ossify nearly the complete constructs of 
HA/TCP, PU and collagen constructs and form a hematopoietic bone marrow, while 
the bone formation on PLGA/PCL scaffolds displayed a immature structure with a 
random spatial organization of collagen bundle and obvious cartilage remaining. 
Furthermore, an extensive level of osteoclast activity present throughout the 
PLGA/PCL scaffold also demonstrated a highly active cartilage and bone remodeling 
in PLGA/PCL compared to the other three scaffolds. These results indicated that, 
although the cells on PLGA/PCL might have an earlier hypertrophic stage in vitro, 
the cartilage remodeling and vessel invading in PLGA/PCL was less efficient in vivo 
compared to the other scaffolds. 
Hypertrophic cartilage remodeling is an critical process to initialize the successive 
endochondral bone formation and such progression is closely related to the 
reciprocal interaction between the cells and natural ECM [25]. Cellular products, e.g. 
proteinases and VEGF, modify the type X collagen‐rich ECM and promote vessel 
formation; ECM also releases sequestered growth factors and cytokines to regulate 
the endochondral commitment of the cells [26]. Hypertrophic cartilage remodeling 
usually couples the expression of VEGF [27]. Surprisingly, a significantly higher 
level of collagen X expression on PLGA/PCL scaffolds did not result in an elevated 
VEGF expression of the cells. This may consequently lead to the formation of less 
mature bone in PLGA/PCL scaffolds compared to the other scaffolds. Moreover, a 
comparable endochondral bone formation was observed on HA/TCP and collagen 
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I gel, although significant difference of VEGF expression was shown for these two 
scaffolds prior to the implantation. Therefore, apart from the natural ECM, the 
scaffolds, acting as a synthetic ECM, also played an essential role in directing the 
cells to form endochondral bone in vivo. 
Noticeably, our data demonstrated that the structure and maturity of the 
endochondral bone is material/scaffold dependent. Among various scaffold 
properties, geometry and composition played important roles. In vivo, higher 
percentage of porosity allows for better cell recruitment and vascularization, 
which leads to improved osteogenesis [28]. On top of that, scaffold pore size can 
dictate the structure and the mode of the newly formed bone (intramembranous 
or endochondral) [24]. In an in vivo study of BMP‐2 induced osteogenesis and 
chondrogenesis via honey‐comb‐shaped HA scaffolds, small diameter ‘tunnels’ (90‐
120µm) favored chondrogenesis followed by osteogenesis, while large diameter 
‘tunnels’ (350µm) favored intramembranous bone formation [24, 29]. Regarding the 
bone structure, increased trabeculae formation appeared to be supported when 
the scaffolds have smaller pores [30]. Similarly, in our study, more lamellar‐like bone 
structure with bone marrow formation was generated on HA/TCP and PU scaffolds 
compared to PLGA/PCL. This might be related to the larger pore size of HA/TCP and 
PU scaffolds, which can facilitate more oxygen and nutrient diffusion and allow 
easier vessel in‐growth during cartilage/bone remodeling. In comparison, the 
small pore size of PLGA/PCL scaffolds might have created a hypoxic environment 
which favored the cartilage maintenance [28]. Furthermore, the confined porous 
structure of HA/TCP and PU can concentrate collagen fibers within the pores 
and triggered their self‐assembly, thereby forming the lamellar like bone [31]. 
Conversely, in fibrous PLGA/PCL scaffolds, new collagen fibers formed by the cells 
were distributed in a random manner, resulting mostly in woven bone [31]. Thus, 
the specific design of the scaffold can drive the arrangement of collagen fibers and 
consequently target bone formation.
Bone in‐growth to the central part of the HA/TCP scaffold had a relatively higher 
volume compared to the PU scaffolds, even though HA/TCP scaffolds were 
a little thicker. The main reason for the difference of bone in‐growth might be 
that, unlike PU, HA and TCP are osteoconductive [32, 33]. This osteoconductive 
property can promote the attachment of bone‐forming cells from the host as 
well as cell migration and vessel formation [14]. Both PU and HA/TCP are slowly 
degrading materials which were unlikely to degrade after 8 weeks of implantation 
[19, 34]. However, compared to PU scaffolds, HA/TCP could actively release calcium 
and phosphate ions which can influence the local ionic concentration to trigger 
and provide the source for the deposition of calcium in the cartilage matrix for 
subsequent remodeling [34]. With respect to PLGA/PCL scaffolds and collagen I gel, 
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the naturally derived collagen I component resembles the organic composition of 
natural bone and is considered more osteoconductive than the synthetic polymers, 
i.e. PLGA and PCL [35], which have also contributed to the differences of the bone 
formation between these two scaffolds. 
For in vivo bone generation, the origin of bone cells and the ossification type are 
closely related to the nature and commitment of the seeded cells. Previous results 
have suggested a tendency of MSCs to undergo endochondral ossification when 
implanted in vivo. Hartman et al. seeded rat MSCs onto porous HA/TCP scaffold to 
investigate ectopic bone formation via the intramembranous approach, while the 
onset of bone tissue was always surrounded by hypertrophic cartilage‐like cells [36]. 
Tortelli et al. combined murine MSCs or mature osteoblasts with porous ceramic 
scaffolds and subsequently implanted them ectopically in mice [37]. New vascularized 
bone was formed through the activation of the endochondral ossification process 
in the MSC‐scaffold complex. Conversely, osteoblasts directly formed bone 
via an intramembranous ossification, without any signs of vascularization [37]. 
Aforementioned results indicated that, activating MSCs toward an endochondral 
ossification route is presumably in line with their natural developmental pattern 
and provides significant advantages in generating vascularized bone tissue. Our 
results demonstrated the tendency of in vitro chondrogenically induced MSC to 
ossify in a non‐chondrogenic environment in vivo, which is also consistent with 
some previous studies [15, 38, 39]. When combined with various scaffolds, scaled‐up 
bone formation with the structure and functionality comparable to that of native 
bones could be achieved in vivo without the use of any osteoinductive growth 
factors, e.g. BMP‐2, at the implant site. Among the tested scaffold materials, HA/
TCP block and collagen I gel supported most mature bone formation within the 
entire constructs. Regarding the clinical applications, Collagen I gel is appealing 
for irregularly shaped defects and its fast degradation allows rapid turnover of 
the new bone tissue in the implantation site. HA/TCP scaffold is more suitable 
for the implantation in the load‐bearing areas, which can provide initial structural 
stability. Nevertheless, considering the ceramic scaffolds are brittle, the mechanical 
property of HA/TCP needs to be further modified, for instance by incorporating 
polymeric components. 
Some limitations of our study have to be addressed: i) the evaluation was only 
performed at one time point of 8 weeks after implantation, ii) the scaffolds were 
in a relatively small size which might favor cell invasion and vascularization, iii) 
the implantation was only performed in a subcutaneous environment where the 
mechanical stimuli are not involved, and iv) due to the differences in composition 
and structure of the selected scaffolds, the specific parameters of a material 
scaffold that dominate the endochondral bone forming process could not be 
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concluded from the current study. More completed understanding will be obtained 
if all structural parameters of the scaffolds are kept constant and meanwhile only 
the composition is varied, or vice versa. Further investigations are warranted to 
dynamically monitor the endochondral bone forming process in an orthotopic 
implantation site. Furthermore, systematical investigations are also needed to 
address how this process is driven by the parameters of the supporting materials, 
so that more appropriate scaffolds can be selected and tailored to target large‐
scale bone regeneration. 
5. Conclusion
In this study, chondrogenic priming rat MSCs in the presence of different 3D 
scaffold materials followed by subcutaneous implantation allowed us to establish 
a reliable scaffold‐based heterotopic model for endochondral bone formation. 
The bone quality and maturity was scaffold/material‐dependent. Eight weeks of 
implantation was not sufficient to ossify the entire PLGA/PCL constructs, while a 
comprehensive remodeling of the cartilage has occurred. HA/TCP, PU and collagen 
I scaffolds supported full bone formation with rich vascularity and marrow stroma 
development. This study revealed that bone could be generated heterotopically 
via the endochondral pathway in absence of osteoinductive growth factors and 
scaffold properties could dictate the morphology and maturity of endochondral 
bone formation. Continued research in this direction would open the attractive 
possibility to target large‐scale bone regeneration.  
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Summary of this chapter
Recapitulation of endochondral ossification leads to a new concept of bone tissue 
engineering via a cartilage intermediate as an osteoinductive template. To enable 
an effective translation of this endochondral approach to clinic, it is imperative 
to possibly shorten the in vitro procedure for the creation of cartilage template 
and meanwhile ensure a sufficient bone formation. Therefore, in the chapter, 
we aimed to investigate the influence of in vitro chondrogenic priming time on 
the in vivo endochondral bone formation both qualitatively and quantitatively. 
To this end, rat bone marrow derived mesenchymal stem cells were seeded 
on two scaffolds with distinguished features, i.e. a fibrous poly(lactic‐co‐
glycolic acid)/poly(ε‐caprolactone) electrospun scaffold (PLGA/PCL) or a porous 
hydroxyapatite/tricalcium phosphate composite (HA/TCP). Next the constructs 
were chondrogenically differentiated for 2, 3 and 4 weeks in vitro followed by 
subcutaneous implantation for up to 8 weeks. A longer chondrogenic priming 
time resulted in a significantly increased amount and homogeneous deposition 
of the cartilage matrix on both PLGA/PCL and HA/TCP scaffolds in vitro. In vivo, all 
implanted constructs gave rise to endochondral bone formation, whereas the bone 
volume was not affected by a longer priming time. An unpolarized woven bone 
like structure, with significant amounts of cartilage remaining, was generated in 
fibrous PLGA/PCL scaffolds, while porous HA/TCP scaffolds supported progressive 
lamellar‐like bone formation with mature bone marrow development. These data 
suggest that, by utilizing a chondrogenically differentiated MSC‐scaffold construct 
as cartilage template, the essential in vitro priming time could be shortened to 
2 weeks to generate a substantial amount of vascularized endochondral bone in 
vivo. The structure of the bone was controlled by the chemical and structural cues 
provided by the scaffold design. 
1. Introduction
The bone forming process during development and regeneration is governed by 
intramembranous or endochondral mechanism, through which bone is generated 
by direct osteoblastic differentiation or remodelling from a cartilage intermediate, 
respectively [1‐3]. Recapitulation of endochondral ossification leads to a new 
route to engineer bone tissue, which generally involves two steps: 1) creating a 
cartilage intermediate in vitro and 2) implanting the cartilage intermediate as an 
osteoinductive template to transform into bone [4, 5]. Recent studies have shown the 
superiority of generating vascularized bone tissue via the endochondral approach, 
which has the potential to overcome the issue of insufficient vascularization faced 
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by the conventional bone tissue engineering based on the intramembranous 
ossification [6‐9]. 
In general, to create the cartilage intermediate, mesenchymal stem cells (MSCs) 
loaded in a three dimensional scaffold or in a cell pellet form are cultured in 
chondrogenic conditions for a certain time period before in vivo implantation. 
The obtained cartilage serves as a morphological template enabling blood vessel 
invasion and endogenous MSCs recruitment for successive bone formation [10]. It 
is clear that such a cartilage construct contains essential “biological instructions” 
to initiate and regulate the endochondral bone forming process, and this largely 
relies on the stage of the chondrogenic differentiation, as chondrocytes possess 
specific metabolic features and secrete diverse biochemical cues when they are in 
different developmental stages [9, 11]. A fine coordination between the progression 
of the cartilage construct and endochondral transformation needs to be launched 
by choosing an optimal time period for in vitro chondrogenic priming.
In literature, the protocol applied for chondrogenically differentiating MSCs was 
typically aimed to reach the stage with a certain degree of hypertrophy before 
implantation, which usually lasts for 4 to 5 weeks [4, 6, 9]. The hypothesis behind 
this approach was that hypertrophy could ensure the progression of endochondral 
differentiation and secretion of substantial amount of vascular endothelial growth 
factor (VEGF), which might enable timely establishment of vascularization into the 
implants [12]. However, this assumption was made mainly based on the use of cell 
pellets, and it has not yet been confirmed [13, 14]. For the final application, it is more 
relevant to elucidate the optimal in vitro priming time for the creation of cartilage 
template when a scaffold material is involved.  
  From a clinical point of view, a long in vitro culture time associates with 
considerably high treatment cost and regulatory burden, which hampers the 
effective translation of this tissue engineering strategy to the clinics. Therefore, it 
is imperative to seek the possibility of shortening this procedure and meanwhile 
ensure a sufficient endochondral bone formation. In order to gain more insight on 
the endochondral approach for future clinical applications, we aimed to investigate 
the influence of chondrogenic priming time on the in vivo endochondral bone 
formation both qualitatively and quantitatively. Furthermore, to examine if such 
influence is universal or also depends on the properties of the applied scaffolds, 
two representative scaffolds with distinguished characteristics were selected 
as cell carrier, i.e. a polymer‐based fibrous poly(lactic‐co‐glycolic acid)/poly(ε‐
caprolactone) electrospun scaffold (PLGA/PCL) and a ceramic‐based porous 
hydroxyapatite/tricalcium phosphate composite (HA/TCP). Rat bone marrow 
derived MSCs were first seeded on these two scaffolds and cultured in chondrogenic 
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condition for 2, 3 and 4 weeks. Afterwards, these cell‐scaffold constructs were 
implanted subcutaneously for up to 8 weeks in nude rats to assess bone formation 
and cartilage remains by histological stainings and histomorphometric analysis. 
2. Materials and Methods
2.1 Cell isolation, seeding and culture
MSCs were isolated from 6‐week‐old male Fischer rats (Charles River) after the 
approval from Radboud University Animal Ethics Committee (Approval no: RU‐
DEC 2012‐195). Briefly, two femora of each rat were removed and the epiphyses 
were cut off. Rat MSCs were flushed out from the remaining diaphyses using the 
proliferation medium through a needle. The proliferation medium consisted of alpha 
Minimal Essential Medium (aMEM; Gibco, Grand Island, USA) supplemented with 
10% fetal bovine serum (FBS; Sigma, St. Louis, USA), 100 U/ml penicillin, 100μg/ml 
streptomycin (Gibco), 50 μg/ml l‐ascorbic acid (Sigma) and 10nM dexamethasone 
(Sigma). The flush‐out was cultured for 1 day in a humidified incubator (37 °C, 5% 
CO2), after which the medium was refreshed to remove non‐adherent cells. The 
cells were cultured for an additional 4 days then they were detached using trypsin/
EDTA (0.25% w/v trypsin, 0.02% w/v EDTA; Sigma) and counted. 
The cells were seeded in two types of scaffold: 1) Fibrous poly(lactic‐co‐glycolic 
acid) (PLGA, Purasorb® PDLG 8531, Purac Biomaterials BV, Gorinchem, the 
Netherlands) combined with poly(ε‐caprolactone) (PCL, LACTEL® Absorbable 
Polymers, DURECT Corporation, Pelham, USA) electrospun scaffold made by a wet‐
electrospinning technique (Esprayer ES‐2000S, Fuence Co., Ltd, Tokyo, Japan) as 
previously described [7]. This PLGA/PCL scaffold was in a disk shape with 6 mm of 
diameter and 2 mm of thickness. 2) Porous sintered hydroxyapatite (HA)/tricalcium 
phosphate (TCP) composite (CAM biceramics, Leiden, the Nethelands) in a cubic 
shape of 3×3×3 mm. This HA/TCP scaffold consisted of HA and TCP with a 75/25 
weight ratio and the volumetric porosity was 75% (provided by the manufacturer). 
Before cell seeding, the scaffolds were sterilized by either autoclave (HA/TCP) or in 
70% ethanol for 2 hours (PLGA/PCL) and subsequently soaked in the proliferation 
medium overnight after being washed with PBS. During cell loading, the scaffolds 
were incubated in the cell suspension with a concentration of 1 × 106 cells/ml (4 
scaffolds per 1 ml of cell suspension) and gently rotated for 3 hours. Afterwards the 
unattached cells from the suspension were collected, centrifuged and reseeded 
onto the scaffolds to ensure a high cell loading efficiency. 
All cell‐scaffold constructs were cultured for 1 week in proliferation medium. 
Thereafter, the medium was changed to chondrogenic medium, consisting of 
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high‐glucose DMEM (Gibco), 1% FBS, 100 U/ml penicillin, 100 μg/ml streptomycin, 
50 μg/ml l‐ascorbic acid, 100 mM of sodium pyruvate (Gibco), 40μg/ml l‐proline 
(Sigma), 1:100 insulin‐transferrin‐selenium (ITS; BD Biosciences, Bedford, USA), 
100nM dexamethasone, 10 ng/ml of transforming growth factor beta‐2 (TGF‐β2; 
R&D systems, Minneapolis, USA) and 100 ng/ml bone morphogenetic protein 
2 (BMP‐2; BD biosciences). The constructs were cultured for 2, 3 or 4 weeks in 
chondrogenic medium which was refreshed twice a week. At each time point, the 
cell‐scaffold constructs were collected and divided into two groups. One group of 
samples were used for in vitro characterization and the other for subcutaneous 
implantation.
2.2 In vitro tests
2.2.1 GAG content
The amount of GAG in each sample was detected by a sulfated glycosaminoglycan 
(sGAG) assay (n=3). After being washed twice in PBS, all samples were digested 
in proteinase K solution (1 mg/ml proteinase K in 50 mM Tris with 1 mM EDTA, 1 
mM iodoacetamide, and 10 μg/ml pepstatin A) (all reagents from Sigma) for 20 
hours at 56°C. The GAG content was determined by using dimethylmethylene blue 
(Polysciences Inc., Warrington, USA), with chondroitin sulfate (Sigma) as standard 
control. Measurements of absorption were performed at 530 nm and 570 nm 
using an ELISA reader (Bio‐Tek Instruments Inc., Winooski, USA). The results were 
calculated according to the previously described method [15]. 
2.2.2 DNA content
DNA content (n=3) was quantified by QuantiFluorTM DNA system (Promega 
Corporation, Madison, USA) using the same cell extract solution as used for 
the GAG assay. Followed the manufacturer’s instruction, a DNA standard curve 
was used to quantify the amount of DNA in each sample and the results were 
measured using a fluorescence microplate reader (Bio‐Tek Instruments Inc.) with 
an excitation wavelength at 485nm and an emission wavelength at 530nm.
2.2.3 RNA extraction and qPCR analysis
After 2, 3 and 4 weeks of chondrogenic culture, RNA of the seeded cells was 
extracted using TRIzol® reagent according to the manufacturer’s instructions (Life 
Technologies, Carlsbad, USA). The obtained RNA was dissolved in RNase free water 
and the concentration was measured with spectrophotometer (NanoDrop 2000, 
Thermal scientific, Wilmington, USA). Subsequently, first strand cDNA was reverse 
transcribed from RNA using iScript™ cDNA Synthesis Kit (Bio‐Rad Laboratories, Inc., 
USA). Afterwards cDNA was further amplified and the expression of specific genes 
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was quantified using IQ SYBR Green Supermix PCR kit (BioRad, Hemel Hempstead, 
United Kingdom) in a real‐time PCR (BioRad, CFX96™ real‐time system) (n=4). 
Chondrogenic‐related gene markers were evaluated, including collagen type II 
(Col2α1), aggrecan (Acan), collagen type X (Col10α1) and VEGF (Vegfa) (Table 1). 
The specificity of the primers was confirmed separately before the real‐time PCR 
reaction. The expression levels were compared to the housekeeping gene β-Actin 
and calculated via the 2‐∆∆Ct method [16]. 
2.2.4 Histological analysis
The in vitro HA/TCP scaffolds were fixed in 10% phosphate buffered formalin for 1 
hour and embedded in methylmetacrylate (MMA, L.T.I., Bilthoven, the Netherlands) 
(n=3). Sections of to 15μm were made using a microtome equipped with diamond 
blade (Leica SP1600, Leica microsystem, Wetzlar, Germany) and then stained with 
0.04% thionin solution (Sigma). The in vitro PLGA/PCL scaffolds were fixed in 10% 
phosphate buffered formalin for 1 hour and embedded in paraffin (n=3). The 
microtome sections with 5 μm of thickness were also stained with 0.04% thionin 
solution after deparaffinization in xylene and rehydration through graded ethanol.
2.3 In vivo implantation
After 2, 3 and 4 weeks of in vitro culture, the cell‐scaffold constructs were implanted 
subcutaneously in 8‐week‐old male nude rats (Crl:NIH‐Foxn1mu, Charles River). 
The protocol was approved by the Animal Ethical Committee of the Radboud 
University Medical Centre (Approval no: RU‐DEC 2012‐195) and the national 
guidelines for the care and use of laboratory animals were applied. For each time 
condition, 3 rats were used for the implantation. All rats received analgesic before 
and after the surgery. Surgery was performed under general inhalation anesthesia 
with a combination of isoflurane, nitrous oxide, and oxygen. The back of the 
rats was shaved and disinfected with povidone‐iodine. Subsequently, four small 
longitudinal incisions were made and a subcutaneous pocket was created lateral 
to each incision. Two HA/TCP and two PLGA/PCL constructs were implanted to 
Table 1. Primer sequences used for qPCR
Forward (5’ → 3’) Reverse (5’ → 3’)
Col2α1 GACGCCACGCTCAAGTCGCT CGCTGGGTTGGGGTAGACGC
Col10α1 GGGCCCTATTGGACCACCAGGTA CCGGCATGCCTGTTACCCCC
Acan CATTCGCACGGGAGCAGCCA TGGGGTCCGTGGGCTCACAA
Vegfa ACTCATCAGCCAGGGAGTCT GGGAGTGAAGGAGCAACCTC
β-Actin TTCAACACCCCAGCCATGT TGTGGTACGACCAGAGGCATAC
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each rat (one construct per pocket). After placing the samples, the skin was closed 
using staples. After 4, 6 and 8 weeks, rats were euthanized by CO2‐suffocation for 
sample collection.
2.4 Histological staining of the in vivo samples
All in vivo samples were fixed in 10% phosphate buffered formalin for 30 hours 
and dehydrated through graded ethanol. For each rat, half of the samples (one 
HA/TCP and one PLGA/PCL construct) were embedded in MMA, and the other half 
samples were embedded in paraffin.
MMA embedded samples (n = 3 for each time condition) were sectioned using 
a microtome equipped with diamond saw (Leica SP1600, Leica microsystem, 
Wetzlar, Germany) and then stained with methylene blue and basic fuchsin (both 
reagents from Merck). 
Prior to paraffin embedding, the fixed samples (n = 3 for each time condition) were 
decalcified by 10% EDTA and the decalcification process was monitored via X‐ray. 
Five μm‐thick sections were made from each sample and used for hematoxylin/
eosin (HE), Elastic Van Gieson (EVG) and collagen II staining.  
2.5 Histological and histomorphometrical analysis
Digital images of all histological sections were made using a light microscope 
equipped with a digital camera (Axio Imager Z1, Carl Zeiss AG Light Microscopy, 
Göttingen, Germany). Histological analysis consisted of a concise morphological 
and histological evaluation of all sections. Histomorphometrical analysis was 
performed with computer‐based quantitative image analysis techniques based on 
color recognition with manual correction (Leica QWin Pro®, Leica Microsystems 
AG, Wetzlar, Germany). For both HA/TCP and PLGA/PCL scaffolds, quantification 
of bone and cartilage area was performed on EVG staining images and collagen 
II staining images, respectively. The region of interest (ROI) in each image 
was defined from the total area of the cross section (including the scaffold 
region) which was manually set using Leica QWin software. Bone and cartilage 
tissue were discriminated by the difference in staining intensity and cellular 
morphology. The parameters “bone area” and “cartilage area” were evaluated and 
defined as a percentage of bone or cartilage tissue within the ROI, respectively. 
Histomorphometrical data were collected based on three sections per specimen 
and averaged to one value per specimen.
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2.6 Statistic analysis 
The data was analyzed using two‐way ANOVA followed by Bonferroni’s Multiple 
Comparison Test (GraphPad Prism 5, GraphPad Software Inc., San Diego, USA). 
Mean values and standard deviations (SD) are reported in each figure as well 
as relevant statistical relationships. Differences were considered statistically 
significant at p < 0.05. 
3. Results
3.1 In vitro cartilage formation pre-implantation
3.1.1 GAG production and DNA content
As shown in Fig. 1a, on both PLGA/PCL and HA/TCP scaffolds the total amount 
of GAG deposition accumulated with chondrogenic culture time and reached the 
highest amount in week 4. PLGA/PCL demonstrated significant higher amount 
Figure 1. GAG (a) and DNA (b) content of PLGA/PCL and HA/TCP constructs after in 
vitro chondrogenic priming. * p<0.05, ** p<0.01; error bars represent standard 
deviation of the mean (n=3)
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of GAG compared to that on the HA/TCP scaffolds. Furthermore, a comparable 
DNA amount was detected on both PLGA/PCL and HA/TCP, which remained stable 
during the entire culture period (Fig. 1b). 
3.1.2 Expression of chondrogenic genes
For both PLGA/PCL and HA/TCP scaffolds, Col2α1 and Acan expression mantained 
stable during the in vitro chondrogenic priming process and comparable expression 
levels were detected on both scaffolds (Fig. 2a and b). On the PLGA/PCL constructs 
there was a peak for the Col10α1 expression at week 3. In comparison, for the 
HA/TCP constructs, the expression of Col10α1 remained constant till week 3 and 
then decreased dramatically at week 4. Moreover, significantly higher expression 
of Col10α1 was shown on the PLGA/PCL constructs compared to that on HA/TCP 
after 3 or 4 weeks of chondrogenic priming (Fig. 2c). Regarding the expression 
of Vegfa, HA/TCP constructs demonstrated a significantly higher level than that 
of PLGA/PCL. Overall, for both scaffolds, the level of Vegfa expression remained 
constant during the in vitro priming.  
Figure 2. Gene expression of collagen II (a), aggrecan (b), collagen X (c) and VEGF (d) 
after in vitro chondrogenic priming. * p<0.05, ** p<0.01; error bars represent 
standard deviation of the mean (n=4)
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Figure 3. In vitro chondrogenic differatiation in PLGA/PCL and HA/TCP scaffolds after 
2 and 4 weeks of culture. Cartilage matrix formation (stained purple) and cell 
penetration inside of the PLGA/PCL scaffolds could be observed after 2 weeks of 
chondrogenic priming (a and c). Nevertheless, the cartilage matrix mainly located on 
one side of the scaffolds (a). When the culture time reached 4 weeks, the cartilage 
matrix spread throughout the entire fibrous structure (b) and a great number of cells 
with typical chondrocyte-like morphology could be observed (d). For HA/TCP scaffolds, 
the cartilage formation could be observed on the pore surfaces of 2-week primed 
constructs (e), while the cell penetration and matrix deposition were very limited in 
the center of the scaffolds (e). Chondrocyte-like cells were embedded in the matrix 
and mixed with undifferentiated cells (g). As the priming time increased, the cartilage 
matrix deposition was augmented and distributed more homogeneously in the 
scaffolds (f). After 4 weeks, the presented cells in the scaffolds mainly consisted of 
chondrocyte-like cells (h).
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 3.1.3 Histological analysis
To visualize the cartilage matrix deposition in the scaffolds, sections were made and 
stained with thionin. During the histological processing, PLGA/PCL scaffolds shrank 
and formed folds on the surfaces as shown in Fig. 4a. Yet cartilage matrix (GAG) 
formation and cell penetration inside of the scaffolds could be clearly observed 
after 2 weeks of chondrogenic priming (Fig. 3a and c). Nevertheless, the cartilage 
matrix mainly located on one side of the scaffolds. When the culture time reached 
4 weeks, the cartilage matrix spread throughout the entire fibrous structure (Fig. 
3b) and a large number of cells with typical chondrocyte‐like morphology could be 
observed (Fig. 3d). 
For HA/TCP scaffolds, the cartilage formation could be observed on the pore surfaces 
after 2 weeks of chondrogenic priming, while the cell penetration and matrix 
deposition were  limited in the center of the scaffolds (Fig. 3e). Typical chondrocyte‐
like cells were embedded in the matrix and mixed with undifferentiated cells (Fig. 
3g). As the chondrogenic priming time increased, the cartilage matrix deposition 
was augmented and distributed more homogeneously in the scaffolds (Fig. 3f). 
After 4 weeks, the cells present in the scaffolds mainly consisted of chondrocytes 
which were surrounded by abundant matrix and appeared in isogenous groups or 
with large lacunae (Fig. 3h).
3.2 In vivo bone formation
3.2.1 General observations
From the total 27 animals available for surgery, one animal died during anesthesia. 
Due to this, 3‐week in vitro priming group had one animal less than the other 
groups for evaluating the bone formation at the 8‐week time point. The remaining 
26 animals recovered uneventfully from the surgical procedure and remained in 
good health. No signs of wound complications were observed post‐operatively. At 
the time point of 4, 6 or 8 weeks, all samples were retrieved and macroscopic signs 
of inflammation or adverse tissue responses were absent for all of the retrieved 
samples.  
3.2.2 Descriptive histology
Bone formation was found in all PLGA/PCL and HA/TCP scaffolds. The bone forming 
quality and quantity were similar in all samples within the same group. 
3.2.2.1 PLGA/PCL scaffold
With different in vitro chondrogenic priming time, extensive cartilage remodeling 
has already occurred within the PLGA/PCL scaffolds after 4 weeks of implantation 
(Fig. 4a and b). The bone/cartilage complex distributed in the scaffolds in a 
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dispersive manner and displayed a trabecula‐like structure. The implanted scaffolds 
that received 4 weeks of chondrogenic priming in vitro showed higher amount 
of bone/cartilage matrix presence in vivo with less fibrous tissue occupation (Fig. 
4b) compared to the constructs which were chondrogenically differentiated for 2 
weeks (Fig. 4a). From the HE staining pictures, a mixture of bone and cartilage tissue 
could be observed in all PLGA/PCL scaffolds independent of in vitro priming and 
in vivo implantation time (Fig. 5). Bone matrix was frequently found deposited on 
the periphery of cartilage tissue or around the enlarged lacunae of chondrocytes. 
The newly formed bone tissue resembled a woven bone structure, in the 
surrounding of which the blood vessel formation could occasionally be observed. 
Concentrically organized bone tissue and marrow development could not be seen 
(Fig. 5). Furthermore, the non‐degraded electrospun fibers of the scaffolds were 
also integrated with the bone/cartilage matrix and surrounding tissue. 
Figure 4. Overview of in vivo bone formation. MMA sections of PLGA/PCL (a and b) 
and HA/TCP (c and d) constructs after 4 weeks of implantation were stained with 
methylene blue and basic fuchsin. In PLGA/PCL constructs, the bone/cartilage 
complex distributed in the scaffolds in a dispersive manner and displayed a trabecula-
like structure. With 2 weeks of in vitro chondrogenic priming time, extensive cartilage 
remodeling has already occurred (a), while 4-week primed PLGA/PCL constructs 
showed higher amount of bone/cartilage matrix presence in vivo with less fibrous 
tissue occupation (b). For HA/TCP scaffolds, bone formation occurred throughout the 
whole implants with 2-week (c) or 4-week (d) in vitro priming, which was characterized 
by close apposition of matrix on the surface of the pores together with islet or bridge 
like bone tissue in the middle space of the pores.
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Figure 5. Morphology of in vivo bone formation in PLGA/PCL constructs (HE staining). 
A mixture of bone and cartilage tissue could be observed in all PLGA/PCL scaffolds 
independent of in vitro priming and in vivo implantation time. Bone matrix (stained 
red) was frequently found deposited on the periphery of cartilage tissue (stained 
purple) or around the enlarged lacunae of chondrocytes. The newly formed bone 
resembled a structure of the woven bone with vascular infiltration in the surrounding 
tissue. Concentrically organized bone tissue and marrow development could not be 
seen. (B: bone; C: cartilage.)
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Figure 6. Morphology of in vivo bone formation in HA/TCP constructs (HE staining). 
The length of the in vitro priming time did not show obvious influences on the 
structure of the newly formed bone (stained red) at each in vivo time point. After 4 
weeks of in vivo implantation, the new bone displayed in an irregular shape and the 
osteoblasts could be recognized aligning at the periphery of the bone matrix (a and 
e). The cartilage remnants (stained purple) were observed to fill small pores or mix 
with the bone tissue (b and f). Marrow stroma development was initiated and filled 
with abundant hematopoietic cells. After 8 weeks in vivo, the matrix exhibited a 
concentric pattern and the collagen bundles arranged in a more parallel manner (c 
and g). The bone marrow cavity was mainly occupied by adipose cells, amongst 
which a great number of blood vessels were well represented. Cartilage remnant was 
hardly seen inside of the scaffolds (d and h). (BM: bone marrow; Black arrow: 
cartilage.)
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3.2.2.2 HA/TCP scaffold
For HA/TCP scaffolds, bone formation occurred throughout the whole implants. 
Only small amount of cartilage remained after 4 weeks of in vivo implantation. 
The bone tissue was characterized by close apposition of matrix on the surface 
of the HA/TCP pores together with islet or bridge like bone tissue in the middle 
space of the pores (Fig. 4c and d). At each in vivo time point, the length of the in 
vitro priming time did not show obvious influences on the structure of the newly 
formed bone and cartilage remnant. 
The maturity of the bone tissue was observed to change over time in vivo. After 4 
weeks of in vivo implantation, the new bone displayed in an irregular shape and the 
osteoblasts could be recognized aligning at the periphery of the bone matrix (Fig. 
6a and e). The cartilage remnants were observed to fill small pores or mix with the 
bone tissue (Fig. 6b and f). Marrow stroma development was initiated and filled 
with abundant hematopoietic cells.  After 8 weeks in vivo, the bone tissue further 
matured. As shown in Fig. 6c and g, the matrix exhibited a concentric pattern and 
the collagen bundles arranged in a more parallel manner compared to the early 
stage bone formation. Bone surface was partially covered by elongated, thin lining 
cells. Moreover, the bone marrow cavity was mainly occupied by adipose cells, 
amongst which a great number of blood vessels were well represented (Fig. 6d 
and h). Cartilage remnants were hardly detected inside of the scaffolds.
3.2.3 Histomorphometrical evaluation
The EVG staining and Collagen II staining were used to visualize the presence of 
bone and cartilage tissue, respectively. As shown in the overview pictures of PLGA/
PCL scaffolds (Fig. 7a), longer in vitro priming time resulted in more homogeneous 
distribution of in vivo bone formation and less fibrous tissue occupation within the 
PLGA/PCL scaffolds. The collagen II staining confirmed the significant existence of 
the remaining cartilage matrix (Fig. 7b). For HA/TCP scaffolds, similar amount and 
location of bone formation was revealed at all in vivo time points with very limited 
presence of cartilage remnant (Fig. 8).
Quantitative results of bone and cartilage amount are depicted in Fig. 9. The 
volume of newly formed bone in PLGA/PCL scaffolds did not alter significantly 
within the in vivo implantation time, with the average bone area fraction ranged 
from 12% to 18% (Fig. 9a). In contrast, for HA/TCP scaffolds, bone formation was 
increased as the in vivo time and the average area fraction value raised from 15% 
to 25% (Fig. 9b). For both scaffolds, the length of in vitro priming time did not show 
obvious influences on bone volume at each in vivo time point. However, significant 
higher amount of cartilage remnants was detected in PLGA/PCL scaffolds when 
the constructs received 4‐week chondrogenic treatment in vitro (Fig. 9c). In HA/
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TCP scaffolds, marginal amount of cartilage was found after 4 weeks of in vivo 
implantation and maintained stable thereafter, of which the area fraction was less 
than 5% (Fig. 9b). 
4. Discussion
To implement endochondral bone formation route for the clinical applications, 
it is imperative to utilize an essentially shortened in vitro priming procedure 
for the creation of a cartilage template to induce bone formation in vivo. In the 
current study, we aimed to investigate the influence of chondrogenic priming time 
on the in vivo endochondral bone formation regarding its quality and quantity. 
Furthermore, to examine if such influence is universal or also depends on which 
Figure 7. Overview of in vivo bone formation and cartilage remnant in PLGA/PCL 
constructs. The decalcified in vivo samples were stained with EVG (a) and collagen II 
staining (b) to visualize the presence of bone and cartilage tissue, respectively. Longer 
in vitro priming time resulted in more homogeneous distribution of in vivo bone 
formation (stained red) and less fibrous tissue occupation within the PLGA/PCL 
scaffolds (a). The collagen II staining confirmed the significant existence of the 
remaining cartilage matrix (stained red) (b). (scale bar: 500µm) 
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Figure 8. Overview of in vivo bone formation and cartilage remnant in HA/TCP 
constructs with different in vitro priming time. The decalcified in vivo samples were 
stained with EVG (a) and collagen II staining (b) to visualize the presence of bone and 
cartilage tissue, respectively. Different in vitro priming time resulted in similar 
amounts and locations of bone formation (stained red) with marginal cartilage 
remnants at each in vivo time point (stained red). (scale bar: 500µm)
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scaffold material is applied, two scaffolds with distinguished characteristics were 
selected as cell carrier, i.e. fibrous PLGA/PCL and porous HA/TCP scaffolds.  
By varying the chondrogenic priming time, we were able to establish cartilage 
constructs with distinct features for this study. With longer priming time, the 
amount and homogeneity of cartilage matrix deposition increased significantly 
over time, and meanwhile the number of undifferentiated MSCs decreased. 
The expression of Col10α1, associated with chondrocyte hypertrophy [17, 18], was 
detected after 2 weeks of chondrogenic priming for both PLGA/PCL and HA/TCP 
constructs. These data suggest that a part of the MSCs on these scaffolds may have 
proceeded toward the hypertrophic stage at this time point. For 4‐week primed 
constructs, a significant decrease of Col10α1 expression was shown, indicating the 
late stage of cell hypertrophy. Notably, for both scaffolds, Vegfa expression of the 
seeded cells has already been detected after 2 weeks, and the level maintained 
stable thereafter. These data confirmed the capability of VEGF release for all 
implanted constructs irrespective of the in vitro priming time. 
After implantation, our data suggested that further differentiation of the MSC‐
scaffold based cartilage constructs prior to implantation did not result in a faster or 
enhanced bone formation in vivo. Similar quantity and quality of new bone tissue 
was generated in vivo in HA/TCP scaffolds irrespective of in vitro culturing time. 
For PLGA/PCL scaffolds, although longer‐primed cartilage templates gave rise to 
higher quantity of cartilage remains and more homogeneously distribution of the 
new bone formation in vivo, the bone amount and maturity was in fact comparable. 
These results are inconsistent with several previous studies. Scotti et al. applied an 
advanced in vitro chondrogenic priming of human MSC pellets for 5 weeks, which 
resulted in accelerated in vivo bone formation compared to short priming for 2 
weeks [13]. In comparison, Freeman et al. chondrogenically differentiated human 
and murine MSCs in pellets with different time periods from 10 days to 4 weeks. 
The results demonstrated 2 or 3‐week priming was optimal to achieve the highest 
in vitro mineralization capacity of the cell pellets rather than 4 weeks [14]. However, 
it has to be noted that, in these studies the in vivo endochondral bone formation 
was tested via a scaffold‐free cell pellet form, where the microenvironment and 
cellular behaviors are different from the case when a scaffold is involved. 
For the first time, our results indicated that, by utilizing a chondrogenically 
differentiated MSC‐scaffold construct as cartilage template, the essential in vitro 
priming time could be shortened to 2 weeks to generate a substantial amount of 
vascularized endochondral bone in vivo. This can be closely correlated to the profile 
of Vegfa expression, which has already been detected after 2 weeks. As previously 
shown by Farrell et al., a considerable amount of VEGF was released from the cell 
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pellets after 2 weeks of in vitro chondrogenic induction [4]. After implantation, the 
distinctive roles of VEGF could be exerted in the cartilage remodeling and bone 
forming process, such as promoting angiogenesis [19], chemoattractant effects 
on MSCs [20] and mediating osteoblastic differentiation [21]. Moreover, it is likely 
that the undifferentiated MSCs also participated in the process of endochondral 
bone formation. An explanation is that, these cells committed to chondrogenic 
lineage after implantation and fulfill their role in hypertrophy together with 
other chondrocytes to facilitate the vascularization and the recruitment of 
osteoprogenitors from the host animal [2, 22]. Another explanation is, that the 
undifferentiated MSCs were instructed by the hypertrophic chondrocytes to 
become osteoblasts or hematopoietic cells, and directly participated in building 
the vascularized bone tissue [23]. In either case, it implies that a certain extent 
of in vitro chondrogenic priming of the MSCs, e.g. for 2 weeks, or possibly with 
Figure 9. Quantification of bone and cartilage amount after implantation. The total 
ratio of newly formed bone in PLGA/PCL scaffolds remained constant within the in 
vivo implantation time (a), while for HA/TCP scaffolds, bone formation was increased 
over time (b). For both scaffolds, the length of in vitro priming time did not show 
obvious influences on bone volume at each in vivo time point (a and b). However, 
significant higher amount of cartilage remnant was detected in PLGA/PCL scaffolds 
when the constructs received 4-week chondrogenic treatment in vitro (c). In HA/TCP 
scaffolds, marginal amount of cartilage was detected (d). (* p<0.05, ** p<0.01; # 
represents significant difference compared to the bone ratio at week 4 in vivo, # 
p<0.05, ## p<0.01; error bars represent standard deviation of the mean, n=3)
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even shorter time, might be sufficient to ensure the progression of endochondral 
differentiation of the seeded cells and enable successful bone formation, even 
after been implanted in a non‐chondrogenic or non‐osteogenic environment. 
Instead of being influenced by the in vitro priming time, our data have suggested 
that the newly formed endochondral bone could be generated in different manners 
based on the chemical and structural cues provided by the scaffold design. Newly 
formed woven bone like structure and significant cartilage presence have been 
observed in PLGA/PCL scaffolds after 4 weeks in vivo. Surprisingly, such structures 
were maintained up to 8 weeks. In comparison, cartilage remnants were hardly 
seen in HA/TCP scaffolds after 4 weeks. Over time, the amount and maturity of 
endochondral bone formation significantly improved after 8 weeks. These findings 
indicated that, HA/TCP scaffold supported more rapidly progression of the 
endochondral bone generation and vascularization compared to PLGA/PCL, which 
might be closely related to the high VEGF expression of the cells stimulated by 
the HA/TCP scaffolds. Regarding the pattern of the bone matrix, HA/TCP scaffolds 
instructed the new bone tissue to deposit on the surface of the interconnected 
pores in a polarized fashion, whereas for PLGA/PCL constructs, a fully integrated 
bone/cartilage/electrospun fiber complex was built without any preferential 
arrangement of bone tissue. Similar results have also shown previously by Scaglione 
et al. and they addressed such different bone‐forming patterns were attributed to 
the specific scaffold geometry [24]. The confined porous structure could concentrate 
collagen fibers and serve as a polarizing template within the pores to trigger the 
formation of lamellar like bone. On the contrary, fibrous scaffolds possessed a 
high level of geometrical complexity, thus the new collagen fibers formed by the 
cells were distributed in a isotropic manner, resulting mostly in woven bone [24]. 
Above all, our data confirmed that scaffolds played a crucial role in influencing 
cell behaviors and bone deposition kinetics. The control over endochondral bone 
formation could be exerted through rational design of the scaffolds.  
This study contributes to the view that chondrogenical priming of rat MSCs in the 
presence of biomaterials followed by in vivo implantation was able to generate 
endochondral bone in vivo. Moreover, we demonstrated that it was not necessary 
to differentiate MSCs till fully hypertrophy to accomplish vascularized bone 
formation. However, it has to be noted that this conclusion needs to be further 
evidenced in a more clinically relevant situation by using human MSCs and 
implanting in an orthotopic location, where the mechanical load and biochemical/
inflammatory factors are closely involved. Moreover, we could not conclude if 
2‐week is the essential time length for chondrogenic priming and if such process 
can be further shortened, because no other shorter period has been chosen for 
this study. Additionally of interest is the further understanding of 1) the function 
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and the fate of the implanted cells, and 2) the specific responses of the seeded 
cells induced by particular scaffold properties and the underlying mechanisms, so 
that the endochondral route can be established to target efficient and large‐scale 
bone regeneration.
5. Conclusion
In vitro chondrogenic priming of rat MSCs for 2, 3 and 4 weeks leads to vascularized 
endochondral bone formation in vivo on two distinct scaffolds, i.e. fibrous PLGA/
PCL and porous HA/TCP scaffolds. A longer in vitro priming time can result in a 
more homogeneous distribution of bone formation, whereas this does not 
have to give rise to a higher amount of in vivo bone formation in the selected 
scaffolds. Evidently, in our study the quality of endochondral bone was influenced 
by the chemical‐physical design of the scaffolds. An unpolarized woven bone 
like structure was generated in fibrous PLGA/PCL scaffolds, while porous HA/TCP 
scaffolds supported progressive lamellar‐like bone formation with mature bone 
marrow development. Further investigations are warranted to investigate the 
essential in vitro priming time and the mechanism of cell‐scaffold interaction in 
the endochondral bone forming process. 
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Summary of this chapter
Costly and lengthy process for creating cartilage template hampers the translation 
of endochondral approach to clinic. A more comprehensive understanding of 
the crosstalk between implanted cartilage template and host cells is essentially 
beneficial to possibly simplify this procedure or develop substitutes for effective 
bone regeneration. Therefore, this chapter aimed to explore the role of cartilage 
template in mediating MSC behavior in the process of endochondral bone 
formation, as well as the possible signaling pathways involved in these biological 
events. To that end, rat bone marrow derived mesenchymal stem cells (MSCs) were 
seeded on a porous hydroxyapatite (HA) /tricalcium phosphate (TCP) composite 
and cultured in chondrogenic condition to create the cartilage templates. 
Afterwards, undifferentiated MSCs were co‐cultured with these constructs in 
a transwell system (separating cartilage template and MSCs with a permeable 
membrane) to assess the migration and osteogenic differentiation capacity of 
the MSCs. Furthermore, the expression profile of chemokine signaling related 
genes was analyzed via PCR array. The results demonstrated that chondrogenically 
differentiated MSC‐HA/TCP constructs (chondro‐TCP) were able to induce MSCs 
migration by possibly activating the IL8/CXCR2 signaling pathway. Additionally, 
they could trigger a considerable elevation of signaling factors responsible for 
MSCs recruitment and osteoclast stimulation, including CCL3, CCL7, CCL19 and NF‐
κB. The osteogenic differentiation of MSCs was not significantly influenced after 
short exposure to chondro‐TCP templates.
1. Introduction
During both embryogenesis and postnatal fracture repair, the majority of bone 
formation is governed by a mechanism known as endochondral ossification [1]. 
Such endochondral process has recently inspired a new concept of bone tissue 
engineering via a two‐step approach, during which a cartilage intermediate is first 
created in vitro, and subsequently implanted as an osteoinductive template in 
vivo to transform into bone [2]. It has been revealed this endochondral approach 
has a superior efficacy for generating vascularized bone tissue compared to 
the traditional intramembranous ossification method [3‐5]. Still, several issues 
hurdle the effective translation of this tissue engineering strategy to the clinics. 
For instance, the creation of cartilage templates is usually time‐consuming (3‐5 
weeks), and requires a large cell number as well as high usage of growth factors, 
e.g, transforming growth factor beta (TGF‐β) and bone morphogenetic proteins 
(BMPs). All of these associate not only the difficulties in obtaining sufficient 
cell source but also considerably high treatment costs and regulatory burdens. 
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Therefore, it is necessary to simplify the in vitro procedure or develop alternative 
products/compounds with similar or better functions as cartilage templates. 
Essentially, this would not be possible without a complete understanding of 
the mechanism underlying this endochondral approach, especially the in vivo 
functions of the cartilage template.
In practice, the engineered cartilage template used in endochondral approach is 
usually created by loading mesenchymal stem cells (MSCs) in a three‐dimensional 
scaffold or in cell pellet form followed by in vitro chondrogenic culturing. After 
implantation, the transformation from cartilage to bone is a very complex 
progression and involves the coordination of a variety of cell populations. Previous 
studies have shown that, instead of the direct contribution of the seeded cells 
from the cartilage templates, the in vivo endochondral bone formation was 
predominately originated by host cells [6]. Based on these results, it is speculated 
that the cartilage template plays an essential role in recruiting the host cells and 
regulating their performance in the successive bone forming process. Yet, this 
hypothesis has not been tested. The exact functions of the cartilage template 
for inducing regenerative functions of the host cells, e.g. MSCs, and the involved 
signaling pathways still remain unknown. 
Therefore, this study intended to investigate the effects of cartilage template 
on MSCs in terms of their migration and osteogenic differentiation ability. 
Furthermore, we also aimed to discover the possible signaling pathways involved 
in the crosstalk between cartilage templates and host MSCs. It is known that the 
communications between the cell populations are realized by different ways, 
including cell‐cell, cell‐matrix interactions, release of the soluble factors, or a 
combination thereof. Our study represented the first step and mainly focused on 
the effects of soluble factors. To that end, rat bone marrow derived MSCs were 
first seeded on a porous hydroxyapatite/tricalcium phosphate composite (HA/TCP) 
and cultured in chondrogenic condition to create the cartilage templates based on 
our previous study [5]. Afterwards, undifferentiated MSCs were co‐cultured with 
these constructs in an indirect co‐culture system (separating cartilage template 
and MSCs with a permeable membrane) to assess the migration and osteogenic 
differentiation capacity of the MSCs. Furthermore, the expression profile of 
chemokine signaling related genes was analyzed via PCR array to investigate the 
mechanism underlying the biological response of MSCs elicited by the cartilage 
template. 
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2. Materials and methods
2.1 Cell isolation 
Four 6‐week‐old male Wistar rats (Charles River, Wilmington, USA.) were used 
for MSC isolation after the approval from Radboud University Animal Ethics 
Committee. Two femora of each rat were removed and the epiphyses were cut 
off. Afterwards, rat MSCs were flushed out of the remaining diaphyses using 
the primary culture medium through an 18G needle (BD Microlance, Drogheda, 
Ireland), which consisted of alpha Minimal Essential Medium (αMEM; Gibco, 
Grand Island, USA) supplemented with 10% fetal bovine serum (FBS; Sigma, St. 
Louis, USA), 100 U/ml penicillin and 100μg/ml streptomycin (Gibco). The flush‐
out was cultured for 2 days in a humidified incubator (37 °C, 5% CO2), after which 
the medium was refreshed to remove non‐adherent cells. The cells were cultured 
for an additional 3 days followed by detachment using trypsin/EDTA (0.25% w/v 
trypsin, 0.02% w/v EDTA; Sigma) and counted. Half of the obtained the cells were 
used for cell seeding on the scaffolds, the other half was frozen in the culture 
medium containing 10% DMSO in the liquid nitrogen condition for later use.
2.2 Preparation of cartilage template
A porous HA/TCP composite (CAM bioceramics B.V., Leiden, the Netherlands) 
was used as cell carrier, which was obtained in a cubic shape of 3×3×3 mm3 
and consisted of HA and TCP with a 75/25 ratio. The volumetric porosity was 
75% (provided by the manufacturer). Prior to cell seeding, the scaffolds were 
autoclaved and soaked in the primary culture medium overnight. During cell 
seeding, the scaffolds were incubated in the cell suspension with a concentration 
of 1 × 106 cells/ml (4 scaffolds per 1 ml of cell suspension) and gently rotated 
for 3 hours. Afterwards, the scaffolds were placed in non‐adherent tissue culture 
plates and the unattached cells from the suspension were collected, centrifuged 
and reseeded onto the scaffolds to ensure a high cell loading efficiency. All of the 
constructs were proliferated for 1 week. Thereafter, the medium was changed to 
chondrogenic medium, consisting of high‐glucose DMEM (Gibco), 1% FBS, 100 U/
ml penicillin, 100 μg/ml streptomycin, 50 μg/ml l‐ascorbic acid, 100 mM of sodium 
pyruvate (Gibco), 1:100 insulin‐transferrin‐selenium (ITS; BD Biosciences, Bedford, 
USA), 100nM dexamethasone, 10 ng/ml of transforming growth factor beta‐2 
(TGF‐β2; R&D systems, Minneapolis, USA) and 100 ng/ml bone morphogenetic 
protein 2 (BMP‐2; BD biosciences). The constructs were cultured for 4 weeks 
to obtain the cartilage templates (named chondro‐TCP). Bare HA/TCP scaffolds 
without cell seeding were used as control (named bare‐TCP).
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2.3 MSCs migration test
A tranwell migration model was used to examine the migration of MSCs in response 
to the cartilage constructs (Fig. 1a). Primary rat MSCs were defrosted, expanded 
and then seeded onto ThinCertTM cell culture inserts (membrane pore size 8μm, 
Greiner Bio‐One) in a 24‐well plate at a density of 5,000 cells/insert. Then 200 μl 
and 600 μl DMEM supplemented with 1% FBS was added into the insert and lower 
chamber, respectively. Subsequently, two chondro‐TCP or bare‐TCP constructs 
were placed in the lower chambers. After 24 h culture in a humidified incubator 
(37 °C, 5% CO2), the inserts were removed and the upper side of the membrane 
was scraped to remove adherent cells. Further, they were fixed in 10% formalin for 
30 min, and stained with toluidine blue (0.05%) for 30 min to visualize the migrated 
cells on the lower side of the membrane. All samples were then photographed 
with Zeiss Imager Z1 equiped with AxioCam MRc5 camera (Carl Zeiss Microimaging 
GmbH, Göttingen, Germany). The number of the migrated cells was quantified 
based on the obtained images using Image J software (National Institutes of 
Health, Bethesda, USA).
2.4 Osteogenic differentiation of MSCs 
To further investigate the influence of cartilage constructs on the osteogenic 
differentiation of MSCs, a second indirect co‐culture system with smaller 
membrane pore size was established (Fig. 1b). MSCs were seeded in the 24‐well 
plate at a density of 100,000 cells per well. Afterwards, two chondro‐TCP or bare‐
TCP constructs were added into the top inserts (ThinCertTM cell culture inserts, 
membrane pore size 0.4 μm, Greiner Bio‐One) overlying the MSCs. Two‐hundred 
μl and 800 μl DMEM supplemented with 1% FBS was added into the insert and the 
Figure 1. Scheme of co-culture systems.
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lower well, respectively. After 4 days, MSCs in the lower well were collected for 
the following tests.  
2.4.1 PCR analysis of osteogenic-related genes 
RNA of MSCs was extracted using TRIzol® reagent according to the manufacturer’s 
instructions (Life Technologies, Carlsbad, USA). The obtained RNA (n=3) was 
dissolved in RNase free water and the concentration was measured with 
spectrophotometer (NanoDrop 2000, Thermal scientific, Wilmington, USA). 
Subsequently, first strand cDNA was reverse transcribed from RNA using iScript™ 
cDNA Synthesis Kit (Bio‐Rad Laboratories, Inc., USA). Afterwards cDNA was further 
amplified and the expression of specific genes was quantified using IQ SYBR Green 
Supermix PCR kit (BioRad, Hemel Hempstead, United Kingdom) in a real‐time PCR 
(BioRad, CFX96™ real‐time system) (n=4). Osteogenic‐related gene markers were 
evaluated, including runt‐related transcription factor 2 (Runx2), collagen type 1 
(Col1α1), alkaline phosphatase (Alp), and bone sialoprotein (Bsp) (Table 1). The 
specificity of the primers was confirmed separately before the real‐time PCR 
reaction. The expression levels were compared to the housekeeping gene β-Actin 
and calculated via the 2‐∆∆Ct method [7].
2.4.2 DNA content and ALP activity 
DNA content (n=3) of MSCS was quantified by QuantiFluorTM DNA system (Promega 
Corporation, Madison, USA) according to the manufacturer’s instructions. Culture 
medium and upper inserts was removed, and cells were washed twice with PBS. 
One ml of milliQ water was added to each well, after which 2 freeze‐thaw cycles 
were performed. A DNA standard curve was made from the Picogreen assay kit 
(Quant‐iT PicoGreen dsDNA, Invitrogen). 100 μl sample or standard were added 
to 100 μl freshly made working solution in the wells. The results were read using a 
fluorescence microplate reader (Bio‐Tek Instruments, Abcoude, The Netherlands) 
with an excitation wavelength at 485nm and an emission wavelength at 530nm.
Table 1. Overview of the primer sequences
Forward (5’ → 3’) Reverse (5’ → 3’)
Runx-2 GAGCACAAACATGGCTGAGA TGGAGATGTTGCTCTGTTCG
Col1α1 GAGCGATTACTACTGGATTGACCC CAAGGAATGGCAGGCGAGAT
Alp GGGACTGGTACTCGGATAACGA CTGATATGCGATGTCCTTGCA
Bsp TCCTCCTCTGAAACGGTTTCC GGAACTATCGCCGTCTCCATT
β-Actin TTCAACACCCCAGCCATGT TGTGGTACGACCAGAGGCATAC
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The ALP activity (n=3) was measured as a marker for osteogenic differentiation 
using the same cell extracts as for the DNA assay. 80 μl of sample or standard 
and 20μl buffer solution (5 mM MgCl2, 0.5 M 2‐amino‐2‐methyl‐1‐propanol) 
was pipetted into a 96‐well plate, and 100μl of substrate solution (5 mM 
paranitrophenylphosphate) was added per well. Subsequently, the plate was 
incubated for 1 h at 37 °C, after which the reaction was stopped by adding 100 μl of 
0.3M NaOH. Serial dilutions of 4‐nitrophenol (0–250 ng/ml) were used for making 
the standard curve. The plate was read in an ELISA reader (Bio‐Tek Instruments) at 
405 nm. ALP activity results were normalized by the amount of DNA. 
2.5 PCR array of chemokine signaling related genes 
The expression profile of chemokine signaling related genes of MSCs was analyzed 
by pathway based quantitative PCR arrays (RT2Profiler PCR arrays, Rat Chemokines 
& Receptors, no. PAMM‐022, SABiosciences) using the same RNA extration as 
described in 2.4.1. RT2 real‐time SYBR Green PCR master mix (SABiosciences) was 
applied according to the manufacturer’s instructions. The tested genes for the PCR 
array were listed in Supplementary Table 1. The protocol used for PCR array was 
95°C for 10 min, followed by 40 cycles of 95 °C for 15 sec and 60°C for 1 min. The 
data were analyzed using the SABiosciences PCR Array Data Analysis Software.
3.  Results
3.1 MSCs migration
In vitro rat MSCs recruitment was tested using a transwell system. Toluidine blue 
staining showed that chondrogenically differentiated HA/TCP‐cell constructs were 
Figure 2. Cell migration. Compared to bare-TCP scaffolds (c), chondro-TCP constructs 
(b) significantly promoted MSC migration, which resulted in a 4-fold change (p<0.05) 
of cell number across the transwell membrane (a). (staining: toluidine blue; error 
bars represent standard deviation of the mean, n=3)
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able to induce MSCs migration across the transwell membrane (Fig. 2). Compared 
to the bare‐TCP scaffolds, chondro‐TCP significantly enhanced rat MSCs migration 
(p<0.05) by 4‐fold.
3.2 Expression of osteogenic genes
The expression of osteogenic gene markers of MSCs was detected after 4 days 
of co‐culture. As shown in Fig. 3, for all detected genes, including Runx2, Col1a1, 
Alp and Bsp, there was no significant difference between MSCs co‐cultured with 
chondro‐TCP and MSCs with bare‐TCP constructs.
Figure 3. Osteogenic gene expressions of MSCs after 4 days of co-culture. 
Figure 4. ALP activity (a) and DNA content (b) of MSCs after 4 days of co-culture.
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 3.3 DNA content and ALP activity
After 4 days of co‐culture, ALP activity could be detected from MSCs which were 
co‐cultured with chondo‐TCP or bare‐TCP constructs, and the amounts were 
comparable. Similar DNA content, which is related to the cell number, was also 
shown for these two groups (Fig. 4).   
3.4 Analysis of chemokine signaling pathway
PCR array was used to identify the genes that might be involved in the behavior 
change of MSCs in response to the cartilage template. The result revealed that 
4‐day co‐culture of MSCs with chondro‐TCP resulted in the expression level 
alteration of a number of genes for MSCs (Fig. 5 and supplementary Table. 1), 
among which several chemokines, i.e. Ccl3, Ccl7, Ccl19 and Nfkb1, and receptors, 
i.e. Cxcr2 and Tlr2, were considerably up‐regulated (gene fold change > 4) (Table. 
2). 
4.  Discussion 
Although endochondral ossification approach showed significant superiority 
in generating vascularized bone for tissue engineering applications, costly and 
lengthy process for creating cartilage template hampers its translation to clinic. A 
more comprehensive understanding of the crosstalk between implanted cartilage 
Figure 5. PCR array of chemokine signaling pathway. Each square represents one 
tested gene and its color indicates the gene fold change (up- or down-regulation) of 
MSCs co-cultured with chondro-TCP compared to MSCs co-cultured with bare-TCP.
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template and host cells is essentially beneficial to possibly simplify this procedure 
or develop substitutes for effective bone regeneration. Therefore, the aim of the 
current study was to analyze the effect of cartilage template on bone marrow 
derived MSCs and also the possible signaling pathways involved in these biological 
events. 
Our results showed that cartilage templates (chondro‐TCP constructs) were 
able to induce MSCs migration when tested using a transwell culture system, 
which suggested their possible role for MSC recruitment in vivo. It is known that 
interactions of chemokines and their receptors mediate the migration of MSCs. 
Among various chemokines, stromal cell‐derived factor‐1 (SDF‐1), also known as 
CXCL12, has been reported to play a pivotal role in MSCs homing and modulating 
[8, 9]. SDF‐1 activates cell recruitment mainly through its receptor CXCR4 [10]. The 
interaction between SDF‐1 and CXCR4 also stimulates the release of matrix 
metalloproteinases (MMPs) [11, 12], which are closely involved in the remodeling of 
cartilage matrix [13]. However, in our study, the presence of chondro‐TCP constructs 
did not activate higher CXCR4 expression of the tested MSCs compared to the bare‐
TCP control. Instead, a significant up‐regulation was found for CXCR2 expression, 
the receptor of interleukin 8 (IL8), indicating that the observed MSCs migration 
might be associated with IL8 signaling. This result is supported by some previous 
investigations, which also demonstrated the effect of IL8 on MSCs homing [8, 14]. 
Overall, PCR array results demonstrated the up‐regulation of a number of 
chemokine signaling related genes, indicating MSCs were actively stimulated 
by the cartilage templates. Amongst the significantly up‐regulated genes, CCL7 
(also known as monocyte‐specific chemokine 3; MCP‐3), CCL 19 (also known as 
macrophage inflammatory protein‐3β; MIP‐3β), CCL3 (also known as macrophage 
inflammatory protein‐1α; MIP‐1α), and NF‐κB (nuclear factor kappa B) were of 
particular interest. The involvement of CCL 3, CCL7 and CCL19 in migration of 
MSCs and hematopoietic stem cells (HSCs) have been reported previously [15, 16]. 
Up‐regulation of these three genes suggested that, besides being recruited by 
Table 2. Overview of up‐ and down‐regulation of the genes in PCR array (Numbers 
indicate the gene fold change compared to the control group). 
Up-regulation (gene fold change > 2) Down-regulation (gene fold change > 2)
Ccl19 (14.5), Tlr2 (10.1), Cxcr2 (8.5), Ccl3 (8.1), Ccl7 
(7.1), Nfkb1 (4.8), Ccbp2 (3.5), Cmklr1 (2.8), Ccl6 (2.8), 
Tnf (2.7), Csf2 (2.5), Bdnf (2.3), Cxcl13 (2.3), C5 (2.2), 
Gdf5 (2.1)
Bmp10 (5.0), Il13 (2.11)
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the cartilage templates, MSCs were also stimulated to express more inducers to 
recruit additional cells participating in the successive actions. In addition to cell 
recruitment, the up‐regulated genes (CCL3, CCL19 and NF‐κB) are also closely 
related to the regulation of osteoclast functions [17‐19]. In particular, the activation 
of NF‐κB pathway, which is commonly mediated by RANKL (receptor activator of 
the NF‐ κB ligand), might significantly promote osteoclastogenesis [19]. As a result, 
the remodeling of cartilage matrix could be directly enabled. These data suggested 
that, short‐term release of soluble mediators from cartilage templates were 
able to effectively trigger a cascade of genes activations of MSCs, which would 
potentially contribute to the bone forming process by recruiting additional cells 
and regulating osteoclast activities. 
Regarding the osteogenic differentiation of MSCs, the presence of chondro‐
TCP constructs did not show any significant effects in a short term. This was 
evidenced by the PCR results that comparable osteogenic gene expressions and 
ALP activities were detected for both chondro‐TCP and bare‐TCP group after 4 
days of co‐culture. Despite all that, the cartilage templates might influence the 
osteogenic differentiation of MSCs at a later time point. As demonstrated in some 
previous studies, chondrocytes were able to significantly induce the osteogenic 
differentiation of MSCs by continuous co‐culture of 21 days [20, 21]. Another 
possibility is, the released soluble factors alone might not be sufficient to support 
osteo‐induction of MSCs. A stronger osteogenic induction for MSCs would possibly 
necessitate soluble factors in conjunction with a direct cartilage‐MSCs contact [22]. 
Some technical remarks should be made regarding the study set‐up. Although co‐
culture systems have been commonly explored in vitro to investigate the interactions 
between different cell populations in a manner of maximally simulating the in vivo 
complexity, it is still very difficult to replicate the real situation. One of the main 
concerns is the choice of co‐culture medium. Varied culture conditions, i.e. full‐ 
or half‐supplemented culture medium (chondrogenic or osteogenic), have been 
applied previously in co‐cultures studying the interaction between chondrocytes 
and MSCs [21, 23]. However, this would inevitably bring too many variables, and also 
have the risk in eliciting artificially high response of MSCs from the supplements. 
Therefore, in our study, the co‐culture was performed in a plain medium. In this 
way, the low‐serum culture condition for cartilage template could be maintained, 
and the effects of cartilage templates on MSCs could be evaluated without the 
possible disturbances from the osteogenic supplements (i.e. ascorbic acid, Na‐
β‐glycerolphosphate or dexamethasone). Nevertheless, it has also to be noted 
that such low nutrition culture condition, in some extent, might also influence 
the survival and function of both MSCs and cartilage templates. Therefore, the 
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exploration of a more suitable co‐culture condition (or system) is required for the 
future studies.
Besides the soluble mediators, follow‐up studies are warranted to investigate 
the influence of cartilage templates on MSCs in form of direct contact. Another 
limitation of our study is, the co‐culture was only performed in a short period 
due to the consideration of cell survival in the plain culture medium. Therefore, 
long‐term effect of cartilage constructs on MSCs need to be further investigated. 
Moreover, as the in vivo endochondral bone forming process involves several other 
cell types in addition to MSCs and chondrocytes, e.g. a variety of hematopoietic 
cells, a more comprehensive understanding about the interaction between 
cartilage template and other cell types is also necessary. When the crosstalk 
between implanted cartilage and host cells is thoroughly unveiled, endochondral 
bone engineering can be further simplified and more effectively applied, i.e. by 
using scaffolds loaded with biological cues that provoke host cell performance 
without implantation of exogenous cells. The data of this study represent the first 
step in this process.
5.  Conclusion
By using an indirect co‐culture system, our results demonstrated that 
chondrogenically differentiated MSC‐HA/TCP constructs (chondro‐TCP) were able 
to induce MSCs migration by possibly activating the IL8/CXCR2 signaling pathway. 
Additionally, they could activate a considerable elevation of signaling factors 
responsible for MSCs recruitment and osteoclast stimulation, including CCL3, CCL7, 
CCL19 and NF‐κB. The osteogenic differentiation of MSCs was not significantly 
influenced after short exposure to chondro‐TCP templates. This study represents 
the first step determining the possible signaling pathways through which the 
cartilage templates exert their functions in generating endochondral bone tissue. 
Continued research in this direction would open the attractive possibility for the 
development of alternative “cartilage templates” to target endochondral bone 
regeneration.   
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Supplementary Table 1: Gene table of PCR array (rat chemokines & receptors)
Position Gene 
symbol
Description Gene 
reference
Fold up- or 
down- 
regulation
A01 Aplnr Apelin receptor NM_031349 2
A02 Bdnf Brain‐derived neurotrophic factor NM_012513 2.29
A03 Cxcr5 Chemokine (C‐X‐C motif) receptor 5 NM_053303 1.85
A04 Bmp10 Bone morphogenetic protein 10 NM_001031824 ‐5.01
A05 Bmp15 Bone morphogenetic protein 15 NM_021670 2
A06 Bmp6 Bone morphogenetic protein 6 NM_013107 ‐1.62
A07 C3 Complement component 3 NM_016994 1.69
A08 C5 Complement component 5 XM_342421 2.19
A09 Ccbp2 Chemokine binding protein 2 NM_078621 3.52
A10 Ccl11 Chemokine (C‐C motif) ligand 11 NM_019205 1.2
A11 Ccl12 Chemokine (C‐C motif) ligand 12 NM_001105822 2
A12 Ccl17 Chemokine (C‐C motif) ligand 17 NM_057151 2
B01 Ccl19 Chemokine (C‐C motif) ligand 19 NM_001108661 14.48
B02 Ccl2 Chemokine (C‐C motif) ligand 2 NM_031530 2
B03 Ccl20 Chemokine (C‐C motif) ligand 20 NM_019233 1.38
B04 Ccl3 Chemokine (C‐C motif) ligand 3 NM_013025 8.13
B05 Ccl4 Chemokine (C‐C motif) ligand 4 NM_053858 1.12
B06 Ccl5 Chemokine (C‐C motif) ligand 5 NM_031116 1.7
B07 Ccl6 Chemokine (C‐C motif) ligand 6 NM_001004202 2.8
B08 Ccl7 Chemokine (C‐C motif) ligand 7 NM_001007612 7.14
B09 Ccl9 Chemokine (C‐C motif) ligand 9 NM_001012357 2
B10 Ccr1 Chemokine (C‐C motif) receptor 1 NM_020542 ‐1.15
B11 Ccr1l1 Chemokine (C‐C motif) receptor 1‐like 1 NM_001106872 ‐1.06
B12 Ccr2 Chemokine (C‐C motif) receptor 2 NM_021866 2
C01 Ccr3 Chemokine (C‐C motif) receptor 3 NM_053958 1.01
C02 Ccr4 Chemokine (C‐C motif) receptor 4 NM_133532 2
C03 Ccr5 Chemokine (C‐C motif) receptor 5 NM_053960 1.1
C04 Ccr6 Chemokine (C‐C motif) receptor 6 NM_001013145 2
C05 Ccr7 Chemokine (C‐C motif) receptor 7 NM_199489 2
C06 Ccr8 Chemokine (C‐C motif) receptor 8 XM_236704 2
C07 Ccr9 Chemokine (C‐C motif) receptor 9 NM_172329 2
C08 Ccrl2 Chemokine (C‐C motif) receptor‐like 2 NM_001108191 2
C09 Cmtm2a CKLF‐like MARVEL transmembrane domain containing 2A NM_001013142 ‐1.18
C10 Cmtm5 CKLF‐like MARVEL transmembrane domain containing 5 NM_001106034 1.99
C11 Cmklr1 Chemokine‐like receptor 1 NM_022218 2.75
C12 Cxcr7 Chemokine (C‐X‐C motif) receptor 7 NM_053352 1.37
D01 Cmtm3 CKLF‐like MARVEL transmembrane domain containing 3 NM_001106164 1.28
D02 Csf1 Colony stimulating factor 1 (macrophage) NM_023981 1.8
D03 Csf2 Colony stimulating factor 2 (granulocyte‐macrophage) XM_340799 2.5
D04 Cx3cl1 Chemokine (C‐X3‐C motif) ligand 1 NM_134455 ‐1.27
D05 Cx3cr1 Chemokine (C‐X3‐C motif) receptor 1 NM_133534 1
D06 Cxcl1 Chemokine (C‐X‐C motif) ligand 1 NM_030845 2
D07 Cxcl10 Chemokine (C‐X‐C motif) ligand 10 NM_139089 1.13
D08 Cxcl11 Chemokine (C‐X‐C motif) ligand 11 NM_182952 1.28
D09 Cxcl2 Chemokine (C‐X‐C motif) ligand 2 NM_053647 ‐1.42
D10 Pf4 Platelet factor 4 NM_001007729 1.19
D11 Cxcl5 Chemokine (C‐X‐C motif) ligand 5 NM_022214 2
D12 Ppbp Pro‐platelet basic protein (chemokine (C‐X‐C motif) ligand 7) NM_153721 1.41
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E01 Cxcl9 Chemokine (C‐X‐C motif) ligand 9 NM_145672 2
E02 Cxcr3 Chemokine (C‐X‐C motif) receptor 3 NM_053415 2
E03 Cxcr4 Chemokine (C‐X‐C motif) receptor 4 NM_022205 2
E04 Tymp Thymidine phosphorylase NM_001012122 2
E05 Epo Erythropoietin NM_017001 ‐1.05
E06 Gdf5 Growth differentiation factor 5 XM_001066344 2.14
E07 Ccr10 Chemokine (C‐C motif) receptor 10 NM_001108836 1.71
E08 Gpr77 G protein‐coupled receptor 77 NM_001003710 1.21
E09 Hif1a Hypoxia‐inducible factor 1, alpha subunit NM_024359 1.42
E10 Il13 Interleukin 13 NM_053828 ‐2.11
E11 Il16 Interleukin 16 NM_001105749 1.45
E12 Il18 Interleukin 18 NM_019165 1.25
F01 Il1a Interleukin 1 alpha NM_017019 2
F02 Il4 Interleukin 4 NM_201270 1.13
F03 Il8ra Interleukin 8 receptor, alpha NM_019310 ‐1.14
F04 Cxcr2 Chemokine (C‐X‐C motif) receptor 2 NM_017183 8.49
F05 Inha Inhibin alpha NM_012590 2
F06 Inhbb Inhibin beta‐B NM_080771 ‐1.11
F07 Lif Leukemia inhibitory factor NM_022196 2
F08 Cxcl13 Chemokine (C‐X‐C motif) ligand 13 NM_001017496 2.25
F09 Ltb4r2 Leukotriene B4 receptor 2 NM_053640 1.85
F10 Mmp2 Matrix metallopeptidase 2 NM_031054 2
F11 Mmp7 Matrix metallopeptidase 7 NM_012864 1.22
F12 Myd88 Myeloid differentiation primary response gene 88 NM_198130 1.77
G01 Nfkb1 Nuclear factor of kappa light polypeptide gene enhancer in 
B‐cells
XM_342346 4.79
G02 Rgs3 Regulator of G‐protein signaling 3 NM_019340 1.53
G03 Sdf2 Stromal cell derived factor 2 NM_001105803 2
G04 Slit2 Slit homolog 2 (Drosophila) NM_022632 1.42
G05 Tapbp TAP binding protein NM_033098 ‐1.06
G06 Tcp10b T‐complex protein 10b NM_001107461 1.4
G07 Tlr2 Toll‐like receptor 2 NM_198769 10.09
G08 Tlr4 Toll‐like receptor 4 NM_019178 1.12
G09 Tnf Tumor necrosis factor (TNF superfamily, member 2) NM_012675 2.66
G10 Tnfrsf1a Tumor necrosis factor receptor superfamily, member 1a NM_013091 ‐1.78
G11 Trem1 Triggering receptor expressed on myeloid cells 1 NM_001106885 2.46
G12 Xcl1 Chemokine (C motif) ligand 1 NM_134361 2
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1. Summary and address to the aims
Although great challenges remain, bone tissue engineering presents a promising 
strategy to replace the current autografts or allografts for the treatment of 
bone defects. The standard procedure of bone tissue engineering involves 
loading osteoprogenitor cells onto proper designed biomaterials to induce cell 
differentiation in a specific pathway, followed by transplantation of this cell‐
scaffold complex into the defect site to regenerate bone tissue. Such a construct 
aims not only to replace the injured tissue, but also to induce and direct the healing 
process, and completely restore the functions of the native tissue. So far, the most 
common approach to generate bone has largely focused on intramembranous 
ossification (i.e. bone formation through direct osteoblastic differentiation), 
however without obtaining convincing results in humans. Until recently, a new 
approach, resembling endochondral ossification, has drawn attention. With 
this approach, bone is formed via the remodeling of a cartilage intermediate. 
Compared to osteogenically differentiated cells, chondrocytes are well adapted 
to limited nutrition supply and hypoxic conditions. In addition, they can produce 
considerable amounts of angiogenic factors during differentiation. These features 
give the endochondral approach a great advantage in maintaining viability of 
the implanted cells and generating vascularized bone tissue. Yet the available 
knowledge and investigations on this endochondral approach is still in its infancy.
This thesis aimed to investigate and optimize the endochondral ossification 
approach to achieve high‐quality bone regeneration. Specifically, its applicability 
with different scaffold materials, optimal in vitro priming time, as well as the 
mechanism of the transformation from cartilage to bone, were explored in a series 
of studies. Chapter 1 gives a general introduction on bone tissue engineering and 
its essential elements, as well as the aims of this thesis. Each following chapter 
presents a separated study. This summary addresses the research questions as 
described in the first chapter in successive order.
1. What is the current state of the art of combining stem cells and biodegradable 
materials for bone regeneration via the endochondral pathway?
Thanks to the improving knowledge of stem cell sources, together with profound 
advances in materials sciences, the “engineering” of man‐made bone grafts 
appears to be increasingly feasible to target the regeneration of large bone defects. 
Chapter 2 first elaborates on bone tissue and osteogenesis mechanisms, in order to 
reach a fundamental understanding of the processes involved in tissue engineering 
approaches for bone regeneration. Next, the preliminary investigations in utilizing 
biomaterials and cell culture strategies to achieve endochondral bone formation 
were highlighted. Different cells sources, e.g. chondrocytes, MSCs and ESCs have 
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been reported to posses the ability of undergoing the endochondral differentiation 
pathway with or without specific stimulations. A variety of biomaterials, with the 
structure and composition closely mimicking the nature cartilage or bone tissue, 
are potential candidates to support the generation of osteochondral tissue, 
among which natural or synthetic polymers and ceramics are the top choices. 
The superiority of generating vascularized bone has been revealed by using the 
endochondral strategy, albeit standardization and optimization of this approach 
are essentially needed to achieve an efficient transformation from cartilage to 
bone tissue. Moreover, a number of issues still need to be addressed before a 
clinical trial can be started, including the appropriate time point for implantation, 
function and fate of implanted cells.
2. Is the porous aliphatic polyurethane/hydroxyapatite composite a suitable 
scaffold for bone tissue engineering applications?
Biomaterial scaffolds meant to function as supporting structures to osteogenic 
cells play a pivotal role in bone tissue engineering. In Chapter 3, we synthesized 
an aliphatic polyurethane (PU) scaffold via a foaming method using non‐toxic 
components. Through this procedure a uniform interconnected porous structure 
was created. Furthermore, hydroxyapatite (HA) particles were introduced into this 
process to increase the bioactivity of the PU matrix. To evaluate the biological 
performances of these PU based scaffolds, their influence on in vitro cellular 
behavior and in vivo bone forming capacity was investigated in this study. A 
simulated body fluid (SBF) test demonstrated that the incorporation of 40wt% HA 
particles significantly promoted the biomineralization ability of the PU scaffolds. 
Enhanced in vitro proliferation and osteogenic differentiation of the seeded MSCs 
were also observed on the PU/HA composite. After being implanted subcutaneously 
in a nude mice model for 8 weeks, a considerable amount of vascularized bone 
tissue with initial marrow stroma development was generated in both PU and PU/
HA40 scaffold. In conclusion, the PU/HA composite is a potential scaffold for bone 
regeneration applications.
3. Is it possible to fabricate a 3D scaffold by electrospinning technique and utilize 
it as cell carrier to enable effective in vivo endochondral bone generation?
To further explore candidate scaffolds for endochondral bone tissue engineering 
applications, in Chapter 4, a novel wet‐electrospinning system, using ethanol 
as collecting medium, was exploited to fabricate a cotton‐like poly(lactic‐co‐
glycolic acid) (PLGA)/poly(ε‐caprolactone) (PCL) scaffold. Such PLGA/PCL scaffold 
consisted of an accumulation of fibers in a very loose and uncompressed manner. 
Rat MSCs were seeded on these scaffolds and chondrogenically differentiated in 
vitro for 4 weeks followed by subcutaneous implantation in vivo for 8 weeks. Cell 
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pellets were used as a control. The glycosaminoglycan (GAG) assay and Safranin O 
staining showed that the cells infiltrated throughout the scaffolds and deposited 
an abundant cartilage matrix after in vitro chondrogenic priming. Histological 
analysis of the in vivo samples revealed extensive new bone formation through the 
remodeling of the cartilage template. In conclusion, using the wet‐electrospinning 
method, we are able to create a 3D scaffold in which bone tissue can be formed via 
the endochondral pathway. This system can be easily processed for various assays 
and histological analysis. Consequently, it is more efficient than the traditional 
cell pellets as a tool to study endochondral bone formation for tissue engineering 
purposes. 
4. Can in vivo endochondral bone generation be achieved in various scaffold 
materials?
Chapter 5 investigated the behavior of bone marrow derived mesenchymal stem 
cells (MSCs) in regard to in vitro cartilage formation and in vivo bone regeneration 
when combined with different three‐dimensional (3D) scaffold materials, i.e. 
hydroxyapatite/tricalcium phosphate (HA/TCP) composite block, polyurethane 
(PU) foam, poly(lactic‐co‐glycolic acid)/poly(ε‐caprolactone) electrospun fibers 
(PLGA/PCL) and collagen I gel. To this end, rat MSCs were seeded on these scaffolds 
followed by the same experimental procedures as described in Chapter 4. After 
in vitro chondrogenic priming, comparable cell amounts and cartilage formation 
was observed in all types of scaffolds. Nonetheless, the quality and maturity of in 
vivo ectopic bone formation appeared to be scaffold/material‐dependent. Eight 
weeks of implantation was not sufficient to ossify the entire PLGA/PCL constructs, 
albeit that a comprehensive remodeling of the cartilage had occurred. For HA/
TCP, PU and collagen I scaffolds, more mature bone formation with rich vascularity 
and marrow stroma development could be observed. These data suggest that 
chondrogenic priming of MSCs in the presence of different scaffold materials allows 
the establishment of reliable templates for generating functional endochondral 
bone tissue without using osteoinductive growth factors in vivo. The morphology 
and maturity of bone formation can be dictated by the scaffold properties. 
5. What is the effect of in vitro chondrogenic priming time of MSCs on in vivo 
endochondral bone formation? 
To enable an effective translation of this endochondral approach towards the clinic, 
it is imperative to possibly shorten the in vitro procedure for the creation of a 
cartilage template and meanwhile ensure sufficient bone formation. Therefore, in 
Chapter 6, we aimed to investigate the influence of in vitro chondrogenic priming 
time of MSCs on the in vivo endochondral bone formation, both qualitatively and 
quantitatively. To this end, rat bone marrow derived mesenchymal stem cells 
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were seeded on two scaffolds with distinguished features, i.e. a fibrous polymer‐
based PLGA/PCL scaffold or a porous ceramic‐based HA/TCP composite. Next 
the constructs were chondrogenically differentiated for 2, 3 and 4 weeks in vitro 
followed by subcutaneous implantation for up to 8 weeks. The results showed 
that, a longer chondrogenic priming time resulted in a significantly increased 
amount and homogeneous deposition of the cartilage matrix on both PLGA/
PCL and HA/TCP scaffolds in vitro. In vivo, all implanted constructs gave rise to 
endochondral bone formation, whereas the bone volume was not affected by a 
longer priming time. An unpolarized woven bone like structure, with significant 
amounts of cartilage remaining, was generated and maintained in fibrous PLGA/
PCL scaffolds, while porous HA/TCP scaffolds supported progressive lamellar‐like 
bone formation with mature bone marrow development.
6. What is the role of cartilage templates in mediating MSC behavior in the 
process of endochondral bone formation? 
Costly and lengthy process for creating cartilage templates hampers the translation 
of the endochondral approach to clinic. A more comprehensive understanding of 
the crosstalk between implanted cartilage template and host cells is essentially 
beneficial to possibly simplify this procedure or develop substitutes for effective 
bone regeneration. Therefore, in Chapter 7, the role of cartilage template in 
mediating MSC behavior in the process of endochondral bone formation was 
explored, as well as the possible signaling pathways involved in these biological 
events. By using an indirect coculture system, our results demonstrated that 
chondrogenically differentiated MSC‐HA/TCP constructs (chondro‐TCP) were 
able to induce MSCs migration by possibly activating the IL8/CXCR2 signaling 
pathway. Additionally, they could trigger a considerable elevation of signaling 
factors responsible for MSCs recruitment and osteoclast stimulation, including 
CCL3, CCL7, CCL19 and NF‐κB. The osteogenic differentiation of MSCs was not 
significantly influenced after short exposure to chondro‐TCP templates. 
2. Closing remarks and future perspectives
In the context of skeletal tissue development and repair, endochondral ossification 
has inspired a shift of the bone tissue engineering concept from the conventional 
intramembranous to the endochondral pathway. Although great challenges still 
remain before this strategy can be eventually progressed into clinical application, 
this thesis contributes to a further understanding of endochondral bone 
regeneration. Based on the obtained results, several key conclusions can be drawn:
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(i) Compared to the use of cell pellets, chondrogenic priming of bone marrow 
derived MSCs in the presence of scaffolds allows a more reliable and efficient 
establishment of templates to generate functional endochondral bone tissue in 
vivo, which can be achieved by using a variety of biomaterials. Among the tested 
scaffold materials in this thesis, collagen I hydrogel and porous calcium phosphate 
scaffold are the top choices to target a vascularized lamellar‐like bone formation 
with mature marrow development. 
(ii) By applying a chondrogenically differentiated MSC‐scaffold construct as a 
cartilage template, the essential in vitro priming time can be shortened to 2 weeks 
in order to generate a substantial amount of vascularized endochondral bone in 
vivo. This is closely contributed by the significant formation of cartilage tissue and 
expression of VEGF early to 2 weeks time point. Moreover, our data also implied 
that a certain extent of in vitro chondrogenic priming of the MSCs, possibly with 
even shorter time than 2 weeks, might be sufficient to ensure the progression 
of endochondral differentiation of the seeded cells and enable successful bone 
formation. If proved by the further investigations, this would lead to an advance 
for applying the endochondral approach in the clinical practice, as a shortened 
in vitro culture procedure would significantly reduce the treatment cost and 
regulatory burden. 
(iii) The properties of scaffold materials play an imperative role in dictating the 
progression and structure of the endochondral bone formation. Among which, 
biomaterial chemistry deeply affects the cell fate at early stages, but the internal 
architecture of the scaffolds also plays a profound role, especially in a long term, 
since it influences bone structure and its deposition kinetics. For both polymer 
(e.g. PU) and ceramic (e.g. HA/TCP) based scaffolds, a confined porous structure 
could concentrate collagen fibers and serve as a polarizing template within the 
pores to trigger the formation of lamellar like bone. On the contrary, fibrous 
scaffolds (e.g. PLGA/PCL) possessed a high level of geometrical complexity, thus 
the new collagen fibers were distributed in an isotropic manner, resulting mostly 
in woven bone.
(iv) After implantation, a cartilage template is able to exert a timely influence on 
the recruitment of the host MSCs and the promotion of osteoclastogenesis by 
activating a number of chemokine signaling related factors. Further efforts to 
determine the signaling pathways involved in endochondral bone forming process 
will possibly allow the development of alternative “cartilage templates” to target 
bone regeneration in a simple and effective manner.
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For the ultimate success of translating the endochondral bone tissue engineering 
approach to clinical practice, a number of limitations and necessary investigations 
need to be addressed. 
First of all, it is important to keep in mind that all discoveries on endochondral 
bone tissue engineering so far emerged from cell culture and animal experiments, 
which cannot be directly translated to human situation. In our studies, rat bone 
marrow derived MSCs were used as the main cell source. However, for the final 
clinical translation, there is no doubt that the efficacy of utilizing human cells to 
generate endochondral bone has to be elucidated. Another issue that needs to 
be addressed is the selection of the animal model. So far we have only tested 
the in vivo bone formation in an ectopic site of immunocompromised animals. 
By significantly reducing the number of variables involved in bone formation, this 
model allows us to obtain an easier understanding of the tendency of cartilage 
template undergoing endochondral bone formation. Still, it has to be noted 
that the conclusions need to be further evidenced in a more clinically relevant 
situation, i.e. in an orthotopic location of immunocompetent animals, where the 
mechanical load, biochemical/inflammatory factors and endogenous progenitor/
stem cells are closely involved.
Although our studies have confirmed that the design of the scaffold can drive 
the endochondral bone forming pattern, the specific parameters that dominate 
this process and its mechanism could not be thoroughly concluded due to the 
differences of the selected scaffolds regarding their chemical compositions and 
physical structures. More complete understanding could be obtained if the scaffold 
properties are more precisely controlled, e.g. all structural parameters of the 
scaffolds are kept constant and meanwhile only the composition is varied, or vice 
versa. In addition, larger‐sized scaffolds have also to be tested in future studies, 
where the cell invasion and vascularization will be more challenging. When the 
interaction between the cells and scaffold materials is unraveled, we are able to 
target endochondral bone regeneration in an efficient manner and on a larger 
scale with the help of selecting and tailoring appropriate scaffolds. 
Furthermore, because high cell density is crucial for the formation of cartilage 
templates, the clinical application of the endochondral approach by using autologous 
cells can be challenging due to the limits of such cell source or complexity of the 
in vitro cell expansion procedure, especially when a large bone defect is involved. 
At this point, the underlying mechanism about how the implanted cells induce a 
specific response of the host cells and the successive tissue regeneration is still 
largely unknown. Further investigations are warranted to elucidate the cellular 
and molecular events involved in this process before a reliable endochondral 
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therapy can be developed. More importantly, only when the crosstalk between 
the implanted cells and the host cells is thoroughly elucidated, endochondral bone 
tissue engineering can be further simplified and more effectively applied.
In summary, bone regeneration via the endochondral pathway requires a 
deliberation of many factors, including a variety of cells, matrixes, and signals, in 
an orderly temporal and spatial sequence. Although extensive efforts still have to 
be devoted, endochondral bone tissue engineering holds great promise for the 
final clinical application. The ultimate goal to implement this approach is not to 
solely replicate the natural ossification process, but to recapitulate and extract 
the essence of this process to target bone regeneration in a simple, cost‐effective 
and controllable way, e.g. by using scaffolds which releases various biological cues 
at right timing that provoke host cell performance to target endochondral bone 
formation without implantation of exogenous cells. For this to happen, a thorough 
understanding of the underlying cellular and molecular mechanism of the 
endochondral approach, including cell‐cell and cell‐matrix/material interactions, 
is required, which needs collaboration among many disciplines, including cell and 
molecular biology, material science, pharmacology, chemistry and medicine.

Chapter 9
Samenvatting, slotopmerkingen 
en toekomstperspectieven
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1. Samenvatting en evaluatie van de doelstellingen
Hoewel er nog veel uitdagingen overwonnen moeten worden, is 
botweefselengineering een veelbelovende aanpak om de huidige 
behandelmethoden via autologe of allogene bottransplantatie te vervangen. De 
standaardprocedure die gebruikt wordt bij botweefselengineering is het laden van 
osteogene voorlopercellen op biomaterialen die de differentiatie van cellen in een 
specifieke richting sturen, gevolgd door de implantatie van deze constructen in 
het lichaam. Een dergelijke aanpak beoogt niet alleen het beschadigde weefsel 
te vervangen, maar induceert en dirigeert ook het genezingsproces om tot een 
volledige genezing van het aangedane weefsel te komen. De huidige methoden 
om bot te genereren zijn grotendeels gericht op intramembraneuze ossificatie 
(d.w.z. botvorming via osteoblast differentiatie), vooralsnog is de werking van deze 
methode echter nog niet op overtuigende wijze resultaat getoond bij mensen. 
Recentelijk heeft een nieuwe aanpak, gebaseerd op endochondrale ossificatie, de 
aandacht getrokken. Deze aanpak richt zich op het vormen van bot door middel van 
kraakbeen. Vergeleken met osteogeen gedifferentieerde cellen zijn chondrocyten 
goed aangepast aan hypoxische condities met daarbij een beperkt aanbod 
van nutriënten. Bovendien produceren chondrocyten tijdens de differentiatie 
aanzienlijke hoeveelheden angiogene factoren. Door deze eigenschappen heeft 
de endochondrale aanpak een groot voordeel bij het levensvatbaar houden van 
de geïmplanteerde cellen en het genereren van gevasculariseerd botweefsel. 
Het onderzoek en de beschikbare kennis over de endochondrale methode staan 
echter nog in de kinderschoenen. 
Het onderzoek beschreven in dit proefschrift heeft als doel om botvorming via 
de endochondrale methode te optimaliseren en zodoende een hoge kwaliteit 
botherstel te bereiken. Meer specifiek werd daarbij in verschillende studies de 
toepasbaarheid van verschillende scaffold materialen, optimale in vitro kweektijd 
en het mechanisme van de omzetting van kraakbeen naar bot onderzocht. 
Hoofdstuk 1 geeft een algemene inleiding over botweefselengineering, daarnaast 
bevat dit hoofdstuk de doelstellingen van dit proefschrift. Elk volgend hoofdstuk 
beschrijft een deelonderzoek. In deze samenvatting worden de vraagstellingen 
zoals beschreven in het eerste hoofdstuk in opeenvolgende volgorde behandeld. 
1. Wat is de huidige stand van de techniek van het combineren van stamcellen 
en biologisch afbreekbare materialen voor botherstel via de endochondrale 
route? 
Dankzij verbeterde kennis over de bronnen van stamcellen, samen met een brede 
vooruitgang in de ontwikkeling van materialen, lijkt het erop dat “engineering” 
in toenemende mate toepasbaar is voor het regenereren van grote botdefecten. 
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Hoofdstuk 2 gaat eerst dieper in op de eigenschappen en mechanismen van 
botweefsel en osteogenese, om zo een fundamenteel begrip van de betrokken 
processen te verkrijgen. Vervolgens worden de in de literatuur beschreven 
onderzoeken over de toepassing van biomaterialen en celcultuur strategieën om 
endochondrale botvorming te verkrijgen toegelicht. Van verschillende type cellen, 
waaronder chondrocyten, MSCs en ESCs, is het bekend dat ze het vermogen bezitten 
om endochondrale differentiatie te ondergaan, met of zonder specifieke stimulatie. 
Verschillende biomaterialen, met een structuur en samenstelling die nauwkeurig 
de aard kraakbeen of botweefsel nabootsen, zijn potentiële kandidaten voor de 
vorming van osteochondrale weefsels. Natuurlijke of synthetische polymeren en 
keramische materialen zijn daarbij de belangrijkste kandidaten. De mogelijkheid 
tot het genereren van gevasculariseerd bot is aangetoond via de endochondrale 
methode, hoewel er standaardisatie en optimalisatie nodig zal zijn om voor een 
efficiënte omzetting van kraakbeen naar botweefsel te zorgen. Voordat een 
klinische test uitgevoerd kan worden moeten bovendien nog een aantal zaken 
uitgezocht worden, waaronder het juiste tijdstip voor de implantatie, de functie 
en het lot van de geïmplanteerde cellen.
2. Is het poreuze alifatische polyurethaan/hydroxyapatiet composiet een 
geschikte scaffold voor botweefselengineering toepassingen? 
Biomaterialen met als doel  te functioneren als ondersteunende structuur voor 
osteogene cellen spelen een centrale rol in botweefselengineering. In hoofdstuk 
3 beschrijven we hoe een alifatische polyurethaan (PU) schuim gesynthetiseerd 
werd met behulp van niet‐giftige bestanddelen. Via deze procedure werd een 
uniforme poreuze structuur gecreëerd, waarbij de holtes in de structuur onderling 
verbonden waren. Bovendien werden hydroxyapatiet (HA) deeltjes aan dit 
proces geïntroduceerd om de bioactiviteit van de PU matrix te verhogen. Om de 
biologische prestaties van deze PU scaffolds te evalueren, werd hun invloed op het 
cellulaire gedrag in vitro en de bot vormende capaciteit in vivo onderzocht. Een 
test met “simulated body fluid” (SBF) toonde aan dat het inbedden van 40 gew% 
HA deeltjes het vermogen tot biomineralisatie significant verhoogde. Verbeterde 
cel proliferatie en osteogene differentiatie van de gekweekte MSCs werden 
waargenomen op de PU/HA composiet. Na subcutane implantatie in een naakte 
muis model voor 8 weken, werd een aanzienlijke hoeveelheid gevasculariseerd 
botweefsel en beenmerg ontwikkeling gegenereerd bij zowel de PU als de PU/
HA40 scaffolds. De conclusie is dat het PU/HA composiet materiaal veel potentiee 
heeft voor botregeneratieve toepassingen. 
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3. Is het mogelijk om een 3D-scaffold te fabriceren via elektrospinning en deze te 
gebruiken als een drager materiaal voor de cellen om in vivo endochondrale 
bot generatie effectief mogelijk te maken? 
Om verder te onderzoeken welke scaffolds geschikt zijn voor endochondrale 
botweefselengineering toepassingen, is in hoofdstuk 4 beschreven hoe een 
nieuwe natte‐elektrospin techniek werd ingezet. Hierbij werd gebruik gemaakt 
van ethanol als medium om de vezels in te verzamelen. Via deze methode werd 
een katoenachtige poly (melkzuur‐co‐glycolzuur) (PLGA)/poly (ε‐caprolacton) 
(PCL) scaffold gefabriceerd, bestaande uit een opeenstapeling van vezels op 
een zeer losse ongecomprimeerde wijze. Op deze scaffolds werden vervolgens 
ratten beenmergcellen gezaaid en deze werden chondrogeen gedifferentieerd 
in vitro gedurende 4 weken, gevolgd door subcutane implantatie in vivo voor 
8 weken. Daarbij werden cel pellets gebruikt als controle. De analyse van 
glycosaminoglycaan (GAG) en safranine O kleuring toonde aan dat na in vitro 
chondrogene priming de cellen de gehele matrix hadden geïnfiltreerd en daarbij 
een overvloedige kraakbeenmatrix hadden gedeponeerd. Histologische analyse 
van de in vivo constructen demonstreerde uitgebreide nieuwe botvorming door 
hermodellering van het kraakbeen. Samenvattend, gebruik makend van de natte 
electrospinning methode, kunnen wij een 3D scaffold creëren die helpt om via 
de endochondrale route bot te vormen. Dit systeem leent zich uitstekend voor 
analyse met verschillende assays en histologische analyse. Daarom is dit systeem 
efficiënter voor het bestuderen van weefselregeneratie via de endochondrale 
methode dan het gebruik van de traditionele cel paletten. 
4. Kan via de endochondrale route bot worden gevormd in verschillende 
materialen? 
In hoofdstuk 5 wordt het gedrag van mesenchymale stamcellen (MSCs) uit het 
beenmerg onderzocht met betrekking tot de in vitro vorming van kraagbeen en 
in vivo botregeneratie in combinatie met verschillende driedimensionale (3D) 
materialen, waaronder: hydroxyapatiet/tricalciumfosfaat (HA/TCP), polyurethaan 
(PU) schuim, poly (melkzuur‐co‐glycolzuur)/poly (ε‐caprolacton) vezels (PLGA/
PCL, bereid via electrospinning)  en collageen‐I gel. Hiertoe werden ratten MSCs 
gezaaid op deze scaffolds gevolgd door dezelfde experimentele procedure als 
beschreven in hoofdstuk 4. Vergelijkbare hoeveelheden cellen en kraakbeen 
werden waargenomen na in vitro chondrogene priming voor alle soorten scaffolds. 
Toch leek de kwaliteit en de maturatie van het in vivo ectopische gevormde bot 
materiaal afhankelijk. Een implantatietijd van acht weken was niet voldoende om 
de volledige PLGA/PCL constructen te ossificeren, maar het kraakbeen was wel 
duidelijk geremodelleerd. Voor de HA/TCP, PU en collageen I scaffolds, werd een 
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meer volwassen botvorming met rijke vascularisatie en beenmerg ontwikkeling 
waargenomen. Deze gegevens suggereren dat chondrogene priming van MSCs in de 
aanwezigheid van verschillende scaffold materialen het genereren van functioneel 
botweefsel via de endochondrale route zonder osteoinductie groeifactoren in vivo 
mogelijk maakt. De morfologie en de maturatie van botvorming worden mede 
gedicteerd door de eigenschappen van het scaffold materiaal.
5. Wat is het effect van in vitro chondrogene priming van de MSCs op in vivo 
endochondrale botvorming? 
Om een effectieve behandeling van deze endochondrale aanpak klinisch mogelijk 
te maken, is het noodzakelijk om de in vitro procedure voor het fabriceren van een 
kraakbeen substraat zo kort mogelijk te houden en ondertussen te zorgen voor 
voldoende botvorming. In hoofdstuk 6 is daarom onderzocht wat de invloed is 
van de in vitro chondrogene primings tijd van MSCs op de in vivo endochondrale 
botvorming, zowel kwalitatief als kwantitatief. Hiervoor werden van ratten MSCs 
gezaaid op twee scaffolds met verschillende kenmerken; een vezelachtige PLGA/
PCL polymeer of een poreuze keramische, HA/TCP composiet. Vervolgens werden 
de constructen voor 2, 3 of 4 weken chondrogeen gedifferentieerd in vitro, gevolgd 
door subcutane implantatie tot 8 weken. De resultaten toonden aan dat een langere 
chondrogene primings tijd resulteerde in een significant verhoogde hoeveelheid 
afzetting van kraakbeenmatrix voor zowel de PLGA/PCL en HA/TCP materialen 
in vitro. In vivo, gaven alle geïmplanteerde substraten uiteindelijk aanleiding tot 
endochondrale botvorming, terwijl het bot volume niet werd beïnvloed door een 
langere priming tijd. Een ongepolariseerde gewoven bot structuur, waarbij nog 
aanzienlijke hoeveelheden kraakbeen zichtbaar waren, werd gegenereerd bij de 
vezelachtige PLGA/PCL scaffolds, terwijl de poreuze HA/TCP scaffolds lamellair‐
achtige botvorming met een rijpere beenmerg ontwikkeling ondersteunden. 
6. Op welke wijze beïnvloeden kraakbeen substraten het gedrag van MSCs 
tijdens het endochondrale proces? 
Een kostbaar en langdurig proces voor het maken van kraakbeen substraten 
belemmert de klinische haalbaarheid van de endochondrale methode. Een 
completer begrip van de communicatie tussen het geïmplanteerde kraakbeen 
substraat en de cellen van de ontvanger is noodzakelijk om deze methode verder 
te verbeteren. Daarom is in hoofdstuk 7 de invloed van het kraakbeen substraat 
op het gedrag van MSCs tijdens endochondrale botvorming onderzocht en werd 
daarnaast onderzocht welke biologische signalen mogelijk betrokken zijn bij dit 
proces. Door gebruikt te maken van een indirect cocultuur systeem, toonden 
onze resultaten aan dat chondrogeen gedifferentieerde MSC‐HA/TCP substraten 
(chondro‐TCP) migratie van MSCs mogelijk veroorzaken door het activeren van het 
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IL8/CXCR2 signaal transductie route. Daarnaast werd een aanzienlijke verhoging van 
de signalerings factoren, zoals CCL3, CCL7, CCL19 en NF‐kB, die verantwoordelijk 
zijn voor het rekruteren van MSCs en het stimuleren van osteoclasten gevonden. 
De osteogene differentiatie van MSCs werd niet significant beïnvloed na korte 
blootstelling aan de chondro‐TCP templates. 
2. Slotwoord en toekomstperspectieven 
In het kader van de ontwikkeling van het skelet en weefselherstel, inspireert de 
endochondrale ossificatie een verschuiving in de botweefselengineering van de 
conventionele intramembraneuze naar de endochondrale route. Hoewel er nog 
steeds grote uitdagingen voordat deze strategie uiteindelijk kan worden toegepast 
in de kliniek, draagt dit proefschrift bij aan een beter begrip van het endochondraal 
botherstel. Op basis van de verkregen resultaten kan een aantal belangrijke 
conclusies worden getrokken: 
(i) In vergelijking met het gebruik van celpellets, biedt chondrogene priming 
van MSCs uit het beenmerg in de aanwezigheid van materialen veel voordelen 
waaronder het creëren van een betrouwbaar en efficiëntesubstraat dat via de 
endochondraal route botweefsel kan genereren. Dit kan worden bereikt worden 
met een verscheidenheid aan biomaterialen. Onder de in dit proefschrift geteste 
materialen geven collageen‐I hydrogelen en poreus calciumfosfaat de beste 
resultaten om een gevasculariseerd lamellair‐achtige botvorming met volwassen 
beenmerg ontwikkeling te verkrijgen. 
(ii) Door gebruik te maken van een construct met chondrogeen gedifferentieerde 
MSCs als een kraakbeen substraat, kan de essentiële in vitro priming tijd om 
een aanzienlijke hoeveelheid gevasculariseerde bot te genereren verkort 
worden tot 2 weken. Dit was duidelijk zichtbaar door de aanzienlijke vorming 
van kraakbeenweefsel en de expressie van VEGF binnen 2 weken. Bovendien, 
suggereren de gegevens ook dat eventueel een nog kortere primings tijd dan 2 
weken, kan volstaan voor voldoende chondrogene differentiatie van de gezaaide 
cellen en uiteindelijk dus botvorming. Als dit inderdaad bewezen wordt door de 
verdere onderzoeken, zou dit een groot voordeel zijn voor de toepassing van 
de endochondrale aanpak in de klinische praktijk, omdat de verkorte in vitro 
cultuur tijd de kosten en administratieve lasten van de behandeling aanzienlijk 
verminderen. 
(iii) De eigenschappen van scaffold materialen spelen een belangrijke rol in het 
dicteren van de progressie en de structuur van de endochondrale botvorming. 
De chemische eigenschappen van het biomateriaal spelen vooral een rol op de 
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korte termijn, terwijl de interne structuur ervan meer invloed heeft op de lange 
termijn aangezien het de botstructuur en de depositie kinetiek beïnvloedt. Voor 
zowel polymeren (bijv. PU) als keramiek (bijv. HA/TCP) gebaseerde scaffolds, kan 
een structuur met kleine poriën collageenvezels concentreren en dienen als een 
polariserend sjabloon in de poriën en zo de vorming van lamellair bot induceren. 
Vezelige scaffolds (bijv. PLGA/PCL) daarentegen bezitten een hoge geometrische 
complexiteit, waardoor de nieuwe collageen vezels zich op een isotrope manier 
verspreiden, wat meestal leidt tot gewoven bot. 
(iv) Na implantatie is een kraakbeen substraat in staat om invloed uit te oefenen 
op de MSCs van de ontvanger en zo osteoclast vorming te induceren door het 
activeren van een aantal aan chemokines gerelateerde factoren. Verdere studies 
om meer begrip te krijgen voor de signaal routes betrokken bij endochondrale 
botvorming, kunnen mogelijk de ontwikkeling van alternatieve “kraakbeen 
substraten” naar botregeneratie vereenvoudigen en efficiënter maken.
Om de endochondrale aanpak voor botweefselengineering succesvol toe te passen 
in de klinische praktijk, moeten nog een aantal hordes genomen worden. Allereerst 
is het van belang om in het achterhoofd te houden dat alle resultaten m.b.t. de 
endochondrale methode zijn voortgekomen uit celkweek en dierproeven. Deze 
resultaten zijn dus niet direct te vertalen naar menselijke situaties. In onze studies 
bijvoorbeeld, werden MSCs gebruikt verkregen uit het beenmerg van ratten. Er is 
geen twijfel over dat voor de uiteindelijk klinische toepassing de effectiviteit van 
het gebruik van menselijke cellen opnieuw zal moeten worden opgehelderd. Een 
ander probleem dat moet worden aangepakt is de selectie van het diermodel. 
Tot dusver hebben we alleen de in vivo botvorming op een ectopische plaats 
van immunogecompromitteerde dieren getest. Dit model werkt door het aantal 
variabelen betrokken bij botvorming aanzienlijk te verminderen, waardoor er 
gemakkelijker er een simpelere vertaling is van de overgang van kraakbeen 
substraat naar bot . Daarom moeten de uitkomsten getoetst moeten worden in een 
klinisch relevante situatie, dwz een orthotopische locatie in immunocompetente 
dieren, waarbij de mechanische belasting, biochemische/ontstekingsfactoren en 
stamcellen nauw betrokken zijn. 
Hoewel onze studies hebben bevestigd dat de structuur van de scaffolds het 
patroon van botvorming kunnen beïnvloeden, is het moeilijk een uitspraak te doen 
over het precieze mechanisme daarvan. De chemische en fysische eigenschappen 
van de gebruikte scaffolds verschilden daarvoor teveel. Om dit beter te kunnen 
onderzoeken is het nodig om een serie materialen te ontwikkelen waarbij telkens 
slechts een parameter (fysisch, chemisch, enz) gevarieerd wordt. Daarnaast 
is het belangrijk om grotere scaffolds te testen, omdat de invasie van cellen en 
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vascularisatie een grotere uitdaging zal zijn. Wanneer de interactie tussen de cellen 
en scaffold materialen is ontrafeld, is het mogelijk om op efficiëntere en grotere 
schaal endochondrale botregeneratie toe te passen mede door het gebruikt van 
afgestemde materialen. 
Een hoge celdichtheid is cruciaal is voor de vorming van de kraakbeen substraten, 
dit kan de klinische toepassing van de endochondrale benadering met autologe 
cellen uitdagend maken. De beschikbaarheid van deze cellen kan dan een 
beperkende factor worden, zeker wanneer het om een groot botdefect gaat. Op dit 
moment is het onderliggende mechanisme van het door de geïmplanteerde cellen 
induceerde reactie op de gastheercellen en de opeenvolgende weefselregeneratie 
nog grotendeels onbekend. Verder onderzoek is nodig om de cellulaire en 
moleculaire gebeurtenissen die betrokken zijn bij dit proces op te helderen, voordat 
een betrouwbare endochondrale therapie kan worden ontwikkeld. Belangrijker 
nog, is het begrijpen van de communicatie tussen de geïmplanteerde cellen en 
de gastheercellen, alleen wanneer dit tot in detail begrepen is kan endochondrale 
botweefselengineering verder worden vereenvoudigd en efficiënter worden 
toegepast. 
Samengevat, botherstel via de endochondrale route vereist begrip van vele 
factoren, waaronder een groot aantal verschillende cellen, matrices en signalen. 
Hoewel er nog grote inspanningen verricht moeten worden, houdt endochondrale 
botweefselengineering een grote belofte in voor klinische toepassing. Het 
uiteindelijke doel van deze aanpak is niet alleen het kopiëren van het natuurlijke 
ossificatieproces, maar ook het recapituleren van de essentie van dit proces op 
een simpele en kosten efficiënte manier. Dit kan bereikt worden door scaffold 
materialen die op het juiste moment de juiste biologische signalen afgeeft om 
endochondrale botvorming te verkrijgen zonder implantatie van cellen. Om dit 
te kunnen realiseren is een grondig begrip nodig van de onderliggende cellulaire 
en moleculaire mechanismen van de endochondrale route, met inbegrip van 
cel‐cel en cel‐matrix/materiaal interacties. Dit vereist de samenwerking van 
vele disciplines, met inbegrip van cel‐ en moleculaire biologie, materiaalkunde, 
farmacologie, chemie en geneeskunde.
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